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Microfluidics for Assisted Reproductive Technologies 
 
1.1 Introduction 
Infertility affects almost 10% of couples in the United States and the causes are 
roughly equal between male and female derived infertility
1
. As reproduction is a 
major quality of life issue: there is a large motivation for the advancement of assisted 
reproductive technology. Although a relatively new field, microfluidics has already 
demonstrated the benefits of automation, consistency, sensitivity, and precision to the 
field of assisted reproductive technologies (ARTs). Efforts in this field utilize the 
high-throughput nature of microfluidics as well as the potential to perform highly 
sensitive non-destructive tests for gamete/embryo quality to overcome some of the 
toughest and most laborious challenges faced by assisted reproductive technologies. 
 One of the most common benefits of microfluidics is its cost efficiency due to 
the low amounts of materials used, however in the field of ART, this benefit is of 
secondary importance. The advantage of highly accurate high-throughput gamete 
sorting and the identification of the most suitable male and female gamete to use for 
fertilization justify the use of microfluidics even if it were more expensive to operate.  
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 Male gamete quality assessment chips typically operate at a relatively high-
throughput range due to the large quantities of available material, while female 
gamete quality assessment chips are the complete opposite in terms of sorting speed 
as the low amounts of available sample justify the use of sophisticated biophotonic 
non-destructive tests of gamete quality. Fertilization-on-chip devices either mimic 
existing ART techniques or incorporate selectivity barriers within the microfluidic 
device based on sperm motility to mimic the motility selection of the uterus and 
fallopian tube.  
Cryopreservation has been key to increasing the efficiency of fertility 
treatments in ART. Cryopreservation devices focus on reducing osmotic stress 
particularly for vitrification where concentrations of cryoprotectant agents (CPA) are 
particularly high. Microfluidic cryopreservation devices also reliably standardize the 
vitrification protocol with precision and accuracy to the fluid transfer of the CPA 
exchange: addressing the large unknown that is the variable fluid behavior in current 
manual pipetting even within the best trained and skilled personnel.  
Microfluidic embryo cultures have also employed biomimicry of the fallopian 
tubes in multiple strategies to assist embryos into developing with superior 
developmental competence. Such strategies include mimicry of the mechanical 
stimulation provided by fallopian tube flow as well as the recirculation of secreted 
factors that chemically stimulate embryo growth. As developmental competence 
increases with technological advancement of each stage whether using conventional 
clinical lab techniques or lab on a chip (LOC) techniques, it is increasingly more 
sensible and feasible to perform single embryo transfers (SETs). The chances of 
multiple births, typically an unfavorable outcome, exponentially decrease with each 
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embryo transferred beyond one. It is therefore paramount in this stage to select the 
best embryo to transfer as to maximize the chance of a successful SET. To address 
this issue, multiple non-destructive tests have been developed to determine embryo 
quality after embryo culture and these include advanced spectroscopy techniques that 
directly examine the embryo, indirect metabolite analysis of spent culture media as 
well as real-time embryo development monitoring combined with predictive 
algorithms for selecting the best embryo for. 
 
1.2 Gamete Manipulations 
Gamete manipulations using lab-on-a-chip technologies focus on non-destructive 
quality analysis of sperm and oocytes. Andrology strategies take advantage of the 
high-throughput characteristics of microfluidics due to the high number of gametes 
available and are particularly useful for individuals with low numbers of viable sperm. 
On the contrary, gynecology strategies focus on in-depth analysis due to the limited 
number of gametes and the high importance of oocyte quality on subsequent embryo 
development. Despite the widespread acceptance that morphology is a poor indication 
of future developmental success
2
, it is still the primary measure of quality. Female 
lab-on-a-chip devices employ the precision and accuracy provided by microfluidic 
devices to develop more sophisticated measures of oocyte quality assessment.  
Male gamete sorting 
The determination of viability for sperm is rather simple as the sole concern is DNA 
integrity as advanced assisted reproductive technologies such as intracytoplasmic 
sperm injection (ICSI) is capable of overcoming numerous infertility issues that 
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complicate natural conception. Intracytoplasmic sperm injection is such a powerful 
technique that it is possible to use dying or even dead sperm to achieve fertilization. 
However, it is well known that the use of dead or dying sperm for ICSI results in 
adverse outcomes including low fertilization, poor embryo development, high 
abortion rates, and prevalent childhood diseases
3
. Due to the large number of sperm 
available, it is rare that live and motile sperm cannot be found even if in low number 
for the majority of male infertility cases. As ICSI only requires a single viable sperm 
and the significant adverse result of using dead or dying sperm, the first conventional 
sorting criterion is that the sperm be motile: evidence that it is alive. The second 
criterion is that it has normal morphology in the absence of defects such as multiple 
heads, multiple tails, large or small heads, or abnormal mid-sections. Such defects in 
morphology indicate defected genotype on which it is based and are discarded during 
conventional sperm sorting. 
For lab-on-a-chip applications, mobility provides a simple mechanism for 
separation as non-motile sperm and debris are incapable of crossing streamlines in 
laminar flow regime. The enclosed system of microfluidic devices as well as the high 
level of fluid control allow sorting of non-motile sperm and debris with high accuracy 
and at high-throughput speeds. Conveniently for microfluidic applications, the second 
conventional criterion for sorting: abnormal morphology also often affects motility. 
When designing the microfluidic device with high safety factors (where only highly 
motile sperm are selected), the device would also eliminate abnormal albeit motile 
sperms simultaneously from the sample.  
One passively driven microfluidic device to sort sperm by motility used 
gravity to create two streams flowing in a laminar regime
4
 (Fig. 1.1). It relies on the 
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motile sperm’s ability to cross enough streamlines by traveling in the transverse 
direction to flow. The passive flow of the microfluidic device delivers the sperm to 
the collection chamber separate from the waste collection chamber. Viable sperm 
sorted into the collection chamber can then be collected for ICSI. The continuously 
separating nature of the microfluidic device allows for reasonable volumes of sample 
to be sorted for easy identification of viable sperm even in cases of severe male 
infertility.   
In another example, a microfluidic device with a long hydrostatic channel 
connected to a detection cuvette allowed for the screening of male subfertility with 
the staining of sperm with calcein-AM
5
 (Fig. 1.2a-b). The long hydrostatic channel 
served as a selective barrier for motile sperm: allowing only the sperm of healthy 
motility to traverse the long distance to reach and populate the detection cuvette (Fig. 
1.2c-f). The fluorescence profile is monitored by microfluorometer over a 50 minute 
period (Fig. 1.2g-h). As the detection cuvette is populated by more sperm, the 
fluorescence from the combined calcein-AM increases the fluorescence intensity 
proportionally to the number of sperm in the detection cuvette over time. This 
fluorescence profile of each sample can then be screened relative to a reference 
sample to determine their subfertility level. The device, being small and disposable, 
has shown promise as an accurate in-home screening technique for male subfertility. 
It was a microfluidic study that definitively demonstrated that sperm behave 
predictably in certain well defined flow conditions. The study determined that the 
sperm would tend to either swim towards or against flow depending on the intensity 
of the flow velocity
6
. This device demonstrated the predictability of this behavior and 
applied it to separate, align, and orient sperm of mouse, bull, and human species. 
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 One recent advancement of note in male infertility microfluidic devices 
employ an integrated charge-coupled device (CCD) to the microfluidic device to 
provide a wide field of view to sort and track sperm populations
7
 (Fig. 1.2i) The 
sophisticated automated sperm monitoring algorithm is capable of determining sperm 
average velocity, straight line velocity, straightness of swim path, and average 
acceleration. The attention given by the software to each individual sperm provides 
the capability to identify the most motile sperm, which by conventional wisdom is the 
healthiest, for potential applications in ICSI. Such detailed quantification of sperm 
quality eliminates the arbitrary elements of conventional sperm selection when there 
are numerous viable sperm available.  
Even more recent advances in sperm quality assessment by microfluidic 
devices include a device that quantifies both sperm concentration and motile 
percentage
8
 (Fig. 1.3a-i).  The device uses a microfluidic component for the 
separation of motile sperm of similar mechanisms as its predecessors and is designed 
to be centrifuged to sediment the sperm sample for quantification. Concurrently, a 
sophisticated method for quantifying human sperm quality was developed using a 
microfluidic resistive pulse technique (RPT)
9
. The change in current over time from 
the resistive properties of the sperm is measured as it travels along a long narrow 
aperture where the voltage is applied. The signal profile can be easily analyzed for the 
sperm’s swimming behavior in terms of beat frequency and swim velocity as well as 
the sperm’s volume. Such proposed techniques offer economic advances to 
comparable sperm analysis provided by conventional computer assisted sperm 
analysis (CASA).  
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 The latest microfluidic assay for determining sperm DNA integrity 
demonstrates strong evidence that sperm motility is a strong indication of high 
chromatin and DNA integrity
10
 (Fig. 1.3j). The device is capable of using raw semen 
and uses a viscoelastic medium and long hydrostatic channels that mimic the motility 
selection process of the female reproductive tract. The length of the device can be 
adjusted according to the subfertility of the sample for an optimal level of motility-
based sorting. 
 Although not strictly lab-on-a-chip, fluorescence activated cell sorting (FACS) 
uses a cytometer in combination with DNA-binding dyes and fluorescence detection. 
It has been used for detecting minute differences in fluorescence signal originating 
from a 3.8% difference in total DNA content between X and Y chromosome bearing 
bovine spermatozoa
11
 (Fig. 1.4). When the difference in DNA content is detected, an 
applied electric field sorts the droplet containing the spermatozoa into X and Y 
chromosome bearing bins. The system can reach up to 25,000 individual spermatozoa 
per second and is useful in agricultural industries. However it is known that high 
shear stress and high voltage cause extensive DNA fragmentation
12, 13
. This is a 
concern that should not be ignored as both high shear stress and voltage exist in the 
cytometer and sorting region of FACS. 
Female gamete quality assessment 
Oocyte quality is a large factor that affects later developmental success during and 
after fertilization. Despite the importance of oocyte selection, especially for SETs, the 
determination of oocyte quality is typically based on highly subjective morphological 
properties. However, a more sophisticated analysis of oocyte quality must not 
compromise the quality of the oocyte as it needs to be retrieved for further use. As 
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such, there are significant challenges in developing the appropriate tools to probe the 
oocyte for a quantitative analysis of its quality. 
 One such microfluidic device that studied this problem developed an optical 
solution to study the refractive index and optical absorption of the oocyte to determine 
its maturity as well as a microindentor to measure the hardness and reduced Young 
modulus of the oocyte: a tool that can be used for further study of the oocyte
14
 (Fig. 
1.5e-f). The optical probe was capable of detecting a significant difference in 
absorption spectra between mature and immature oocytes. This development provides 
a solution to alleviate some of the subjectivity that exists in oocyte selection for ART. 
 During common ART procedures such as in vitro maturation (IVM), in vitro 
fertilization (IVF) and in vitro embryo culture (IVC), the oocyte or zygote undergoes 
a process where its cumulus cells are removed, sometimes called denuding. The most 
common form of denuding requires a technician to repeatedly flush the cumulus 
oocyte complex (COC) into and out of a narrow pipette tip. Such a procedure is 
known to cause high mechanical stress
15
. As such, a novel micromanipulation device 
was designed using the precise control provided by microfluidics. The device is 
capable of reorienting the cumulus into a ring around a zygote. The cumulus ring 
surrounding the zygote is then attached to a removal port, which combined with the 
suction from an adjacent port, rotates the COC to remove the ring: leaving the 
denuded zygote with less mechanical stress
16
 (Fig. 1.5a-d). The ability to precisely 
control the zygote position by device geometry and fluid control enable predictable 
and reliable cumulus removal. 
 Recent advances in microelectromechanical systems (MEMS) for ART 





. Enucleation is a process where the nucleus is removed from the 
cell body: a key component in the cloning process. Such a technique is normally 
performed by highly trained technicians but typically still suffers from low success 
rates and repeatability. The use of this device overcomes limitations of conventional 
enucleation by providing precision and reproducibility. The group also demonstrated 
the combination of MMT with ultrasonic vibration doubled the output force of the 
MMT to improve the positioning accuracy by 100-fold
18
 (Fig. 1.6). 
 Optofluidic devices are a specialized research field that combines microfluidic 
and optics designs. One such optofluidic device was developed using optical ablation 
for microsurgery of oocytes
19
. While microfluidic channels have been shown to be 
effective at cell positioning as well as long-term and real-time monitoring, optical 
ablation is an effective noninvasive method to destroy intracellular organelles. Such 
microsurgery techniques are a valuable tool that can provide insight about the 
functions of the organelle and developmental repercussions for damaged oocytes.  
 
1.3 In Vitro Fertilization 
There are two prevalent methods of fertilization in ART that are modified in lab-on-a-
chip devices. The first method is the use of fertilization medium and conventional 
insemination with sperm and the default method of IVF. However if it is deemed that 
conventional insemination is likely to be unsuccessful, ICSI will be used in ART. The 
conventional insemination IVF technique is relatively simple where medium 
containing washed sperm is mixed and incubated with medium containing oocytes. A 
sperm will make contact with oocyte where it penetrates the zona pellucida as it 
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would naturally for fertilization. The second method is ICSI, a powerful technique 
that overcomes numerous male and female infertility challenges. Intracellular sperm 
injection overcomes many stages of fertilization where complications may occur by 
assisting the sperm in penetrating the egg through direct injection of the sperm into 
the egg cytoplasm. 
There have been a significant amount of microfluidic fertilization devices that 
enhances the conventional insemination and IVF technique. Depending on the design, 
it can boast higher fertilization efficiency with lower total number and concentrations 
of sperm needed. The device can also increase primary outcomes by lowering 
instances of polyspermic penetration compared to conventional fertilization medium.  
One such IVF microfluidic device was designed using 
polydimethylsiloxane(PDMS)/borosilicate material and was driven passively by 
hydrostatic pressure
20
 (Fig. 1.7a). The device employed a now commonly used weir-
type trap design for oocytes while sperm are allowed to flow through the device. This 
device demonstrated that by limiting the time the oocytes were exposed to the sperm, 
as the sperm had a limited chance to penetrate the oocyte as the flowed by, the device 
design allowed for significantly lower rates of polyspermy. 
Another device of similarly inspired weir-type design focused its study on 
low-sperm count fertilization. The device demonstrated that although the rate of 
fertilization decreases in a microfluidic device for high sperm count samples, the 
microfluidic device was effective at significantly increasing the fertilization rate of 
low sperm count samples
21
 (Fig. 1.7b).  This result is primarily due to the geometry 
and scale of the microfluidic device that increases the effective concentration of 
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sperm in the area surrounding the oocyte thus greatly increasing the chances of 
fertilization. 
More sophisticated devices later emerged that also used weir-type traps to 
individually compartmentalize oocytes within the microfluidic device
22
 (Fig. 1.7c). 
The device applied the microfluidic enhancement of the conventional insemination 
IVF technique and the individual compartments were capable of providing single 
embryo development tracking over 96 hours. Such a device demonstrates great 
potential for a microfluidic device to provide a fully integrated and automated system 
for ART research and clinical applications. 
The microfluidic enhancement to conventional insemination IVF is clear, but 
the advancement in microfluidic system in ICSI has just begun. Recently, there has 
been effort in producing a fully integrated and automated microfluidic system for 
ICSI
23
. The device uses sperm separation by motility to select viable sperm for ICSI 
and is further combined with a chemical and mechanical cumulus denuding 
compartment. A series of embedded electrodes are used to orient the oocyte and laser 
trapping is used to immobilize the selected sperm. The actual ICSI procedure is 
performed on-chip by a piezo-actuator driven needle. The device then releases the 
fertilized zygote to individualized compartments for single embryo long term culture 
and monitoring. This fully integrated system is one of the first to fully integrate both 
male and female gamete processing and selection for usage, ICSI, and long term 





Cryopreservation is now an essential part of assisted reproductive technology and 
substantially increases the efficiency of techniques/processes such as SETs, donor-





 cryopreservation. There are two prevalent strategies of cryopreservation: 
1) slow-rate freezing or equilibrium freezing; and 2) ultra-rapid cooling or 
vitrification.  
 The microfluidic designs used to explore microfluidic cryopreservation, like 
the chronological development of conventional cryopreservation, started with slow-
rate freezing. The unprecedented control of fluid osmolality was capable of 
minimizing osmotic stress using diffusion and laminar flow
26
 (Fig. 1.8). By lowering 
the osmotic stress, the device improved post-thaw survivability by up to 25% on 
average over convention cryopreservation techniques.  
With recent technological advancements to vitrification, recent studies on 
mature human oocyte cryopreservation demonstrated that vitrification has enhanced 
outcome in terms of higher survival rates, cleavage, and pregnancy rates compared to 
its slow-rate freezing alternative
27
. The osmotic fluid control provided by 
microfluidics gives an unprecedented level of precision and osmolality control not 
available with manual pipetting. This is particularly important in vitrification where 
higher concentrations of cryoprotectant agents (CPAs) are used. In an effort to lower 
the osmotic stress the cells experience, a protocol for fluid exchange was developed 
that moves the cell into solutions of sequentially increasing concentrations of CPAs so 
that it lessens the osmotic change per step and divides the osmotic change necessary 
for vitrification over several steps over time. Some groups have demonstrated that the 
increase in the number of steps, and therefore the less osmotic stress introduced per 
13 
 




. However the significantly 
increased number of pipetting steps in a fixed amount of time became increasingly 
difficult to perform manually. Microfluidics provides the capability of continuous 
perfusion, essentially an infinite amount of steps, and is capable of providing real-
time and continuous optical microscopy and lab-on-a-chip automation for 
reproducibility by eliminating operator variability. Facing these current limitations, 
the motivations for using microfluidics for CPA exposure of oocytes and embryos for 
vitrification is clear and many groups have begun microfluidic designs for study. 
A computerized microfluidic control of media exposure for human cleavage 
embryos was designed to permit gradual cryoprotectant exposure to limit the large 
osmolality changes currently used in manual pipetting vitrification. It demonstrated 
that the microfluidic method produced similar embryo survival, morula formation, 
cavitation, and blastocyst formation rates compared to its conventional manual 
pipetting method alternative
30
. This device was the first to explore gradual CPA 
exposure for vitrification.  
Osmotic stress can be accurately predicted using computer modelling by 
Kedem-Katchalsky equations and known permeability parameters
31
. This was first 
explored using a device with only permeable CPAs demonstrating that the Kedem-
Katchalsky model which has historically been used to model step-wise increases in 
CPA concentration can also be reliably used to model osmotic stress behavior of cells 
exposed to continuously changing CPA concentrations by microfluidic perfusion
32
 
(Fig. 1.9). The microfluidic device design however had limited access to cells for 
loading and removal which limited its ability to explore cryosurvival and 
developmental response to the different CPA exposure regime. The device also lacked 
14 
 
impermeable solutes that are highly recommended and present for practical 




 Most recently, another microfluidic device using both permeable and 
impermeable solutes was designed to further confirm the remarkable accuracy of the 
Kedem-Katchalsky equations to model osmotic stress of oocytes and zygotes for 
vitrification. By using a combination of both permeable and impermeable solutes, the 
device was capable of controlling the shrinkage rate of the cell independently of its 
minimum cell volume. The study demonstrated the importance of shrinkage rate and 
its effect on sub-lethal damages
34
. The minimization of shrinkage rate had no effect 
on cryosurvival of murine zygotes as both manual and microfluidic CPA exposure 
had 100% cryosurvival. The shrinkage rate however did have an effect on sub-lethal 
damages. The lowering of shrinkage rate, and therefore sub-lethal damage, 
significantly increased the developmental competence of cryopreserved murine 
zygotes. This study is the first to experimentally and mathematically separate the 
effects of shrinkage rate from minimum shrinkage volume and is first to demonstrate 
a sub-lethal improvement in cryopreserved embryos.  
 
1.5 Embryo Culture 
Microfluidic techniques provide embryo culture devices with mechanical fluid 
stimulation, automated culture media renewal, real-time and long-term imaging, as 
well as autocrine factor retention. Currently, only up to half of human embryos 
fertilized by IVF develops into the blastocyst stage in in vitro culture with 
15 
 
approximately another 50% that attains successful implantation. The motivation of 
microfluidic design typically aims to simulate the natural environment of the in vivo 
environment. As in cryopreservation, automation also eliminates much of the user 
variability. Such control of physical and chemical parameters is needed for the careful 
dissection of experimental parameters necessary to further improve embryo culture 
outcomes
35
 (Fig. 1.10a). 
  Early studies of microfluidic embryo culture devices studied the effect of 
microchannel culture as well as the material selection for microfluidic device 
fabrication. The foundation for microfluidic in vivo embryo culture was laid with the 
demonstration of advanced blastocyst development, higher survival rates, and fewer 
degenerated embryos in both silicon/borosilicate and PDMS/borosilicate devices
36
 
(Fig. 1.10b). This study employed static (no flow) microchannel culture allowing for a 
direct comparison with static microdrop systems. The improved developmental 
outcome is presumably due to the lower volume and the embryo’s enhanced ability to 
regulate its microenvironment with paracrine and/or autocrine factors. 
 Although the addition of flow conditions is more similar to in vivo 
environments of embryo culture, it was discovered that simple continuous media 
perfusion within a microchannel and weir-type trap during embryo development was 
detrimental to embryo development across a range of flow rates
37
.  Multiple reasons 
for the poor outcome were suggested, but the primary reason may be the loss of 
paracrine and autocrine factors and the inability of embryo self-regulation of its 
microenvironment. Subsequently developed was a dynamic microfunnel embryo 
culture system that provides mechanical stimulation from fluid flow while retaining 
biochemical stimulations by allowing the retention of autocrine factors from the 
16 
 
embryo’s attempt to regulate its microenvironment
38
 (Fig. 1.11a). The Murine 
embryos subjected to microfunnel pulsatile culture had significantly higher number of 
blastomeres per blastocyst. The more advanced embryo development was also shown 
to result in enhanced implantation and pregnancy rate than static culture controls.  
 The embryo culture devices so far have been preimplantation embryos. 
Microfluidic devices can also be used for zebrafish embryo development into 
zebrafish larvae. The use of the devices showed no increase in gross malformations of 
zebrafish larvae
39
 (Fig. 1.11b).  The cost effectiveness of the zebrafish model 
combined with low reagent volumes used during the microfluidic device embryo 
culture could be used for new analytic assays for the pharmaceutical industry. 
 More recently, more sophisticated microfluidic automation demonstrates fully 
integrated devices to culture and analyze developing zebrafish embryos
40
 Microfluidic 
automation demonstrated the fluid control for automatic embryo loading, 
immobilization, medium perfusion, and release of viable embryos. It also had 
embedded control systems to control chemical and mechanical fluid stimulations, as 
well as temperature regulation. The ability to simultaneously perform automatic 
image acquisition and real-time monitoring provided the functionality to analyze 
subtle indications of developmental quality. 
 
1.6 Embryo Analysis 
As the practice of SETs become more prevalent in assisted reproductive technology, 
the importance of embryo selection for the best embryo becomes paramount to 
improve implantation rates. Current research direction is toward non-destructive 
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analysis of embryo quality. While non-destructive direct analysis on the embryo is 
uncommon, some recent solutions have been developed that uses advanced photonics 
such as light induced dielectrophoresis (DEP) or coherent anti-stokes raman 
spectroscopy (CARS). Neither technique currently has lab-on-a-chip applications, but 
has a great potential for on-chip integration. Current microfluidic devices for non-
destructive embryo analysis employ indirect analysis of embryo quality such as spent 
medium metabolite analysis. Current limitations of such devices however are resulted 
from the devices being designed as targeted assays that measure specific metabolites 
of interest, therefore the microfluidic design becomes exponentially complex with 
each additional metabolite of interest. Such limitations highlight the strength of 
advanced spectroscopy capable of analyzing a broad spectrum of metabolites. 
 DEP devices have been used to directly evaluate the quality of preimplantation 
murine embryos. The electrical admittance of the embryo changes according to its 
development. This change, when controlled using the appropriate optoelectronic 
tweezer (OET) medium and in the presence of an OET induced DEP, can attract early 
stage development embryos while repelling late stage development embryos
41
. Such a 
non-invasive sorting mechanism uses a reproducible and quantitative measurement to 
determine embryonic developmental stages without the subjectivity of morphology 
assessment. 
 Another recent advancement in spectroscopy that has proved powerful for 
direct measurements of cell metabolism is CARS. The technique is capable of non-
invasively monitor lipid concentration and distribution within the cell
42
. This label-
free method of monitoring lipid content over time allows for the assessment of lipid 
metabolism of embryos.  
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In an effort to avoid exposure of embryos to intense UV light needed for 
metabolite assays, a reasonable strategy is to physically separate the embryo 
development with spent medium aspirate analysis into two separate microfluidic 
devices. One group demonstrated such potential with a fully automated analysis for 
performing the necessary aliquotting, mixing, data acquisition, and data analysis 
operations to quantify glucose, pyruvate, and lactate levels
43
 (Fig. 1.12).  
Another strategy to avoid harmful UV light exposure to developing embryos is 
to use longer emission and excitation wavelengths of UV light and to spatially 
segregate optical interrogation from embryo culture. The device was capable of fluid 
priming, fluid mixing, chemical reaction, fluid washing and injections to analyze 
glucose metabolism
44
 (Fig. 1.13). With integrated embryo culture, this device is 
capable of performing real-time and continuous culture aspirate measurements for 
over 6 hours. 
Although not yet integrated into microfluidic devices, many powerful broad 
spectrum analysis techniques have been used to analyze embryo metabolism. Such 
techniques not only simplify the analysis of multiple metabolites of interest, but also 
provide the possibility to study metabolites that one would not initially expect to be 
interesting. They also benefit from high sensitivity in addition to versatility and 
include nuclear magnetic resonance (NMR), mass spectroscopy (MS), near-infrared 







One of the most pressing challenges for ART as the trend for SET continues to grow 
is a method to non-invasively evaluate embryo and gamete quality. This challenge is 
also compounded by the now accepted realization that morphology, the most 
conventional method, is a poor indication of quality. Microfluidics has already shown 
promise to provide alternative methods of quality measurement with strategies 
tailored to the gamete or embryo analyzed using automation and sensitivity and 
sometimes combined with sophisticated biophotonic analysis. It is worthy to note that 
the use of microfluidic devices will not eliminate the need for an embryologist but 
will enhance outcome and reduce variability. The operation of complex microfluidic 
processes such as a series of mixing, dilutions, and sorting as well as sophisticated 
biophotonic techniques require a large amount of supporting equipment. Research 
effort in embedded microfluidic designs aim to decrease the amount of supporting 
equipment needed. Future device design should consider usability and adoptability for 
embryologists. Embryologists would also require additional training to include a 
change in current procedures to incorporate microfluidic techniques. As microfluidic 
devices for ART matures, this would be considered as enhanced job training as an 







Fig. 1.1 Image captures and illustrations of the movement of sperm sample during 
sorting.  Non-motile and dead sperm will be transported along the laminar streamline 
from the top left inlet reservoir to the top right channel while motile sperm can move 





Fig. 1.2 (A-H) Sperm assessment with microfluorometer.  (I)Schematic representation 






Fig. 1.3 (A-I) Motility sorting based on phase-guide structure. The motile sperm will 
cross the interface barrier to the buffer zone.  (J) Sperm motility selection based on 





Fig. 1.4 (A) Overview of sperm sorter set up. (B) Fluorescence detector integrated 
with hydrodynamics system. (C) Droplets containing spermatozoa are sorted to 











Fig. 1.6 Magnetically driven microtools with ultrasonic vibration for oocytes 





Fig. 1.7 (A) Weir-type trap design for fertilization.  (B) Small scale design of 
microfluidic device promotes the effectiveness of fertilization. (C) 





Fig. 1.8 Increased viability is achieved by reducing osmotic shock during 





Fig. 1.9 (A)Schematic of microfluidic network. (B) Separation of two streams at the 
inlet channel. (C) Mixing of streams in the analysis chamber. (D) Volumetric 





Fig. 1.10 (A) Flow channels design for sub-microliter volume culture. (B) 





Fig. 1.11 (A) Microfunnel with Braille pin piezoelectric actuators providing dynamic 
controls to enhance embryo culture. (B) Zebrafish embryo culture to larvae in a 
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Microfluidic Reduction of Osmotic Stress in Oocyte and Zygote Vitrification 
 
Microfluidic cryoprotectant exchange enables vitrification of murine zygotes with 
superior morphology as indicated by a smoother cell surface and higher 
developmental competence compared to conventional methods. Bovine oocyte 
vitrification also benefit as evidenced by higher lipid retention. Experimental 
observations and mathematical analysis demonstrate that the microfluidic advantage 
arise predominantly from eliminating high shrinkage rates associated with abrupt and 
uneven exposure to vitrification solutions that readily occur in current manual 
protocols. The microfluidic cryoprotectant exchange method described has immediate 
applications for improving animal and human oocyte, zygote, and embryo 
cryopreservation. On a fundamental level, the clear demonstration that at the same 
minimum cell volume, cell shrinkage rate affects sub-lethal damage should be broadly 
useful for cryobiology. 
 
2.1 Introduction 
The successful cryopreservation of embryos and oocytes has significantly expanded 
the scope of infertility treatment
1,2
. A major concern in cryobiology is the osmotic 
stress that cells experience as their water content is exchanged with cryoprotectant 
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agents (CPA) to eliminate formation of damaging intracellular ice crystals. While 
immediately lethal osmotic stress has largely been overcome, sub-lethal effects still 
remain and affect overall embryo development and treatment outcomes. This concern 
is particularly high for the fast cooling protocol called vitrification where the CPA 
used have high osmolality and non-cell permeable components
3
. Compared to 
mammalian cells with diameters on the order of 10 micrometers, oocytes and zygotes 
with diameters on the order of 100 micrometers have ~1000 times larger volume of 
water that needs to be replaced with CPAs. However, the cell surface area does not 
increase proportionally making the required water-CPA exchange through the cell 
membrane difficult and the cell highly susceptible to osmotic stress. Early studies on 
osmotic stress suggested the existence of a threshold minimum cell volume where 
shrinkage becomes sufficient to cause lethal damage to cell membrane integrity
4
. This 
theory formed the basis of many prominent osmotic stress studies investigating the 
threshold minimum cell volume in different cell types
5,6
. In an attempt to reduce 
osmotic stress, one common method for oocyte and zygote vitrification involves a 3-
step equilibration process where the cells are manually pipetted into subsequently 
higher levels of CPA concentrations to avoid sudden changes of osmolality
7
, allowing 
the cell to shrink in stages, and sometimes to re-expand, to avoid the critical minimum 
cell volume.  
In species with oocytes, zygotes, and embryos that are difficult to cryopreserve, 
it has been shown that higher number of equilibration steps increases the rate of 
cryosurvival
8
 and developmental competence
9
. However despite improved outcome, 
protocols with high number of equilibration steps have not been clinically adopted 





 and recently, the Toner group pioneered the use of 
microfluidic CPA exchange to overcome limitations of manual pipetting
11
. They 
demonstrated precise control of fluid exchange to maintain a large cell volume during 
CPA exchange. However, the study did not incorporate impermeable solutes highly 
recommended for cryopreservation
12
 nor was the device designed for cell removal 
after CPA exchange to allow actual vitrification. Consequently, while the oocyte was 
maintained at large volumes, it is not clear whether the protocol could produce 
developmentally competent cells after vitrification and warming.  
Early studies of osmotic stress focused primarily on minimum cell volume 
particularly because cryosurvival was a major concern in cryobiology and the 
minimum cell volume was experimentally easy to observe. Currently, the issues of 
cryosurvival have largely been overcome and the field is focusing efforts on 
increasing developmental competence in order to increase the effectiveness of single 
embryo transfers (SETs) to exponentially decrease chances of unintended multiple 
births while still achieving live births. The current methods of CPA mixing are 
incapable of separating the minimum cell volume effects from the shrinkage rate. It 
also suffers from poor mixing efficiency as well as a lack of controllability and 
consistency. Although previous studies using these manual pipetting techniques 
demonstrated that the minimum cell volume is lethal, the effects of shrinkage rate 
(which increase as minimum cell volume decreases) is unknown. Here we report a 
novel microfluidic device that overcomes these challenges. Using this device we 
provide an evaluation of the impact of microfluidic CPA exchange procedures on 
cryosurvival, cell health as evaluated by lipid content, and developmental competence. 
Because of the highly controlled nature of this microfluidic CPA exchange procedure, 
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we were able to distinguish effects of cell shrinkage rate independent of minimum cell 
volume. Our results demonstrate for the first time that for a constant minimum cell 
volume and CPA exposure time, minimizing the cell shrinkage rate leads to improved 
outcomes. 
 
2.2 Materials and Methods 
Kedem-Katchalsky Modeling. The device was designed to minimize osmotic stress 
by Kedem-Katchalsky equations using MatLAB (MathWorks, Natick, MA). The 
osmolarity contributions of each CPA component in the VS is assumed to be additive. 
Lp is 8.94*10
-7
 cm/sec/atm, ωDMSO is 2.54*10
-5
 cm/sec, ωEG is 1.0*10
-5
 cm/sec. tf is 
the user-defined time duration of CPA exchange, and n is the step number of 
computer analysis. The solvent/solute interaction, σ did not have a dramatic effect on 
model. The ideal shrinkage regime will have the most gradual and a constant 
shrinkage rate, thus the deviation γ = 0. Using an n of 820 000 to facilitate faster 
computation, the deviation γ of each shrinkage regime was calculated and compared 
with the ideal γ = 0. 
Device design and fabrication. Microfluidic devices were made using conventional 
photolithography and soft lithography using polydimethylsiloxane (PDMS) (Dow 
Corning, Midland, MI). The device consists of two layers: The microfluidic channel 
layer (150 µm) that houses the oocytes/zygotes as well as delivers the CPA solutions 
and the holding pipette layer (20 µm) that provides the vacuum for the 
oocytes/zygotes to remain stationary under constant volumetric flow rate but changing 
CPA concentrations and associated viscosity and fluid density.  
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 The device was designed with a serpentine mixing channel, an oocyte/zygote 
exposure chamber and a set of height-differential (10 cm) powered suction 
microchannels. The loading and withdrawal of oocytes or zygotes from the device 
was achieved through a port drilled by a 200 µm microdrill bit (Kyocera, Kyoto, 
Japan) into a glass slide (Fisher Scientific, Waltham, MA) on which the PDMS is 
bonded to provide laminar flow in and out of the device. This combined with control 
of vacuum created an effective method of retrieval with no edges or corners for 
oocytes / zygotes to be trapped within the device. 
Fluorescence quenching and fluorescence microscopy. Fluorescence quenching 
mixing characterization was achieved using VS supplemented with 20 µM fluorescein 
(Sigma-Aldrich, St. Louis, MO) mixed with culture media with 2 M potassium iodide 
(KI, Sigma-Aldrich, St. Louis, MO). Both solutions were flowed into the microfluidic 
device at 350 µL / hr. As the two solutions mix, the binding of iodide with 
fluorescence shifts the excitation spectrum to decrease captured fluorescence signal 
from fluorescence microscopy. For normalization, the channels were filled with 1) 
premixed equal volumes of VS supplemented with fluorescein and culture media 
supplemented with potassium iodide, 2) just VS supplemented with fluorescein, and 3) 
VS supplemented with fluorescein premixed at equal volumes with culture media 
without potassium iodide. 
 Regular fluorescence microscopy was used to characterize the increasing CPA 
concentrations over time. The VS solution was supplemented with 20 µM fluorescein 
and the culture media had no potassium iodide. The VS syringe pump operated from 0 
to 700 µL / hr while the culture media syringe pump operated from 700 to 0 µL / hr. 
After serpentine channel mixing, the fluorescence signal contributed by the VS 
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solution as it increases is proportional to the CPA concentration for that mixed 
solution in time.  
Oocyte / zygote loading, trapping, and withdrawal. Loading of oocyte / zygotes 
through the loading/withdrawal port is achieved by activation of the suction channel 
powered by a negative height differential (~10 cm) in the absence of syringe pump 
flow. The activation and deactivation of the suction channel is operated by a 3-way 
valve at the end of the height differential. The exposure chamber contains 15 holding 
microchannels where up to 15 oocytes/zygotes are immobilized via the continued 
activation of the suction port. The cells are released out of the device through the 
loading / withdrawal port by the termination of suction port in the presence of syringe 
pump flow. 
Automated and manual vitrification. Automated vitrification was achieved by two 
programmable syringe pumps (Chemyx, Stafford, TX) capable of providing linear 
gradients. The vitrification solution syringe pump was programmed to provide a 
linearly increasing flow rate from 0 to 700 µL / hr in 10 minutes. The culture media 
syringe pump was programmed to provide a linearly decreasing flow rate from 700 to 
0 µL / hr in 10 minutes. After mixture by serpentine channel, the solution of 
constantly flow rate ~700 µL / hr but changing CPA concentrations from culture 
media to vitrification solution conditions is delivered to the exposure chamber to 
exposure cells. During operation, the spent fluid escapes via the loading / withdrawal 
port as well as the suction port. The media that escapes from the loading / withdrawal 
port is discarded.  
 Manual vitrification for MII oocytes and zygotes were performed by fully 
trained individuals using a previously described technique
22
 with slight modification. 
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Mouse or bovine MII oocytes were transferred to 20 μL washing solution drop for 1 
min and then merged with two 20 μL equilibration solution drops sequentially for 2 
min each merging, then oocytes were transferred to equilibration solution for 2-3 min. 
After equilibration, oocytes were transferred through three 20 μL vitrification solution 
drops for 5 sec, 5 sec and 10 sec, and then stayed in the fourth drop of vitrification 
solution until cryopreservation. High Security Vitrification (HSV) straws (CryoBio 
Systems, L’Aigle, France) were used for loading oocytes and the loaded straws were 
plunged into liquid nitrogen within a 90 second interval. Mouse zygotes vitrification 
procedures were similar as those for oocytes, except longer incubation (8 min) in 
equilibration solution.  
Oocyte and zygote harvest. All procedures described within were reviewed and 
approved by The University Committee on Use and Care of Animals at the University 
of Michigan and were performed in accordance with the Guiding Principles for the 
Care and Use of Laboratory Animals. 
Bovine ovaries were obtained from a local abattoir at random stages of the 
estrous cycle or pregnancy and transported to the laboratory in warmed PBS 
containing antibiotics. Cumulus-oocyte complexes were aspirated from follicles of 2-
6 mm diameter and matured for 24h in M199 medium (Sigma-Aldrich, St. Louis, 
MO) at 39°C in 5% CO2, 5%O2, 90% N2. Mature oocytes were then denuded of 
cumulus cells before use.  
Meiotically competent germinal vesicle intact (GVI) oocytes were collected 
from antral follicles of 21-23d old CF-1 female (Harlan, Indianapolis, IN) ovaries 44-
46h after 5 IU equine chorionic gonadotropin (eCG, Sigma-Aldrich, St. Louis, MO) 
stimulation. Denuded GVI oocytes were triple washed in HTFH (human tubal fluid-
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HEPES, Irvine Scientific, Santa Ana, CA) /0.3% BSA and cultured in HTF/0.3% 
BSA at 37ºC in 5% CO2 incubator for 18h to obtain MII oocytes.  
 To collect zygotes female B6C3F1 mice at 6 to 8 weeks old were injected 
with 5 IU equine chorionic gonadotropin (eCG, Sigma-Aldrich, St. Louis, MO). 
Forty-eight h later mice were injected with 5 IU human chronically gonadotropin 
(hCG, Sigma-Aldrich, St. Louis, MO). Upon hCG injection, female mice were placed 
with mature B6C3F1 males of known fertility until sacrificed 18h later. Zygotes were 
released from the ampulla, denuded in human tubal fluid-HEPES (HTFH, Irvine 
Scientific, Santa Ana, CA) / 0.1% Hyaluronidase, triple washed in HTFH / 0.3% BSA 
and placed in pre-equilibrated potassium simplex optimized medium (KSOM) + 
amino acids (AA) (Millipore, Billerica, MA) at 37ºC in 5% CO2 incubator until use. 
Phase contrast microscopy, roughness index, and sphericity. Zygotes were 
analyzed at 400x magnification for phase contrast microscopy. The RI was quantified 
as standard deviation of the grey values within the region of interest (ROI). The ROI 
was defined as the middle 50% of cell surface so that edge effects are nullified. The 
zygotes were oriented such that the polar bodies do not visually obstruct the center of 
the zygote. Zygotes exposed to CPA by automated or manual pipetting protocols were 
stained by Hoechst 33342 at 5μg /ml for 10 min but unwashed to retain cytoplasmic 
staining. The Hoechst stained zygotes used were analyzed using confocal microscopy. 
The volume and surface area were then quantified using ImageJ to calculate sphericity. 
Warming, embryo culture, and developmental competence analysis. Murine 
oocyte and zygote warming were performed by fully trained individuals using a 
previously described technique
22
. Murine zygotes, either NVE or vitrified and 
warmed were transferred to 50µl pre-equilibrated KSOM+AA microdrops under oil 
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and cultured at 37ºC in 5% CO2, 5% O2, 90% N2 gaseous conditions. Embryo 
morphologies in each experimental group were assessed at 96h of culture for 
blastocyst development using an inverted microscope (200x; Leica DM2RB, Wetzlar, 
Germany).  
Cytoplasmic lipid content. Bovine oocytes in control, automated and manually 
vitrified groups were fixed on Poly-L-Lysine coated coverslips separately overnight 
using 2% paraformaldehyde. Fixed oocyte samples were triple washed with 1xPBS 
the next day, stained with 100 nM Nile Red (Sigma-Aldrich, St. Louis, MO) for 20 
min at room temperature, then washed one time with 1xPBS and stained with Hoechst 
33342 (5μg /ml) for 10 min. After Hoechst staining, oocyte samples were triple 
washed with 1xPBS and mounted in 90% Glycerol with anti-fading reagent. Lipid 
contents in bovine oocytes were visualized under confocal microscopy and were 
quantified with ImageJ. 
Developmental competence analysis. To count the total number of cells 
(blastomeres) in blastocysts derived following no treatment (control) or automated 
and manually vitrified and warming; blastocysts were placed on Poly-L-Lysine coated 
coverslips and fixed overnight with 2% paraformaldehyde. Fixed blastocyst samples 
were triple washed in 1xPBS the next day, stained with Hoechst 33342 (5 μg/ml) for 
10 min, triple washed with 1xPBS, and then mounted in 90% Glycerol with anti-
fading reagent. Blastomere numbers were counted under fluorescent microscopy 
(400x) by two individuals, both blinded to knowledge of treatment, and reported 




2.3 Results and Discussion 
Kedem-Katchalsky Modeling. A cell’s volumetric change in response to a defined 
input of CPA concentrations can be accurately modeled
13–15
. Kedem-Katchalsky 
equations (Eq 1-2) typically use step-wise input functions of CPA concentrations as 
this is the experimental limitation of manual pipetting. However with the use of 
microfluidics, we expand the experimental possibilities to include continuous 
temporal gradients of CPA concentrations using ethylene glycol (EG), dimethyl 
sulfoxide (DMSO), and sucrose. We note that although a related mathematical 
analysis was performed by Heo and colleagues, they did not consider the inclusion of 
impermeable CPAs, such as sucrose, in the vitrification solution (VS) as is highly 
recommended for practical cryopreservation
12
 and necessary to control shrinkage rate 
independently of minimum cell volume (Fig. 2.1A).  
Eq 1: 
                   
 
Eq 2: 
                   ̅ 
 
How ideal a CPA exchange protocol is in terms of avoiding abrupt cell 
shrinkage can be mathematically appreciated as the deviation (%volume / sec) of the 
shrinkage (%volume / sec) (Eq 3) over time. Where f(t) is the function of cell volume 
shrinkage over time (Eq 4). The ideal shrinkage regime would have constant cell 
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shrinkage over time, and thus the deviation γ = 0 % volume / sec. Such a rate will 
allow the shrinkage rate to be minimized while still transitioning the cell to its 
minimum cell volume by the end of the user-defined duration. The direct exposure 
had the fastest maximal shrinkage rate of 7.51 % volume / sec. Manual-pipetting 
caused a large deviation, γ = 0.19 % volume / sec where the zygote is at times 
shrinking quickly while other times static and sudden introduction of CPA from 
manual-pipetting also produced a fast maximal shrinkage rate of 4.13 % volume / sec. 
Auto-microfluidics reduces the shrinkage regime deviation, γ = 0.09 % volume / sec 
and prevents instances of quick cell shrinkage by eliminating sudden changes in 
osmolality producing maximum shrinkage rates of only 0.35 % volume / sec.  
Eq 3: 
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Zygote vitrification affecting morphology and cryosurvival. Fresh murine zygotes 
(Fig. 2.1C,H) were subjected to defined CPA exposure regimes (Fig. 2.1D-G). The 
direct exposure (Fig. 2.1G,L) represents a transfer of zygotes directly from culture 
media to VS, a protocol known to be detrimental to cryosurvival (59.6 ± 3.2%, n=40). 
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Manual-pipetting (Fig. 2.1D,I) and auto-microfluidic (Fig. 2.1E,J) fluid exchange 
both had high cryosurvival (100 ± 0%, n=200 and 100 ± 0%, n=224) and 
experimental cell shrinkage agreed with models (Fig. 2.1B). Despite no significant 
difference between manual-pipetting and auto-microfluidic CPA exposure on 
cryosurvival, high magnification reveal significant morphological improvement with 
a more uniform and gradual shrinkage rate (Fig. 2.1I,J). Confocal images further 
demonstrate distinct morphological differences between manual-pipetting and auto-
microfluidic CPA exchange. Additional morphological studies (Fig. 2.1F,K) 
demonstrate the importance of applying sucrose, the impermeable component of the 
vitrification solution gradually for a smooth cell surface and simulated direct VS 
exposures by microfluidics (Fig. 2.1G,L) demonstrate the importance of avoiding 
abrupt CPA exposures to avoiding the large crater-like deformations on the cell 
membrane that are sometimes visible in manual-pipetting protocols (Fig. 2.1I) where 
cell water volume may escape unevenly due to high gradient of CPA concentrations 
preferentially on one side of the cell.  
 Zygote surface smoothness can be assessed while in vitrification solution 
under 400X magnification and phase contrast microscopy. Rough surfaces cast dark 
and light areas on the cell surface under phase contrast. The roughness index (RI) can 
then be quantified as the standard deviation of the grey value of the cell. Zygotes 
exposed to automated microfluidic CPA exposure (Fig. 2.1E,J; RI=23.50, standard 
error (StdErr)=0.11, n=27) are significantly (p<0.001) smoother than its manual 
pipetting analogue (Fig. 2.1D,I; RI=33.72, StdErr=0.09, n=26) (Fig. 2.2A) . Abrupt 
sucrose also had rough surfaces statistically comparable to manual pipetting which 
also consists of an abrupt exposure to sucrose (RI=34.32, StdErr=0.23, n=20). Direct 
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exposure curiously had smooth surfaces despite an abrupt exposure to all CPAs: EG, 
DMSO, and sucrose (RI=25.08, StdErr=0.30, n=20). Non-Vitrified or CPA Exposed 
(NVE) zygotes, alternatively referred to as fresh zygotes, had visual occlusions that 
cast dark regions in phase microscopy due to significant differences in refractive 
indexes within its cytoplasmic content. The lack of EG and DMSO, which have an 
added benefit of homogenizing refractive indexes of cytoplasmic content, prevented 
the direct comparison of NVE zygotes to other experimental groups. This roughness 
index is non-invasive and can be instantly quantified with real-time monitoring within 
the microfluidic device. 
 Zygote sphericity is calculated by measuring the cell surface area and volume 
by confocal microscopy. Zygotes exposed to CPA by automated microfluidics (Fig. 
2.1E,J) has significantly (p<0.001) more spherical morphology than zygotes exposed 
to CPA by manual pipetting (Fig. 2.1D,I). Abrupt sucrose, which consists of an abrupt 
exposure sucrose, causes rough cell surfaces and some deformations in cell shape that 
negatively affects sphericity (sphericity = 0.780, StdErr = 0.002, n=16). CPA Manual 
pipetting, which also consists of an abrupt exposure to sucrose, causes ripples and 
deformations in cell shape (sphericity = 0.790, StdErr = 0.001, n=24) that is 
statistically comparable to the abrupt sucrose group. Automated microfluidic CPA 
exposure retains a smooth cell surface and a lack of deformations to cell shape that 
allows the cell to retain its spherical morphology (sphericity = 0.956, StdErr = 0.001, 
n = 27; Fig. 2.2B) that is statistically similar to the sphericity of NVE zygotes 
(sphericity =  0.965, StdErr =  0.001  , n= 20). Direct exposure causes large 
deformations in cell shape that, despite its smooth surface, have the largest impact on 
sphericity (sphericity = 0.586, StdErr = 0.004, n = 18). 
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Microfluidic device design. Continuous temporal gradient of CPA concentrations is 
realized by two synchronized programmable syringe pumps connected to the inlets of 
the microfluidic device with geometry-mediated CPA mixing and exposure embedded 
into device design (Fig. 2.3A). Immobilized by holding microchannels within the 
exposure chamber, the microfluidic device allows for real-time monitoring by 
microscopy (Fig. 2.3B). The loading/withdrawal port is a microdrilled hole within the 
glass substrate that is aligned to the end of the PDMS channel. It loads cells when the 
suction is activated in the absence of syringe flow and a cell withdrawal port when the 
suction is deactivated in the presence of syringe flow. The suction microchannels (20 
µm by 20 µm) were powered by a negative height differential and is activated / 
deactivated by a 3-way valve. Abnormal deformation in the zona pellucida was 
observed at ~18 cm. As such, a height differential of ~10 cm was used and the flow 
velocity was adjusted such that the cells would remain trapped during syringe flow. 
The small size of the cell loading / withdrawal port (~200 µm diameter) allow for 
laminar flow as well as the absence of the weir-type geometries or dead space at the 
outlet that may trap the cell within the device. We demonstrate the reliability and 
versatility of the automated microfluidic device by vitrifying 474 murine or bovine 
oocytes and zygotes with 100 % recovery as well as the capability of vitrifying up to 
15 oocytes/zygotes simultaneously. 
Increased bovine cytoplasmic lipid retention. Bovine oocyte from the manual-
pipetting and auto-microfluidic methods were studied to demonstrate the biological 
advantages of lowering shrinkage rate. Confocal images of bovine oocytes with Nile 
Red staining were normalized to NVE oocytes at 100 ± 0.01 % (mean ± StdErr; n = 
17) lipid content to characterize post-warming cytoplasmic lipid retention. Vitrified 
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oocytes using manual-pipetting CPA exposure have significantly lower cytoplasmic 
lipid retention 51.8 ± 0.01% (n = 18) than bovine oocytes vitrified using auto-
microfluidic CPA exposure 76.6 ± 0.02 % (n = 17; p < 0.01; Fig. 2.4A).  
Increased developmental competence. To demonstrate the effects of sub-lethal 
damage from shrinkage rate on embryo developmental competence, we assessed 
number of blastomeres per blastocyst after 96h culture of NVE murine zygotes as 
control with zygotes vitrified with manual-pipetting and auto-microfluidic CPA 
exchange. NVE zygotes have 109 ± 4 blastomeres (n = 46) after 96h embryo 
development. Both vitrification methods caused sub-lethal damage that significantly 
reduced blastomeres per blastocyst verses controls. Furthermore, the vitrification 
method with the faster shrinkage rate (manual-pipetting) resulted in significantly less 
blastomeres per blastocyst (89 ± 3 blastomeres, n = 35) compared to the method with 
reduced shrinkage rate (auto-microfluidic; 98 ± 3 blastomeres, n = 46, p < 0.05). Thus, 
sub-lethal damage was significantly decreased using vitrification by auto-microfluidic 
CPA exposure which preserved zygotes with higher developmental competence 
compared to its manual-pipetting analogue (Fig. 2.4B).  
For the rapid cooling cryopreservation method of vitrification, the pre-cooling 
CPA exchange protocol plays a critical role in the overall outcome. The challenge is 
that there are multiple conflicting needs that must be met. Introducing sufficient 
amount of CPA into the cell is critical to avoid ice formation. On the other hand, it is 
also important to avoid excess CPA exposure time and concentrations as the 
chemicals are inherently toxic to cells. This confounding factor gives rise to the desire 
to decrease the time spent to reduce toxicity effects which directly conflicts with the 
desire to increase time spent to reduce osmotic stress. What all the specific 
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mechanisms are that contribute to osmotic stress is however still unclear. One of the 
most prevalent theories of osmotic stress is that there is a minimum cell volume below 
which a cell will become lethally damaged. This was achieved in early studies of 
osmotic stress primarily because lethality and minimum cell volume are 
experimentally simple to quantify. However there could be other factors contributing 
to osmotic stress and as the field of reproductive sciences focus on increasing the 
efficiency of single embryo transfers, the focus has changed from lethality or 
cryosurvival to cell health and developmental competence. Impressive and 
painstaking work by Kuwayama and coworkers and Otoi and colleagues that utilized 
multiple pipetting steps suggests that a gradual exchange of CPA is important
8,9
. 
These and other previous studies on the role of CPA-induced cell damage were unable 
to distinguish osmotic stress caused by rapid shrinkage rates independently and in a 
well-controlled manner from that caused by the cells reaching a certain minimum 
volume. Here, we demonstrate using both mathematical modelling and experimental 
validation that shrinkage rate can be independently controlled while keeping the 
minimum cell volume reached the same. Furthermore, we show that maintaining a 
low shrinkage rate throughout the CPA exchange procedure is critical for reducing 
sub-lethal cell damage. These experiments are enabled by precise control of cell CPA 
exposure using microfluidic cell immobilization, microfluidic-enabled continuous 
gradual increase of CPA concentrations, and the use of impermeable solutes as a key 
component in VS.  
 More specifically, the oocytes or zygotes are trapped within the exposure 
chamber by weir-type holding microchannels powered by a negative height 
differential for suction (Fig. 2.3B). The loading / withdrawal port is a simple but 
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effective 200 µm diameter hole. Immobilized oocytes or zygotes within the 
microfluidic exposure chamber enabled real-time and high magnification imaging that 
is often lost during manual pipetting as stereoscopes are often used for their wide field 
of view but low magnification. Mixing of CPA within the microfluidic device is 
achieved by conventional serpentine channel geometries (Fig. 2.3C) to provide 
linearly increasing concentrations of CPA (Fig. 2.3D) to the cell exposure chamber. 
Using this system, we controlled minimum cell volume to be identical for all 
experimental groups while varying the maximal shrinkage rate and shrinkage profile.  
One challenge for comparing CPA exchange protocols and their sub-lethal 
effects is the readout. Unlike lethal damage, the differences are more subtle. With 
improved vitrification protocols that now largely avoid lethal damage; the use of 
vitrification is become widespread. Measurement and improvement of sub-lethal 
damage associated with vitrification is thus timely and critical. We analyzed 
qualitative differences in cell morphology (Fig. 2.1H-J, Fig. 2.2) that demonstrate 
significant differences in morphology despite no difference in cryosurvival: a now 
clearly insufficient readout in cryopreservation of gametes and embryos. Interestingly, 
the amount of osmotic stress from shrinkage rate had a direct relationship with its 
impact on sphericity. To address the readout challenge, we quantified developmental 
competence by cryopreserving murine zygotes and comparing cell numbers of 
blastocysts (Fig. 2.4B). We additionally quantified cytoplasmic lipid retention of 
bovine zygotes (Fig. 2.4A). Cytoplasmic lipid content is a major energy source, 
inversely related to sub-lethal cell damage, and a contributor to developmental 
competence
16–19
. There are reports that lipid content can be predictive of future 
developmental success
20
. The significant difference in post-warm cytoplasmic lipid 
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between auto and manual exposure groups is evidence that the shrinkage rate and its 
effect on morphology is more energetically costly to the zygote, although the exact 
mechanism of energetic cost is yet unknown. All measures show that the microfluidic 
gradual CPA exchange protocol that minimized cell shrinkage rate is superior.  
 
2.4 Conclusions 
In addition to the fundamental insights obtained, the automated microfluidic CPA 
exchange method developed has important practical implications. The variability with 
manual pipetting in terms of pipetting volume error as well as pipetting rigor and its 
associated convective forces make the commonly-used protocols difficult to 
reproduce exactly even within a single operator. This operator variability can be a 
source of dramatically different cryosurvival rates reported in the past
21
. Such 
variability makes standardization and the identification of the most optimized 
vitrification method and vitrification solution difficult within the field of cryobiology. 
The automated microfluidic system provides unprecedented accuracy and precision in 
fluid control and is a suitable tool that eliminates operator variability in the discovery 
and use of new CPA formulation and procedures in the continuous development of 
cryopreservation technology. In this regard it is important to note that the microfluidic 
cell introduction and recovery rate for 474 oocytes and zygotes has been 100%. 
Beyond direct applicability of the described protocols to enhance oocyte and zygote 
vitrification, we anticipate the new mechanistic insights that complement and add to 
the minimum cell volume theory to be generally helpful in guiding future 




Fig. 2.1 A) Kedem-Katchalsky model predictions of zygote shrinkage during different 
cryoprotectant agent (CPA) exchange protocols. Auto represents automated-
microfluidic CPA exposure. Manual represents manual-pipetting CPA exposure. 
Direct represents direct exposure from culture medium to VS known to be detrimental 
to cryosurvival. All shrinkage regimes had similar minimum cell volume but 
significantly different shrinkage patterns. B) Experimental observation of zygote 
volumes matched that of predictive models. CPA exchange profiles for: C) No CPA 
exposure, D) Commonly used manual pipetting protocols, E) Automated microfluidic 
protocol with gradual addition of all CPA components, F) Gradual exposure of 
permeable CPA components but abrupt exposure to the impermeable component 
sucrose, and G) Direct and sudden exposure from culture media to VS. Black line 
represents EG, Blue line represents DMSO, and Red represents sucrose. H) Murine 
zygote before CPA exposure. I-L) show representative zygote morphology after 
exposure to each of the CPA protocols represented in the graphs above each image. J) 
Zygotes exposed to gradual CPA exchange show a smooth and round morphology 
whereas zygotes exposed to other protocols show small ripple-like or large crater-like 




Fig. 2.2 A) Murine zygotes subjected to automated microfluidic CPA exposure had 
significantly (p<0.001) smoother cell surface than their counterparts subjected to 
manual pipetting-based CPA exposure. Sudden exposures to sucrose formed cell 
surfaces with similar roughness to that of manual pipetting. Direct exposure had 
smooth cell surfaces comparable with automated CPA exposure. The RI analysis is 
non-invasive and can be quantified in real-time within the microfluidic device. Non-
Vitrified or CPA Exposed (NVE) zygotes had visual occlusions that cast dark regions 
in phase microscopy due to significant differences in refractive indexes within its 
cytoplasmic content due to the lack of EG and DMSO that prevent direct comparison 
from other experimental groups. B) Confocal microscopy reveals that murine zygotes 
subjected to automated microfluidic CPA exposure have significantly high spherical 
morphology (p<0.001) than manual pipetting and direct CPA exposure and maintains 
its surface smoothness and sphericity at a level statistically comparable to NVE 
zygotes. Manual pipetting and abrupt sucrose CPA exposure forms ripples and some 
large deformations in cell shape that produced comparably low sphericity. Direct 
exposure causes large deformations in cell shape that, despite its smooth surface, have 
the largest impact on sphericity. Error bars: standard error. Different letters signify 




Fig. 2.3 A) Device schematic. B) Holding microchannels immobilize cells within the 
exposure chamber allowing for real-time morphological assessment during CPA 
exchange. C) Fluorescence quenching experiment demonstrating efficient mixing. D) 
Synchronized syringe pumps combined with the serpentine channel provide linearly 





Fig. 2.4 A) Vitrification causes a loss of cytoplasmic lipid for bovine oocytes. 
However the use of automated-microfluidic CPA exposure increases cytoplasmic 
lipid retention compared to manual-pipetting CPA (p<0.01). Inlets demonstrate 
difference in lipid droplet size and distribution. Scale bar: 50 µm. B) Vitrification-
derived sub-lethal damage decreases developmental competence after 96 hours of 
embryo culture of murine zygotes. However automated-microfluidic CPA exposure 
significantly increases number of blastomeres per blastocyst compared to its manual-
pipetting analogue and provides evidence that sub-lethal damage was reduced. Error 
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Conclusions and Future Direction 
 
Previous osmotic stress studies employ experimental groups with differing 
concentrations of permeable or impermeable cryoprotectants (CPAs). Those 
employing vitrification solutions (VSs) containing impermeable solutes have  also 
introduced the impermeable CPA such as glucose, sucrose, sorbital or trehalose 
abruptly at the end of the CPA exchange procedure. As such, osmotic stress studies of 
the past have been unable to experimentally separate osmotic damage from minimum 
cell volume and shrinkage rate during CPA exposure.  
 The use of continuous CPA exposure by microfluidics and the use of 
impermeable solutes such as sucrose in the VS allowed for the ability to 
independently control shrinkage rate and minimum cell volume. The lowering of 
shrinkage rate during CPA exposure lowered sub-lethal osmotic stress to increase 
cytoplasmic lipid retention of bovine oocytes and developmental competence of 
murine zygotes. When considering shrinkage rate as strain rate and minimum cell 
volume as strain, it is then evident that the observed improved quality agree with 
fundamental principles of materials science.  
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 Recent developments in fabrication techniques such as carbon vapor 
deposition (CVD) diamond microfluidic devices that have low thermal mass. Such a 
microfluidic devices would allow for an enclosed vitrification vehicle that allows high 
cooling rate to facilitate vitrification as well as an enclosure that prevents cell loss and 
eliminate risk of liquid nitrogen contamination.  
 There is evidence that different VSs are more preferable depending on the cell 
type to be vitrified. However, a single cell type may have different VSs where there 
are conflicting studies that one is better than the other. This can at times be attributed 
to confounding factors such as user variability. The use of a microfluidic device that 
eliminates user variability can more easily determine the most optimal VS between 
opposing views.  
Current VSs employ a high concentration of vitrification solution. The toxicity 
concerns fuel an ever present desire to decrease the CPA concentration in the VS 
however this is limited by the cooling rate (Fig. 3.1). As new cooling techniques are 
developed to increase cooling rate, it will become possible in the future to develop 
new VSs with lower CPA concentration and toxicity. The use of a microfluidic device 
without user variability will facilitate the development of new VSs as cooling 
technology continues to improve.  
The mechanistic principles studied in CPA exposure can be applied to CPA 
removal in post-vitrification warming. The lowering of expansion rate of cells during 
post-vitrification warming is expected to also improve oocyte, zygote, and embryo 
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quality. The development of a microfluidic device for post-vitrification warming has 
the added benefit of facilitating donor oocyte transport. 
A fully integrated microfluidic device with the capability to perform CPA 
exposure, function as a vehicle for vitrification , and CPA removal will allow for full 
automation for the entire cryopreservation process. The microfluidic device would be 
capable of performing protocols not possible with conventional techniques to 





Fig. 3.1 Generic phase diagram. The length of the dotted blue line signifies the 
cooling rate provided by current cooling technology. The ever present desire to 
decrease CPA concentration is thwarted by the inability to achieve safe vitrification 







Rounded multi-level microchannels with orifices made in one exposure enable 
aqueous two-phase system droplet microfluidics 
 
Exposure of a negative photoresist-coated glass slide with diffused light from the 
backside through a mask with disconnected features provides multi-level rounded 
channels with narrow orifices in one exposure. Using these structures, we construct 
microfluidic systems capable of creating aqueous two-phase system droplets where 
one aqueous phase forms droplets and the other aqueous phase forms the surrounding 
matrix. Unlike water-in-oil droplet systems, aqueous two-phase systems can have 
very low interfacial tensions that prevent spontaneous droplet formation. The multi-
level channels fabricated by backside lithography satisfy two conflicting needs: (i) the 
requirement to have narrowed channels for efficient valve closure by channel 
deformation and (ii) the need to have wide channels to reduce the flow velocity, thus 





Production of molds with multi-level rounded channel features to cast PDMS 
prepolymer against typically requires multiple steps or costly procedures.
1–5
 Here, we 
use an inexpensive, single exposure, backside diffused light lithography (BDLL) 
procedure with photomasks that contain channel features of different widths and 
disconnected regions to generate multi-level rounded microchannels with strategically 
placed orifices. The effect of BDLL to generate channels with bell-shaped cross-
sectional shapes that are wider than the original mask feature and differential height 
according to mask width
6
 is used here to create narrow connections between multi-
level features that are not connected on the original photomask (Fig. 4.1A and B). The 
rounded, narrow channel orifices allow for efficient channel constriction by Braille 
pin actuation
7
 of channels that are otherwise too large to be closed reliably (Fig. 
4.1C).  
The system is demonstrated to be useful for generating aqueous two phase system 
(ATPS) droplets. Unlike oil/water microfluidic droplet systems that take advantage of 
high interfacial tensions to spontaneously generate droplets,
8–12
 the most 
biocompatible ATPS systems with low polymer contents
13
 have low interfacial 
tensions that prevent the practical use of spontaneous droplet formation.
14
 The multi-
level rounded channels with orifices fabricated by BDLL with disconnected 
photomask features (DPFs) allow for the efficient valve closure at the orifice as well 
as reduction of flow velocity in the widened downstream channel region to generate 
reliable ATPS droplet formation. 
 
4.2 Materials and Methods 
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Channel characterization and device fabrication 
To assess relative channel dimensions, a photomask of 500 μm squares with varying 
distances was used to expose the negative photoresist (SU-8) by BDLL (for varying 
durations proportionately to height) at heights of 30, 50, 90, 150 and 200 μm.
6
 A 
schematic and brief explanation of the BDLL procedure and setup is shown in Fig. 4.2. 
The channel shapes, widths, and heights were determined using environmental 
scanning electron microscopy and fluorescence imaging of channels filled with 
0.01% fluorescein. 
A hydrodynamic focusing device was used to facilitate droplet formation. SU-8 
was exposed for 90 s through a photomask containing a 400 μm DPF between the 
central channels (Fig. 4.3). The resulting PDMS replicas were bonded to 100 μm thick 
PDMS membranes to produce a closed channel system for Braille actuation. 
ATPS threading regime and droplet formation 
The ATPS used in this study was near critical-point at 3.2% w/w dextranMw 500 000 
(Pharmacosmos, Denmark) and 2.5% w/w PEG Mw 35 000 (Sigma-Aldrich, St Louis, 
MO) prepared as previously described.
13
A threading regime was produced using the 
device shown in Fig. 4.4 with flow rates of 0.01 mL h
−1
 and 0.10 mL 
h
−1
 for dextran and PEG phases using a syringe pump. 
An actuating Braille pin was placed underneath the orifice in the centre channel to 
discontinue the dextran flow by valving. The Braille pin was controlled using a 
computer user interface
15,16
 to actuate in a frequency range between 2.5 Hz and 0.83 





4.3 Results and Discussion 
Characterization of BDLL 
Channels resulting from BDLL are larger than the features on the photomask. A 500 
μm photomask produced 955 μm channels with 100 s exposure in a 100 μm high 
photoresist with a standard deviation of 8 μm. For BDLL with a given DPF, increased 
photoresist thickness with associated increased exposure allows for a wider DPF to be 
connected on the developed photoresist. For every 50 μm in SU-8 thickness, the 
maximum DPF over which connections can be formed increases by 25 μm (Fig. 
4.5C).  
For a given photoresist thickness, by adjusting the exposure times, mask line 
widths, and DPF positions and sizes, we can separately control the heights of different 
sections of channels and orifices (Fig. 4.5D and E). For a given sub-saturating 
exposure, channel height increases with increasing the mask line width. The 
constricted orifice height, however, can be independently adjusted to decrease by 
increasing the size of the DPFs. This method produces a multi-level channel with a 
channel orifice as evidenced by fluorescence images (Fig. 4.5A) and phase contrast 
cross-sectional images (not shown, but similar to Fig. 1 in ref. 6). A profile plot shows 
the calculated channel height across the x-axis based on the fluorescence intensity 
(Fig. 4.5B). The channel is multi-level, starting from a 45 μm height, narrowing to an 
orifice with only a 16 μm height, then widening to a 90 μm high channel. 
Monodisperse droplet formation 
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For a fixed channel geometry, the volumetric flow and the capillary number, Ca 
= ηV/γ (the ratio of viscous stresses to surface stresses) dictate droplet formation, 
where η is the viscosity, V is the characteristic velocity, and γ is the interfacial tension. 
Flow conditions of Ca < 1 are required for efficient droplet formation;
14
 otherwise, the 
length of the channel (Lc) required for droplet formation to occur by Rayleigh 
instabilities becomes too large. Because ATPSs typically have extremely low 
interfacial tensions (≤0.1 mN m
−1
) and high viscosity, the flow velocity required to 
achieve a Ca supportive of spontaneous droplet formation becomes too small for most 
applications. A 0.01 mN m
−1
 interfacial tension oil/water/surfactant system has been 
explored for droplet formation but using sub-centimetre scale channels where, despite 
the use of a slow flow velocity, much of the droplet breakup still occurs after a 
significant delay.
17
 An ATPS droplet system was previously used to perform droplet 
sorting.
18
 In this system, however, the ATPS phases were composed 
oftetrabutylammonium bromide and ammonium sulfate at concentrations of 15% and 
30% w/w making them possess a very high interfacial tension (4–5 mN m
−1
) that is 
advantageous for spontaneous droplet formation but negating much of the bio- and 
cyto-compatibility advantage of ATPSs. More recently, droplets of an ATPS with a 
relatively low interfacial tension of 0.1 mN m
−1
 were prepared with 




Here, we used a microfluidic system that utilizes rounded channels with orifices 
combined with Braille pin valving (Fig. 4.1) to allow droplet formation (Fig. 4.6) 
using a near-critical point ATPS with the lowest interfacial tensions among ATPS 
droplet systems demonstrated to date. The ATPS had measured viscosities of 3.1 cP 
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for the dextran-rich and 4.9 cP for the PEG-rich phases with an estimated interfacial 




 As expected, the channel alone generated no droplets, 
with laminar streams of ATPS being stable for at least 27 mm at a flow rate of 0.01 
mL h
−1
. The flow rate required to achieve a Ca ≈ 1 required for spontaneous droplet 
formation in our channel would be 0.5 μL h
−1
. However, the periodic valve closure at 
the channel orifices of a hydrodynamic focusing junction using Braille actuation (Fig. 
4.1C and D) effectively generated droplets. We observed that sample evaporation did 
not have a dramatic effect on droplets for the two hour duration of our experiments 
performed under room temperature conditions. 
A range of monodisperse droplets of defined sizes and inter-droplet spacings could 
be formed by varying either the dextran/PEG flow ratio, the Braille pin actuation 
frequency, or both (Fig. 4.6). We produced droplet sizes between 0.9 nL and 3.4 nL 
with droplet spacings between 200 μm and 1400 μm. Increasing the PEG flow rate 
increased the spacing between droplets but not the size of the droplets (Fig. 4.6A). 
Decreasing the Braille actuation frequency increased both the droplet volume and the 
distance between drops (Fig. 4.6B). 
Although not all combinations of flow ratios and Braille actuation frequencies 
were tested, our results indicate that a large combination of droplet sizes and droplet 
spacings can be achieved by adjusting both the flow ratio and the Braille actuation 
frequency. Due to the high capillary number, droplets in motion assume a teardrop 
shape but assume a spherical shape once the flow is arrested (Fig. 4.6C and D). Thus, 
we demonstrate highly controlled low interfacial tension droplet formation using a 





We demonstrate an extension of a previously described backside diffused 
light lithography (BDLL) method
6
 to produce multi-level channels with strategically 
positioned channel orifices. The fabrication equipment required is inexpensive 
compared to conventional photolithography and the procedure is also straightforward 
involving only a single exposure and no alignment steps that are required in multi-
step multiple-mask procedures conventionally used for fabrication of multi-level 
features. Using our multi-level channel, we formed ATPS droplets at the lowest 
interfacial tensions reported to date. Such ATPS droplet formation capabilities are 
useful for biocompatible droplet-based cell patterning
13,20
 and production of 
monodisperse hydrogel particles.
19
 We also envision this straightforward 
microchannel orifice fabrication method to be useful for many applications beyond 








Fig. 4.1 (A) Photomask feature used to generate multi-level channels for ATPS 
droplet generation. White box: area of interest for (B, C and D). (B) Close-up view of 
the junction region of the photomask. White regions represent transparent portions of 
the mask. Dotted lines outline the actual channel feature obtained from this mask due 
to the channel widening effect of BDLL. M1: mask line width 1, M2: mask line width 
2, DPF: disconnected photomask feature. (C) Fluorescent image of an actual channel 
obtained from the mask. (D) Schematic of the side-view of the device shown in (C). A 
Braille pin aligned to the shallow orifice region allows for efficient channel valving. 




Fig. 4.2 Schematic of Backside Diffused Light Lithography. UV light passing the 
photomask diffuses radially in the cover glass to expose an area wider than the area of 
the photomask. The rounded shape results from a spatial-intensity profile that results 
from diffused and diffracted light. More detail and characterization of this process is 






Fig. 4.3 Photomasked for device in Fig.4.4. The device is of basic hydrodynamic 
focusing design save for Disconnected Photomask Feature (*) for the center channel 
that eventually becomes an orifice after BDLL. Photomask dimensions. PM1 L: 10.5 





Fig. 4.4 Device used for droplet generation. The device is of basic hydrodynamic 
focusing design save for a small orifice (*) for the center channel that allows for 
efficient channel valving by Braille actuation. Channel dimensions. C1 L: 10.6 mm, 




Fig. 4.5 (A) Fluorescent image of a multi-level channel with an orifice. The white box 
indicates the area used for profile plotting. CW1: channel width 1, CW2: channel 
width 2. (B) Profile plot indicating the calculated channel heights. (C) The maximum 
DPF that produces orifices. The increased photoresist thickness and associated light 
exposure allow for a larger DPF to be connected after development. All conditions 
below the points will form connected orifices (smaller DPF gives larger orifices). (D) 
Channel feature heights are smaller for smaller mask line widths. (E) For a fixed DPF 
and mask line width 2 of 1 mm (feature that gives rise to CW2 in (A)), the orifice 
height and width decrease with decreasing mask line width 1 (the mask feature that 
gives rise to CW1). With a large mask line width 1, the DPF needs to be increased to 




Fig. 4.6 Formation of aqueous two phase system (ATPS) droplets with a very low 
interfacial tension. (A) Varying dextran/PEG flow ratio changes distance between 
droplets, but the volumes of droplets remain constant. (B) Decreasing valving 
frequency increases the droplet volume and the inter-droplet distance. (C) Droplets in 
motion assume a teardrop shape due to the high capillary number of the system. (D) 
Phase contrast image of droplets at 1 : 7 flow ratio with 2.5 Hz, 1.25 Hz and 0.8333 
Hz shows that droplets conform to a spherical shape when the flow is terminated. 
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Precisely targeted delivery of cells and biomolecules within microchannels 
using aqueous two-phase systems 
 
Laminar and pulsatile flow of aqueous solutions in microfluidic channels can be 
useful for controlled delivery of cells and molecules. Dispersion effects resulting from 
diffusion and convective disturbances, however, result in reagent delivery profiles 
becoming blurred over the length of the channels. This issue is addressed partially by 
using oil-in-water phase systems. However, there are limitations in terms of the 
biocompatibility of these systems for adherent cell culture. Here we present a fully 
biocompatible aqueous two-phase flow system that can be used to pattern cells within 
simple microfluidic channel designs, as well as to deliver biochemical treatments to 
cells according to discrete boundaries. We demonstrate that aqueous two-phase 
systems are capable of precisely delivering cells as laminar patterns, or as islands by 
way of forced droplet formation. We also demonstrate that these systems can be used 
to precisely control chemical delivery to preformed monolayers of cells growing 
within channels. Treatments containing trypsin were localized more reliably using 





Microfluidic systems have been used extensively for analysis of drug and chemical 
actions on cells and to reveal mechanisms of cell-cell signaling through soluble 
factors (Torisawa et al. 2010; Wu et al. 2010; Young and Beebe 2010). Such systems 
provide a range of capabilities that are not available in conventional petri dish culture 
including the abilities to precisely manipulate small liquid volumes, localize 
treatments within cell populations and perform analyses on small numbers of cells 
(Olofsson et al. 2009; Villa-Diaz et al. 2009; Jovic et al. 2010; Liu et al. 2010). This is 
usually accomplished through generation of either laminar or pulsatile flow (Gu et 
al. 2004; Bransky et al. 2008). 
Laminar flow is among the most common methods for selective delivery of cells and 
molecules within microfluidic channels. This method has been used to deliver bacteria, 
blood cells, and many other mammalian cell types in controlled fashions (Takayama 
et al. 1999; Regenberg et al. 2004; Lucchetta et al.2005; Berthier et al. 2011). It has 
also featured in experiments that probe cell functions through delivery of selective 
treatments (Sawano et al. 2002). However, for most small molecules and proteins, as 
well as some larger particles, selective laminar flow delivery is usually limited to 
several millimeters from the convergence point of the laminar streams. Further 
downstream, diffusive effects can result in the formation of concentration gradients. It 
is possible to increase the distance over which selective treatments can be applied by 
increasing the velocity of flow, but this requires the use of either significantly larger 
sample volumes or significantly smaller channel sizes, and may result in undesirable 




Pulsatile flow is also useful for treating cells in microchannels and has been used in a 
variety of cell signaling experiments (Gu et al. 2004; Jovic et al. 2010). However, 
dispersion of materials during pulsatile flow is even more problematic than for 
laminar flow, limiting selectivity of treatments to the time/frequency domain. 
Furthermore, pulsatile flow is not amenable to cell patterning because most types of 
cells sediment as they move through channels resulting in rapid loss of pattern fidelity. 
Although diffusion gradients and dispersion of materials may be desirable for certain 
experiments, one can envisage a great number of experiments that could benefit from 
stable delivery of materials over the entire channel length. Therefore, in order to 
perform a more extensive repertoire of cell-based experiments in microfluidic 
channels it is necessary to establish methods for more selective in-channel cell 
patterning and chemical delivery over greater channel distances. 
This need is partially satisfied with biphasic flow, the most commonly used systems 
consisting of air-and-water or oil-and-water (Zheng et al. 2004; Guillot and 
Colin 2005; Teh et al. 2008; Brouzes et al. 2009; Vijayakumar et al. 2010). These 
systems provide high precision chemical separation and delivery; however, neither air 
nor oil are fully biocompatible with cells and can result in cells death due to 
mechanical disruption caused by surface stresses or non-biocompatible phase 
components (Bilek et al. 2003; Wei-Heong Tan2007). Recently, aqueous two-phase 
systems (ATPSs) have been incorporated in several cell-based microfluidic 
applications, including collection of plant and animal cells, separation of erythrocytes 
and leukocytes from whole blood, and production of polyethylene glycol diacrylate 
hydrogel microspheres (Yamada et al. 2004; Nam et al. 2005; Soohoo and 
Walker 2009; Tsukamoto et al. 2009; Ziemecka et al.2011). Other applications of 
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ATPSs in microfluidic systems include separation of proteins and nucleotides through 
continuous partitioning or by electrophoresis across the interface between the two 
polymer solutions (Hahn et al. 2011a, b). In contrast to other biphasic flow systems, 
ATPSs are fully biocompatible and are composed of phases that differ from each 
other only by the polymer constituents. The most commonly used ATPS for cell and 
biomolecule applications is the polyethylene glycol (PEG)-dextran system. Both PEG 
and dextran can dissolve in aqueous media, including cell culture media, at 
concentrations low enough to avoid damage to cells (Tavana et al. 2009). Furthermore, 
the PEG-dextran ATPS is capable of partitioning materials, i.e. the biomolecules or 
cells of interest can distribute preferentially to either PEG or dextran (Albertsson 1972; 
Yamada et al. 2004). 
Here we report the use of ATPSs in microfluidic channels for delivery of adherent 
cells and biomolecules to discrete channel regions. We demonstrate that mammalian 
cells can be directly patterned in precise laminar patterns or as islands by ATPS-
mediated delivery. Furthermore we demonstrate that ATPSs can be used to deliver 
chemical treatments to cells growing within microfluidic channels with higher 
precision than conventional aqueous buffers. 
 
5.2 Materials and Methods 
ATPS compositions 
ATPSs were formed by mixing equal volumes of stock solutions comprised of the 
following: i. 5.0% wt/wt PEG Mr 35,000 kDa (Sigma, St Louis MO) and 6.4% wt/vol 
dextran Mr 500,000 kDa (Pharmacosmos A/S, Denmark) or ii. 14.0% wt/wt PEG Mr 
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35,000 kDa and 14.0% wt/wt dextran Mr 10,000 kDa (Pharmacosmos). The resulting 
emulsions contained final concentrations of 2.5% PEG and 3.2% dextran for the 
dextran Mr 500,000 kDa system and 7.0% PEG and 7.0% dextran for the dextran Mr 
10,000 kDa system. The emulsions could be separated into distinct phases by gradual 
overnight equilibration or by centrifugation at 4000 RCF for 15 min. For cell 
patterning, polymers were dissolved in DMEM containing 10% FBS by gently 
triturating the solutions until all polymer particles were completely dissolved. For 
trypsin delivery, polymers were dissolved in F12K CO2 independent medium without 
FBS. 
To improve partitioning to the dextran phase, trypsin was mixed with negatively 
charged carboxymethyl dextran (CM-dextran) (Sigma) prior to addition to the 
equilibrated dextran phase. The final concentration of CM-dextran in the dextran 
phase was 0.1 mg/mL. The final concentration of trypsin (Worthington, Lakewood, 
NJ) was 900 Units/mL. 
Channel Designs 
Simple microfluidic channel designs were selected to highlight the general utility of 
ATPS-mediated cell and reagent delivery. Laminar flow was generated using several 
flow focusing channels of varying geometries that were created using standard 
photolithographic and soft lithographic processes (McDonald et al. 2000). The first of 
these designs was a flow focusing channel with three inlet channels and a main 
channel of 25 mm in length and either 1.5 or 1 mm in width, 0.1 mm in height. The 
width of the central channel in the hydrodynamically focusing geometry (PEG 
channel) was either 0.25 or 0.5 mm and could be used to adjust the width of the PEG 
divider stream in the main channel independent of volumetric flow rate. The second 
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design consisted of seven inlets with a 25 mm-long main channel, 1.5 mm wide and 
0.1 mm in height. This device could be used to generate four laminar dextran streams 
separated by three PEG streams. 
Droplet dispensing devices were created using backside photolithography and 
contained two dispensing orifices flanked by PEG focusing channels with a central 
PEG channel separating the two orifices (Futai et al. 2004). PDMS replicas were 
bonded to 100 μm-thick PDMS membranes to permit Braille actuation at the orifices. 
Cell Culture 
The C2C12 myofibroblast cell line was used for all experiments. C2C12 cells were 
maintained in DMEM with 10%FBS in a humidified CO2 incubator at 37°C. Cells 
were seeded in fibronectin-coated microfluidic devices at a final density of 20,000 
cells/uL. Prior to seeding, cells were labeled with CellTracker dyes or Hoechst 33342 
(both from Molecular Probes, Carlsbad, CA) as per manufacturer instructions and 
washed and centrifuged twice to remove excess dye. Cells were then suspended in 
dextran solutions and drawn into plastic syringes fitted with Tygon tubing to interface 
with microfluidic devices. 
For laminar cell patterning, cells were seeded in the dextran phase into either three 
channel or seven channel devices with dextran/cell channels separated by PEG. Once 
two-phase laminar flow became stable, devices were disconnected from the flow 
sources and placed in a 37°C CO2 incubator for 1 h to allow cells to attach. ATPS 
solutions were then replaced by cell culture medium and cells were incubated for an 
additional 24 h before microscopic analysis. 
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Islands of cells were seeded by way of Braille-actuated droplet formation in bell-
shaped channels (Futai et al.2004; Gu et al. 2004). FITC dextran was added to the cell 
dextran mixture to facilitate alignment of the dextran/cell dispensing orifices with the 
Braille actuation pins. Initial flow rates of 0.3 mL/h for PEG and 0.05 mL/h for 
dextran were used to establish laminar flow in Braille devices and clear the channels 
of loosely adherent cells that entered the channels during flow stabilization. This flow 
rate was gradually reduced to 0.15 mL for PEG and 0.002 mL/h for dextran to allow 
droplet formation to occur. Droplet size and spacing were controlled by modifying the 
Braille pin actuation interval and PEG/dextran flow ratio. After stable droplets 
containing cells were formed the channels were clamped shut at both upstream and 
downstream regions to arrest droplet movement. Cells were then allowed to attach to 
the channels for 1 h before the ATPS medium was replaced with culture medium. 
Selective treatment of cells with biomolecules was demonstrated on cells cultured to 
confluence in laminar flow focusing devices. Trypsin was delivered to cells for 5 min. 
ATPS/trypsin treated regions were compared to both the non-treated side of the 
channel and channels treated with biomolecules dissolved in medium without the 
ATPS. 
Staining, microscopy and statistical analysis 
Cell-patterned devices were fixed in 4% paraformaldehyde after 24 h of culture and 
then washed twice with PBS. Devices used for biomolecule delivery were fixed 
immediately after treatment. Actin cytoskeleton staining was performed by staining 
cells with Alexa-568 phalloidin (Molecular Probes) as per manufacturer instructions. 
Nuclear staining was achieved by labeling cells with Hoechst 33342. 
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Imaging was performed on a Nikon SMZ 1500 stereoscope and Nikon TE300 
inverted microscopes equipment with mercury excitation sources (Nikon, Tokyo, 
Japan). Image collection and analysis was performed using simple PCI (Hamamatsu, 
Sewickley, PA), Metamorph (Molecular Devices, Sunnyvale, CA) and Image J 
software. Statistical analyses were performed using SigmaPlot and SigmaStat (Systat 
Software, Chicago, IL) 
 
5.3 Results and Discussion 
Characteristics of ATPS flow in microchannels 
ATPSs could be delivered as laminar streams using simple y-type or t-type channel 
designs. In contrast to laminar flow of polymer-free buffer solutions such as PBS, 
ATPS laminar flow required greater relative volumetric flow ratios of dextran to PEG 
to achieve similar channel occupancy of the laminar streams. The fractional channel 
occupancy differed for each phase systems due to viscosity differences between 
dextran and PEG which were dependent on both polymer concentration and molecular 
weight. Laminar streams of dextran and PEG could be differentiated based on the 
presence of discrete phase boundaries (Fig. 5.1(a)). As expected, molecules placed 
within one phase of the two-phase system were often strongly retained within that 
phase and displayed little diffusive dispersion in downstream channel regions as 
compared to PBS controls (Fig. 5.1(a-d)). 
The lack of diffusive dispersion, due to molecule partitioning, is governed by specific 
energetic and affinity interactions between the molecules of interest and one or both 
of the phases(Albertsson 1972). Red food colorant and Coomassie G250 both 
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partition almost exclusively to the PEG phase and clearly demonstrate that ATPS 
delivery in laminar streams can selectively confine chemicals to discrete channel 
regions more effectively than aqueous buffers alone (Fig. 5.1(c), (d)). Based on these 
initial observations, we sought to exploit ATPS partitioning properties to more 
effectively deliver both cells and bioactive molecules within microchannels. In order 
to more effectively control the delivery of these materials within channels we 
generated calibration curves for dextran/PEG channel occupancy as a function of 
volumetric flow ratio (Fig. 5.1(e)). 
Patterning cells by ATPS laminar flow 
Laminar flow of ATPS could be used to establish clear laminar patterns of adherent 
cell in t-type microchannels (Fig. 5.2(a-c)). By varying the number of inlet channels it 
was possible to establish up to four laminar streams for patterning adherent cells (Fig. 
5.2(d), (e), (h)). By varying the width of the PEG spacing channel or by decreasing 
the dextran/PEG flow ratio it was possible to obtain cultures that displayed no gaps 
(Fig. 5.2(d), (h)), small gaps (Fig. 5.2(f)), or large gaps between cell populations. 
Using this method multiple populations of cells could be directly seeded into 
microchannels as laminar patterns. After devices were removed from the syringe lines 
cells attached to the channel surfaces within 1 h. Cells remained organized in their 
initial patterns for at least 24 h after seeding. We found that this method of cell 
delivery was compatible with both active pumping by syringe pump as well as gravity 
or capillary driven flow. Furthermore, ATPSs retained their patterns even after flow 
was removed, remaining laminar long enough for cells to sediment and begin 
attaching to the channels. 
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Laminar patterns of adherent cells will be useful for experiments that seek to 
investigate the interactions of multiple cell populations under flow conditions. 
Additionally, the ability to directly pattern gaps between populations of cells will 
facilitate in-channel migration assays. 
Patterning islands of cells through forced ATPS droplet formation 
Laminar cell patterning can be useful for a variety of migration and co-culture assays 
in which it is convenient for cells to be patterned on opposite sides of channels. 
However, some experiments may seek to explore radial migration phenomena and 
colony migration under flow conditions, or to observe effects of unidirectional 
signaling of soluble factors. Therefore, it will also be useful to pattern cells in 
additional configurations such as islands along the length of channels. This cannot be 
achieved by pulsatile flow of conventional aqueous solutions due to dispersion effects. 
However, ATPSs permits the formation of controlled dextran droplets surrounded by 
PEG. Cells are contained within the dextran droplets by the interfacial tension 
between the two polymer phases. 
To control droplet formation, we used a computerized Braille microfluidic platform to 
valve bell shaped channels by way of pin actuation. This allowed us to control droplet 
size and spacing and to arrest the droplets for cell attachment to occur (Lai et 
al. 2011). Using two actuation orifices, we were able to form alternating droplets of 
dextran within a PEG-filled channel (Fig. 5.3(a), (b)). After droplets were arrested in 
the channels, cells remained associated with the dextran phase (Fig. 5.3(b-d)). By 
alternating the actuation timing of the dextran channels we could rapidly produce 
alternating droplets containing different materials as indicated by the presence of 
alternating droplets containing either FITC or TRITC labeled dextran (Fig. 5.3(b)). 
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When cell tracker labeled C2C12 cells were incorporated into the dextran phase, 
alternating colonies of red and green Cell Tracker-labeled cells were observed that 
readily adhered to the channel surface (Fig. 5.3(c), (d)). 
Selectivity of biomolecule delivery can be improved using ATPSs 
Many biomolecules and particles partition within ATPSs to either dextran or PEG. 
Partitioning is influenced by the size of the molecule or particle, its charge, specific 
interactions with the phase-forming polymers, and properties related to phase system 
composition such as molecular weight of the polymers (Albertsson 1972). Cells 
partition well in the dextran Mr 500,000 phase system; however, many biomolecules 
partition weakly to dextran in this phase system. Thus, in order to increase specificity 
for the dextran phase during delivery, we used dextrans of lower molecular weight 
and incorporated charged dextrans to interact electrostatically with the molecules of 
interest. 
The effects of trypsin were more selective when ATPS was used as a delivery 
medium. Trypsin, a 23 kDa enzyme, can be used to rapidly dissociate cells from their 
substrate by cleaving a variety of proteins that mediate cell adhesion and has been 
used previously to remove cells within microfluidic channels (Takayama et al. 1999; 
Nie et al. 2007; Villa-Diaz et al. 2009; van der Meer et al. 2010). Trypsin exists 
primarily as a cationic protein, and thus we expected its selectivity for dextran to be 
enhanced through the addition of negatively charged dextran (CM-dextran). When an 
ATPS was used as the delivery medium, trypsin activity was confined exclusively to 
the dextran treatment phase (Fig. 5.4(a), (e), (g)). When a conventional aqueous 
delivery medium was used, cells on both sides of the channel were affected by trypsin, 
although cells on the treated side were more thoroughly dissociated (Fig. 5.4(b), (f), 
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(h)). The intensity profile of Hoechst-labeled cells served as a quantifiable measure of 
cell dissociation (Fig. 5.4(c), (d)). ATPS delivery resulted in a strict boundary, 
whereas conventional aqueous delivery resulted in a gradient effect (Fig. 5.4(c), (d)). 
This can be appreciated by measuring the slope of the signal intensity profile in the 
center of the laminar region of the channel (Fig. 5.4(d)). The effects of ATPS on 
trypsin selectivity could be readily observed both in upstream laminar regions (Fig. 
5.4(e)) but also for laminar regions near the end of the channel (Fig. 5.4(g)). 
Collectively these results demonstrate that ATPS delivery in microchannels is capable 
of more selective confinement of molecule to parts of microfluidic channels than is 
conventional aqueous delivery. This can result from several factors that influence 
selectivity. First the higher viscosity of the ATPS results in more limited diffusion 
than for other less viscous aqueous mediums. However, this factor alone cannot 
account for the apparent selectiveness of ATPS delivery. The most critical factor is 
the partitioning behavior of the ATPS. This will vary based on the molecule of 
interest and the composition of the ATPS, however most molecules partition to one 
phase or the other. Molecules that partition strongly to the dextran phase will be well 
maintained regardless of the flow rate or viscosity of the systems. Molecules that 
favor PEG can also be confined to half of the channel based on the configuration of 
the phase system. In this case molecules are confined to one side of the channel both 
by viscous-limitations to diffusion and active partitioning into a thin PEG divider. 
This concept is illustrated in Fig. 5.5. 
Based on calculation for steady state diffusion from a semi-infinite source, we 
estimate that ATPS can perform at least twice as well as conventional laminar 
delivery under slow flow or arrested flow conditions (assuming only modest (kpart of 
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trypsin ~0.6) partitioning of molecules) (Takayama et al. 2003; George et al.2008). If 
molecules display an even stronger preference for a single phase, this advantage is 
further enhance as a function of the partition coefficient. At higher flow rates we 
would expect the performance of the ATPS to be even better, although the advantage 
relative to conventional laminar flow becomes less dramatic. However, the only 
scenario in which ATPS does not provide enhanced selectivity is for molecules that 
distribute equally among phase, which rarely occurs. 
 
5.4 Conclusions 
We demonstrate that ATPSs can be used to compliment a variety of microfluidic 
techniques used to culture mammalian cells. We used both the interfacial and 
partitioning properties of the ATPS to enhance delivery of cells and molecules within 
microfluidic channels. For cell delivery we demonstrated that up to four populations 
of adherent cells can be patterned simultaneously. We also demonstrated that cells can 
be encapsulated within dextran droplets and delivered within PEG to produce patterns 
of small colonies or islands. Additionally, we achieved enhanced selectivity of 
chemical delivery to cells using an ATPS. This was accomplished for trypsin, and 
permitted more selective cell harvesting. We propose a model for selective delivery 
based on the viscosity of ATPS, partitioning behavior and configuration of the phases 





Fig. 5.1 Characteristics of ATPS flow in Microchannels. (a). An ATPS displays a 
clear phase boundary when delivered as laminar streams within a PDMS-glass 
microchannel. Food colorants are clearly retained in PEG within the phase boundary. 
(b). Buffer solution do not display partitioning and have no phase boundary. 
Molecules diffuse laterally as laminar streams move through the channel. The 
diffusion characteristics of red food colorant (c) and Coomassie G250 (d) were 
plotted based on intensity of dye across the channel. The shaded regions of these plots 
correspond to the actual channel occupancy of the stream immediately downstream 
from the channel junction. ATPS solutions maintain a strict boundary at regions 
further downstream whereas buffers allow molecules to diffuse from these regions. (e). 
Example of volumetric flow calibration curve used to determine fractional channel 





Fig. 5.2 Precise laminar patterns of adherent cells can be generated through ATPS 
laminar flow patterning. (a). Schematic of cell delivery in dextran with a central PEG 
spacer. (b). A two cell-type device design. (c). A four cell-type device design. (d-e). 
Two populations of C2C12 cells labeled with cell tracker green and cell tracker red 
were patterned using the minimum PEG spacer. (f-e). By using devices of different 
PEG channel width it is possible to change the gap between cell populations using 
identical volumetric flow conditions as evidence by actin-phalloidin staining of fixed 
patterned cells. (h). it was demonstrated that up to 4 cell populations can be patterned 
simultaneously. Patterned cells were pre-stained with green cell tracker, red cell 




Fig. 5.3 Braille microfluidics can be used to directly pattern islands of cells by way of 
forced ATPS droplet formation. (a). Schematic of a Braille device with sites of 
actuation (blue marks) and clamp sites for arresting flow (black arrows). (b). Using 
alternating actuation of Braille orifices it is possible to deliver alternating droplets of 
dextran within PEG, as evidenced by several consecutive droplets containing either 
TRITC-dextran (red) or FITC-dextran (green) (c-d). When cells are incorporate into 
droplets it is possible to deposit alternating islands of cells that remain patterned for at 




Fig. 5.4 Trypsin delivery is well confined by ATPSs. (a). Representative image of 
Phase Contrast/Hoechst-labeled cells following ATPS delivery of trypsin on the right 
side of the channel. (b). Representative image of aqueous delivery of trypsin showing 
effects on both sides of the channel. (c-d). Intensity profiles reveal a clear boundary 
for ATPS delivery and a gradient effect for aqueous delivery. (e-h). Boundaries are 
maintained in both upstream and downstream channel regions for ATPS delivery 
whereas aqueous delivery shows a gradient effect across the width of the channel that 
is apparent in all channel regions. Scale bar = 200 um, n = 3 observations, curves 
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Simple multi-level microchannel fabrication by pseudo-grayscale backside 
diffused light lithography 
 
Photolithography of multi-level channel features in microfluidics is laborious and/or 
costly. Grayscale photolithography is mostly used with positive photoresists and 
conventional front side exposure, but the grayscale masks needed are generally costly 
and positive photoresists are not commonly used in microfluidic rapid prototyping. 
Here we introduce a simple and inexpensive alternative that uses pseudo-grayscale 
(pGS) photomasks in combination with backside diffused light lithography (BDLL) 
and the commonly used negative photoresist, SU-8. BDLL can produce smooth multi-
level channels of gradually changing heights without use of true grayscale masks 
because of the use of diffused light. Since the exposure is done through a glass slide, 
the photoresist is cross-linked from the substrate side up enabling well-defined and 
stable structures to be fabricated from even unspun photoresist layers. In addition to 
providing unique structures and capabilities, the method is compatible with the 
“garage microfluidics” concept of creating useful tools at low cost since pGS BDLL 
can be performed with the use of only hot plates and a UV transilluminator: 
equipment commonly found in biology labs. Expensive spin coaters or collimated UV 
aligners are not needed. To demonstrate the applicability of pGS BDLL, a variety of 
weir-type cell traps were constructed with a single UV exposure to separate cancer 
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cells (MDA-MB-231, 10–15 μm in size) from red blood cells (RBCs, 2–8 μm in size) 
as well as follicle clusters (40–50 μm in size) from cancer cells (MDA-MB-231, 10–
15 μm in size). 
 
6.1 Introduction 
The direction of microfluidics as a field is toward more complex operations, and 
complexity embedded within the device design is especially attractive. Multi-level 
channel designs have useful applications in microfluidic devices to embed complex 
operations into the device while insulating the complexity from the user (no need for 
additional external controls and robust function). Such multi-level channel designs 
have been used for chaotic mixers,
1
 weir-type cell traps for cell isolation,
2
 and weir-
type cell traps for cell fusion.
3
 The lack of moving parts allows for simple operation, 
however typical applications of such microfluidic devices necessitate the rapid-
prototyping process to be quick and cost efficient. 
Fabrication of multi-level channel features in microfluidics typically requires 
multiple exposures where each layer is serially spun, each photomask precisely 
aligned, and exposed by ultraviolet (UV) light. Alternative methods of producing 






  laser 
fabrication,
7









  deformable molds,
12
  and liquid molding
13
 are also 
laborious and/or require specialized equipment. 
The intrinsic limitation of typical photomask-based photoresist patterning methods 
is the binary nature of an all-or-none illumination of exposed areas. Thus, many 
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groups have used grayscale photomasks to generate a range of illumination densities 
using a single exposure. Grayscale photolithography suffers from high costs because 
grayscale photomasks are generated using scanning lasers,
14
 ultra-high resolution 
binary masks,
15
 variable Inconel deposition on glass,
16
 or High-Energy Beam 
Sensitive (HEBS) glass.
17
 Low-cost alternatives to grayscale photolithography are 
complex, requiring the use of a microfluidic photomask.
18
Most grayscale 
photolithography use positive photoresists
14–18
 that are less common in microfluidic 
device fabrication. Negative photoresists have been used in conjunction with 
grayscale exposure techniques, however the resulting channels were of low resolution 
and on the order of milimetres.
19
 Others have used negative photoresists for multi-
level photolithography with the use of 3D diffusers
20
 and digital micro-mirror 
devices.
21
 However each study was either unable to fabricate multi-level features 
independent of feature width in a single exposure or required a relatively sophisticated 
semiconductor mask that may deter non-microfluidic scientists from adopting 
microfluidic technology. BDLL has been used to create microfluidic devices with 
bell-shaped cross-section microchannels
22
 and multi-layered orifices with 
disconnected photomask features.
23
 While this technology has been capable of fine 
control of short-range tapering and orifice heights, the method has lacked the ability 
to sustain long channels of varying height. BDLL with pGS photomasks overcomes 
this shortcoming while maintaining cost-effectiveness and simplicity for the 
fabrication of microfluidic devices in a single UV exposure. 
Cell separation by size is applicable to cancer research for uses including 
identification of metastatic cancer cells in blood
24
 and separation of cancer cells from 
follicles in oncofertility preservation for young women.
25,26
 We use pGS BDLL as a 
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tool to create multi-level weir-type cell traps using only equipment commonly found 
in many biology labs. This technology increases the accessibility of microfluidics, 
making a powerful and ever-expanding tool chest of experimental techniques 
available to more researchers in multiple fields. 
 
6.2 Materials and Methods 
Characterization of pGS BDLL 
pGS masks were printed by CAD/Art Services (Bandon, OR) at 20 000 DPI. 
Individual pseudo-gray areas were created using an isotropic pattern of binary opaque 
and transparent 10 by 10 μm squares (Fig. 6.1a). With such patterns, areas of 100%, 
25%, 19.8%, 16%, 13.2%, 11.1%, 9.5%, 8.2%, 7.1%, 6.2%, 5.5%, 4.9%, 4.4%, 4%, 





 μm on the photomask for pGS BDLL. 
Device fabrication and channel characterization 
pGS masks with varying per cent transparent areas were used for BDLL as described 
previously
22,23
 and illustrated in Fig. 6.1b. Negative photoresist (SU-8 2075 and 2025, 
MicroChem, Newton, MA) was deposited on coverglass slides at 50 μm, 100 μm, and 
200 μm with a spin coater and SU-8 2075 was also deposited onto the same 
coverglass slides (Fisher Scientific, Waltham, MA) without the use of a spin coater to 
produce a 1200 μm thick layer of photoresist (Fig. 6.1c). 
Each thickness and per cent transparent condition was exposed at four durations: 
90 s, 135 s, 180 s, and 225 s on an 8 mW cm
−2
 UV illuminator (816A Ultraviolet 
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Transilluminator, Fisher Scientific, Waltham, MA) to demonstrate the effect of per 
cent transparent and exposure time and spin/unspun height on resultant channel height 
on the SU-8 mold. Soft bake, and post exposure bake conditions were controlled 
according to spin height per manufacturer recommendations. In the unspun condition, 
since there was no manufacturer recommendation, a soft bake of 15 min at 65 °C and 
90 min at 95 °C and a post exposure bake of 10 min at 65 °C and 30 min at 95 °C was 
used. 
Conventional soft lithography was used on these SU-8 molds to produce 
polydimethylsiloxane (PDMS, Dow Corning, Midland, MI) devices. The resultant 
PDMS channel heights were determined using light microscopy as well as 




MDA-MB-231 cancer cell transfection and cell culture 
We previously described MDA-MB-231 human breast cancer cells stably transduced 
with green fluorescent protein (GFP).
31
 Growth media consisted of Dubelco's 
Modified Eagle Medium supplemented with 10% fetal bovine serum and 1% 
antibiotic–antimycotic (Life Technologies, Carlsbad, CA). Upon confluence, cells 
were washed with phosphate buffered saline, trypsinized, resuspended in growth 
medium, and used in experiments at the concentrations specified. 
Enzymatic digestion of ovarian tissue and follicle isolation 
For all experiments, we isolated ovaries from 6–8 days old female mice F1 
CBA/JxC57BL/6N. Ovaries were extracted and separated from the connective tissues 
and enzymatically digested in 20 μL (13 Wünsch units per mL) liberase DH (Roche, 
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Indianapolis, IN) in 500 μL L15 (Leibovitz's) media (Sigma-Aldirch, St. Louis, MO). 
The total digestion time was 1 h at 30 °C and every 15 min, enzyme digested pieces 
were dispersed by gentle pipetting to isolate follicles.
32
 The enzyme digestion was 
arrested by adding 10% serum and the suspension of the follicles and stromal cells 





 suspension) were added to the follicle-stromal cell suspension to mimic the 
scenario of cancer cell contaminated tissue. A dramatically higher amount of cancer 
cells than what is clinically expected was used to facilitate calculation of isolation 
efficiency. 
Red blood cell, cancer cell and follicle sorting 
Cells and follicles were sorted using multi-level channels to produce weir-type traps. 
Devices were fabricated using pGS BDLL with channel heights of 58 μm and weir-
type traps of 21 to 8 μm in height for blood sorters and channel heights of 120 μm and 
20 μm traps for the follicle sorters. Blood sorting devices were passively driven using 
a 3 cm positive height differential. The effectiveness of the weir-type trap can be 









, Lampire, Pipersville, PA) 
are freely allowed to pass through. Follicle sorting devices were driven passively in 
the form of a suction channel by a 7 cm negative height differential on the opposing 
end of the weir-type trap to filter 500 μL L15 medium containing ovarian follicles and 
cancer cells followed by 500 μL L15 media containing no cells to flush most 
remaining cells and debris through the follicle trap. Ovarian follicles were extracted 
by reversing the height differential between the inlet and the outlet and collecting 




6.3 Results and Discussion 
Characterization of pGS BDLL 
pGS BDLL is capable of producing multi-level microfluidic devices at superior levels 
of cost-efficiency and simplicity over conventional photolithography, alternative 
multi-level fabrication techniques and previous grayscale photomask technologies. A 
relatively low-cost, low-resolution photomask printed on transparency sheets was 
used to create an isotropic pattern of binary opaque and transparent 10 by 10 μm 
squares to produce channels of different heights by BDLL with SU-8 negative 
photoresist (Fig. 6.1a and b). This same technique was also demonstrated using 
unspun layers of SU-8 approximately 1200 μm thick (Fig. 6.1c). 
Of note, the rough surface of the unspun SU-8 yields smooth and uniform features 
(Fig. 6.1d) comparable to traditional photolithography masters. This is made possible 
by the relatively small effect of film height on resultant channel height especially for 
very thick SU-8 films (1200 μm) where even substantial ( 100 μm) differences in 
film thickness have negligible effect on resultant channel height. Since UV light 
exposes the photoresist through the substrate in BDLL, a low amount of UV light is 
used such that the depth penetration of the UV light is small relative to the film 
thickness. The roughness of the film surface opposite of the UV light source has no 
effect on the resultant microchannel. As the UV light is uniformly and carefully 
controlled with the pGS photomask, uniform channel features can be fabricated from 
an unspun photoresist layer even with an extremely rough surface. A high-
magnification SEM image of the resultant SU-8 molds (Fig. 6.2) to demonstrate 
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flatness of resultant channels. At 1200× magnification, it becomes clear that the 
surface contains dimple-shaped imperfections. The random manner of the 
imperfections suggests that they arise from UV light diffracted by dust and/or 
scratches on the UV transilluminator, quartz glass and/or coverglass and not from the 
repeating binary pattern of opaque and transparent squares. 
To demonstrate the utility of pGS BDLL over conventional photolithography, we 
produced a device to separate red blood cells (RBC) from cancer cells (MDA-MB-
231) using nine different levels of per cent transparent to produce an array of weir-
type traps of eight different heights (one source channel height and eight weir-trap 
heights). The equivalent sorter device developed using conventional lithography 
would require 9 layers of photoresist deposition involving 5 different types of SU-8 
photoresist (2075, 2025, 2005, 2002, and 2000.5) and 9 individual spin coating cycles, 
pre-exposure bakes, UV exposure, and post-exposure bakes. 
Fabricated channel height can be finely controlled down to 8 μm by a combination 
of per cent transparent area of the pGS mask as well as the exposure time of the UV 
transilluminator. Furthermore, devices designed for cell sorters were fabricated using 
unspun SU-8 without the use of spin coaters. The effect of exposure time was 
characterized for each spin height and unspun photoresist thicknesses for 100% 
transparent photomasks (Fig. 6.3). Our findings show a relationship between exposure 
time and channel height and is in agreement with manufacturer specifications for 
suggested exposure times for conventional photolithography. We discovered that the 
resultant channel heights are somewhat dependent on film thickness especially at 
thinner film thicknesses but independent of over-baking during post-exposure bake 
(data not shown). The effect of pGS BDLL was further characterized by analysing the 
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effect of per cent transparent pGS photomasks for each photoresist thickness and 
exposure time. Together, these two parameters determine the exposure energy 
according to eqn (1): ETotal = IUV*T*t, where ETotal is the total exposure energy [mJ 
cm
−2
], IUV is the intensity of the UV light source [mW cm
−2
], T is the transparent 
fraction of the mask [unitless], and t is the exposure time [sec]. For a given film 
thickness (even unspun layers), exposure energy can be modulated to generate a wide 
range of feature sizes in a reproducible fashion (Fig. 6.4). 
The usefulness of microfluidics for biological applications is clear, however, the 
adoption of microfluidic tools by biology labs is stunted by the need for specialized 
photolithography equipment such as spin coaters and collimated UV light 
aligners.
27
 The characterization of pGS BDLL for the fabrication of microfluidic in 
this work makes sophisticated multi-level device fabrication accessible to a wide 
array of biology labs. pGS BDLL only requires hot plates and a UV transilluminator: 
equipment normally used for DNA and protein analysis and common to most biology 
labs. The adjustability of pGS BDLL was used to construct weir-type traps for two 
cell separation applications requiring distinctly different ranges of channel heights. 
Cell sorting of MDA-MB-231 cancer cells from red blood cells (RBCs) 
Blood analysis of cancer patients for circulating tumour cells (CTCs) is an active area 
of research with potential for advanced prognosis and identifying individual-specific 
therapeutic response.
28–30
 As such, the effective use of microfluidics for the rapid 
detection of CTCs within patient blood has high potential to be a cost-effective 
method toward fast and individualized patient care. 
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Motivated by future applications in analyses of blood samples from cancer patients, 
we used pGS BDLL to generate a mold for soft lithography to produce multiple multi-
level PDMS channels simultaneously and inexpensively. A prepared mixture of red 
blood cells and breast cancer cells were passed through a device with multiple types 
of weir structures with different sized traps to screen for the optimal structure where 
cancer cells could be trapped but red blood cells pass through. The effectiveness of 
the cancer cell trap diminished as the weir-type trap size increased from 8 to 21 μm, 
where it can no longer trap cells of similar size (Fig. 6.5). 
Cell sorting of murine follicles from stromal cells and MDA-MB-231 cancer cells 
Cell-size based separation of different cell types poses a potential application in the 
field of fertility preservation in cancer survivors. Ovarian tissue can be removed prior 
to the whole body exposure to toxic chemotherapy, cryopreserved and later 
transplanted back to the patient to restore fertility. The major drawback of the tissue 
autotransplantation is the potential risk of reintroduction of cancer cells back to the 
patient. Ovarian follicles, the functional units of the ovary, can be mechanically or 
enzymatically isolated from other cell types and transplanted back to the patient as a 
pure population of the reproductive units using current tissue engineering techniques. 
With future potential applications of clinical treatment-scale separation of ovarian 
follicles from cancer cells as a motivation, we used pGS BDLL to create a mold with 
a wide structure for soft lithography to produce a PDMS device with increased 
separation capacity to isolate the large ovarian follicles from the smaller cancer cells. 
Our design was effective at sorting of follicles from stromal and cancer cells. In 
these trials, 88% of the cancer cells were removed while 84% of ovarian follicles 
were recovered, as shown from examination of cell mixture before and after sorting 
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by a microfluidic device (Fig. 6.6). Our experimental observations suggest a fraction 
of cancer cells failed to be isolated from follicles due to the cancer cells adhering to 
the extracellular matrix around the follicles. More experimentation will reveal the 
collagenase and liberase activity for the optimum cancer cell removal. In a clinically 
relevant scenario, we anticipate that an 88% contaminant removal may be enough to 
eliminate all cancer cells. 
Disadvantages of pGS BDLL 
Despite ease of fabrication of multi-level microchannels using pGS BDLL, it is 
difficult to stably fabricate microchannel features of width and length <100 μm. Due 
to the lower adhesion of SU-8 to the glass substrate relative to conventional silicon 
wafers, features of aspect ratio <1 are easily washed off during development process. 
Finally, although it is possible to fabricate multi-level microfluidic devices with 
unspun SU-8 films, the process uses a large amount of negative photoresist. Long and 
frequent use of pGS BDLL for device fabrication will eventually justify the purchase 
of a spin coater to decrease SU-8 usage per device fabricated. 
 
6.4 Conclusions 
Despite the proven usefulness of microfluidics for biological applications, its 
widespread use is still deterred by the need for specialized equipment needed for 
photolithography. This work demonstrates a microfluidic device fabrication technique 
using only equipment commonly found in biology labs. Furthermore, we show the 
ability of pGS BDLL to fabricate sophisticated multi-level devices that are otherwise 
highly laborious to create using conventional photolithography. To explore potential 
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cancer research applications as well as to demonstrate the range of structures pGS 
BDLL is capable of creating, we developed two application specific devices. One is a 
device with multi-channel, multi-height narrow weir-type traps that can screen 
designs that are best for trapping metastatic cancer cells in blood while letting red 
blood cells flow through. Another is a large-width weir-type trap for the isolation of 
follicle clusters from a mixture that contains unwanted stromal and cancer cells. 
While our demonstrations focused only on cancer diagnosis and oncofertility 
preservation, the technique should be broadly useful anywhere rapid prototyping of 







Fig. 6.1 a) pGS photomask. Binary patterns of transparent/opaque squares produce 
different levels of “gray”. Transparent squares are 10 μm by 10 μm. b) Schematic of 
BDLL. UV light from the UV transilluminator passes through the pGS photomask 
and glass substrate to expose SU-8 to produce rounded channels of different height 
depending on how much energy is allowed to pass through the pGS photomask. c) 
Unspun layer (1200 μm) of SU-8 on glass slide. The surface is crude, normally 
ineffective for conventional photolithography. d) However, an unspun layer of SU-8 
can be used to reliably fabricate multi-layered microfluidic channels using pGS 




Fig. 6.2 SEM image of a 24 μm tall channel using unspun SU-8 at 8.16% transparent 




Fig. 6.3 Using 100% transparent photomasks, different heights can be generated by 
changing exposure time. The resultant channel height from BDLL is also dependent 





Fig. 6.4 Using pGS photomasks, the total amount of energy used to expose the 
photoresist can be controlled using gray scale level and/or exposure time allowing for 
the fabrication devices with multiple channel heights in a single UV exposure. Total 
energy is calculated using the percent gray value, exposure time, and the intensity of 





Fig. 6.5 pGS BDLL was used to produce PDMS microfluidic devices with 8 weir-
type traps. PBS containing red blood cells and GFP-MDA-MB-231 cancer cells were 
passively driven through the weir-type traps by a 3 cm height differential to simulate 
the trapping and florescence microscopy was used for identification of CTCs trapped 
within the weir-type traps. The efficiency of weir-type traps depends on the height of 
the trap produced by pGS BDLL and is evidenced by the slippage and trapping of 
cancer cells while RBCs are allowed to freely pass through. Each channel is 





Fig. 6.6 Follicle sorting from GFP-MDA-MB-231 cancer cells. To further 
demonstrate the range of possible channel heights and their applications, a separate 
larger PDMS weir-type trap was produced with unspun SU-8 molds using pGS BDLL. 
Scale bar: 500 μm. a) Device schematic. b) Cancer cells were added into a solution 
containing primordial follicles within a petri dish. c) Follicles are trapped by weir-
type traps while undigested collagen matrix squeezes through and cancer cells freely 
pass through. Flow was passive driven by a 7 cm height differential via suction of the 
outlet. d) The trapped follicles can be extracted from the device onto another petri 
dish by reversing the height differential of the inlet/outlet after a short flushing period 
with culture medium. The efficiency of cancer cell elimination is 88% and follicle 
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Label-Free Direct Visual Analysis of Hydrolytic Enzyme Activity Using Aqueous 
Two-Phase System Droplet Phase Transitions 
 
Dextran hydrolysis-mediated conversion of polyethylene glycol (PEG)-dextran 
(DEX) aqueous two-phase system droplets to a single phase was used to directly 
visualize dextranase activity. Dextran droplets were formed either by manual 
micropipetting or within a continuous PEG phase by computer controlled actuation of 
an orifice connecting rounded channels formed by backside diffused light lithography. 
The time required for the two-phase to one-phase transition was dependent on the 
dextranase concentration, pH of the medium and temperature. The apparent Michaelis 
constants for dextranase were estimated based on previously reported catalytic 
constants, the binodial polymer concentration curves for PEG-DEX phase transition 
for each temperature and pH condition. The combination of a microfluidic droplet 
system and phase transition observation provides a new method for label-free direct 
measurement of enzyme activity. 
 
7.1 Introduction 
Assays for measuring the degradation of dextran either require the use of specially-
prepared labeled polymers as surrogate substrates 
1
 or indirect measurement of 
degradation products, such as the amount of reducing sugar activity hydrolytically 
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released from dextran 
2
. Here, we describe a label-free direct visualization assay for 
the measurement of dextranase activity that utilizes the observation of phase 
transitions of aqueous two-phase system (ATPS) droplets into one phase.   
ATPSs are formed when two immiscible water-based solutions, usually composed 
of long-chain polymers, are mixed at concentrations above which it is 
thermodynamically favorable for the solutions to phase-separate into discrete regions 
3
. This thermodynamic phenomenon is influenced by a variety of factors including pH, 
temperature, ionic content, solute/polymer concentration and the molecular weight of 
the phase-separating constituents 
4
. For aqueous polymer solutions of a given 
weight/weight concentration, solutions composed of larger molecular weight 
polymers phase-separate more readily because of the smaller entropic cost to de-mix 
the smaller number of distinct polymer chains. Thus, when an enzyme hydrolyzes 
polymers within an ATPS, phase separation becomes less favorable because either the 
weight/weight concentrations of the long-chain polymer decrease or the long-chain 
polymers become fragmented into shorter chains. While observations of hydrolysis-
triggered phase transitions of macroscopic ATPSs requires large amounts of enzyme, 
reducing the volume of the polymer substrate phases using microfluidic principles 
makes such phase transition processes practical for the measurement of enzyme 
activity, thereby increasing throughput and reducing the amounts of reagents used.  
The polyethylene glycol (PEG)-dextran (DEX) ATPS is one of the most widely 
used ATPSs in laboratory science 
5
 and industry. The concentrations (typically 
expressed in terms of weight/weight) of PEG and DEX of certain molecular weights 
required for phase separation are described by binodial polymer concentration curves, 
as shown in Fig. 7.1. A two-phase system will transition to a single phase if the 
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concentrations of one or both polymers are decreased below the critical 
concentrations displayed by the binodial curve (Fig. 7.1A). If one considers a phase 
diagram based on molar concentrations (a less common way to present ATPS phase 
diagrams), as the polymer molecular weight decreases the binodal curve shifts up.  
This means that even if the molar concentration of DEX and PEG remains constant, 
as the DEX molecular weight decreases due to degradation, the binodal curve shifts 
such that the same molar concentrations of polymers no longer produce phase 
separation. Dextranase degrades DEX to cause the DEX microdroplets formed in the 
PEG phase solutions to disappear due to phase transition (Fig. 7.1A, right to left 
pointing horizontal arrow; Fig. 7.1B, shifting of the binodal curve). 
Dextran hydrolysis by dextranase is of significance to both the sugar/carbohydrate 
polymer industry and dental medicine. Here, we apply the thermodynamic principle 
of phase transition to measuring the enzymatic activity of dextranase, an enzyme that 
hydrolyzes the alpha-(1,6) glycosidic bonds of dextran (DEX) to produce smaller 
oligosaccharides. We use well-plate and microfluidic droplet-based ATPS assays to 
demonstrate that the time it takes to transition a droplet-based PEG-DEX ATPS to a 
single phase depends on enzyme activity, as modulated by enzyme concentration, 
temperature and pH of the ATPS solution. Based on our data, this process is not 
diffusion limited for the droplet sizes and enzyme concentrations we tested. The 
Michaelis constants for dextranase activity are estimated for the various assay formats 
and enzyme conditions. 
 
7.2 Materials and Methods 
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Chemicals and Reagents. DEX, average molecular weight 500,000, was 
purchased from Pharmacosmos (Denmark). Dextranase and PEG (average molecular 
weight 35,000) were both purchased from Sigma (MO, USA). Microfluidic devices 
were fabricated from Sylgard 184 polydimethylsiloxane (PDMS) and curing agent, 
both purchased from Dow Chemical (MI, USA). The master molds from which the 
microfluidic devices were replica-molded consisted of SU-8 from MicroChem (MA, 
USA) patterned on glass coverslips from Fisher Scientific (MA, USA).  
Aqueous Two-Phase Systems. For the well-plate assays, a biphasic system 
composed of 2.5% PEG 35,000, 3.2% DEX T500 and PBS was formed. The 
equilibrated PEG and DEX phases were collected for dextranase testing. For the 
microfluidic tests, ATPSs were formed from near-critical point DEX (~3.2% w/w) + 
0.01% w/w FITC-DEX and PEG (2.5% w/w) in PBS. The ATPSs were equilibrated at 
room temperature and centrifuged at 600 rcf before use. For all dextranase 
experiments, the pH was adjusted by addition of 1 N HCl to the PBS before 
incorporation of the polymers. Dextranase was added from a highly concentrated 
stock of 500 U/mL to achieve the appropriate concentration, where U is defined as 1 
µmole of dextran degraded per minute in a pH 6.0 solution at 37 ˚C. Solutions were 
then stored on ice to prevent unwanted dextranase activity. 
Dextranase Well-Plate Assays. Images were acquired at specific time points (up 
to 210 min) to test the effects of dextranase concentration (5, 2, 0.5, 0.2, 0.05 and 0.02 
U/mL), pH (6.0 and 7.4) and temperature (25 °C and 37 °C) on DEX droplet 
degradation. After collection of the purified DEX and PEG phases, an appropriate 
amount of dextranase was first added only to the DEX phase. After a defined pre-
incubation period, 0.5 µL droplets of DEX/enzyme mixture were micropipetted into 
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48-well assay plates containing 200 μL of PEG in each well. The micropipetting step 
took no longer than 5 sec. After 20 sec, images of the DEX droplets were captured to 
definitively confirm the loss of the phase boundary and rule out the possibility of 
misidentifying a phase boundary due to differences in the refractive index of the 
solutions. The appearance of a stable interface between the DEX droplets and the bulk 
PEG phase indicated phase separation. Droplet dynamics, including spreading or 
contraction after droplet addition, were also noted. For the relatively few time points 
where phase transition could not be definitively confirmed, additional time points 
were collected and the average time between the first indication of interface 
disappearance (dramatic droplet expansion due to loss of interfacial tension and 
barely visible phase boundary) and definitive interface disappearance (clearly no 
phase boundary) was considered as the DEX degradation time. This type of 
experiment with pre-incubation of a DEX phase only solution followed by periodic 
addition of small aliquots of the degraded DEX phase solution into a PEG phase is 
important for obtaining insights into the role of diffusion (or lack thereof) versus 
reaction, since all of the DEX reactions take place without diffusion into PEG until 
the DEX droplets are added to PEG.  The procedure, however, is tedious. Thus, to 
demonstrate improved time resolution with less hands-on activity from the 
experimenter, we also performed experiments where we dispensed DEX droplets 
containing dextranase into the PEG solution and used time-lapse imaging every 2 sec 
from 0 to 120 min to observe DEX droplet degradation continuously using single 
small droplets. 
Droplet Generating Device Fabrication. Microfluidic devices were fabricated 
using backside diffused light lithography, as described previously 
6
. Briefly, an SU-8-
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coated glass coverslip was exposed from the back (glass side) to UV illumination 
passing through a photomask. Rounded multilevel structures were developed in the 
photoresist using a discontinuous pattern on the photomask, such that light passing 
through the photoresist and the glass slide was scattered, exposing the SU-8 in the 
region corresponding to the discontinuity to less illumination. This diffuse light from 
both discontinuous ends joined to form a channel constriction (orifice) at the 
hydrodynamic focusing junction. The positive features from the photoresist were 
replica-molded using conventional soft lithography in PDMS to form elastomeric 
channels that were subsequently plasma-bonded to a PDMS membrane (100 µm 
thickness) fabricated by spin coating at 200 RPM for 240 seconds followed by 2000 
RPM for 5 seconds. The channel geometries were designed to align with a Braille pin-
array that was programmed to actuate the channel constriction to induce droplet 
formation, as described previously 
7
. 
Microfluidic Droplet Formation. The appropriate amount of dextranase was 
added to the dextran solution, which was stored on ice to limit the dextranase activity. 
This solution was loaded into a cold syringe and placed on a syringe pump. Ice packs 
were used to keep the syringe and tubing connected to the device cool. Using the flow 
focusing channel, a threading regime was produced by syringe pump-driven flow at 
0.01 mL/hour and 0.07 mL/hour for the DEX and PEG phases, respectively. An 
actuating Braille pin was placed underneath the orifice in the center channel to valve 
the flow of dextran at 0.8333 Hz. The Braille pin was controlled using a customized 
circuit-board connected to a computer through a universal serial bus (USB) with its 
own custom user interface. The entire process of loading the chilled DEX/dextranase 
solution and aligning the device prior to droplet generation lasted no longer than 15 
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min. Droplet flow was arrested by collapsing the upstream and downstream channel 
regions using clamps. This produced a closed system that allowed time-lapse imaging 
of droplet dynamics in the presence of dextranase. Droplets were imaged by 
fluorescence and brightfield microscopy (Nikon TS100, Tokyo, Japan), with images 
acquired every 30 seconds for the control and 0.02 U/mL dextranase conditions and 
every 10 seconds for the 5 U/mL dextranase condition. For microfluidic enzyme tests 
at temperatures above normal room temperature (~25 °C), the entire microscope room 
temperature was raised using climate control and further raised to 45 °C using a heat 
gun (Black & Decker, CT, USA). The temperature was continually monitored using a 
thermometer and the room thermostat. Heating the entire room guaranteed a constant 
temperature for the microfluidic device and limited the effects of thermal gradients on 
the PEG-DEX ATPS.  
Calculation of Michaelis Constants. The phase transition weight percentages of 
DEX for different DEX chain lengths at 2.5 % PEG 35,000 for pH 7.4 at 25 °C were 
plotted and fitted with a power curve (Fig. 7.2). The points in the graph were based on 
experimental phase diagrams and previously published phase diagrams for PEG 
35,000 and DEX 500,000 (Fig. 7.3), DEX 100,000
 8
, DEX 40,000 
9
 and DEX 10,000. 
The initial point of our ATPS corresponded to 2.5% PEG 35,000 and 3.2 % DEX 
500,000. As dextranase digests the 500,000 g/mol dextran chain, the weight decreases 
proportionately to the fraction of the chain length digested. The expected molecular 
weight of dextran in the dextranase assay at which phase transition occurs following 
dextranase digestion is estimated to be 1.84% DEX 287,000 g/mol. The main 





. We assumed that these products had insignificant contributions to 
phase formation.  
The Michaelis-Menten kinetics allowed a comparison of the micro-well assays 
and the microfluidic assay. For a given pH, the Kcat of the assay is constant, while the 
Km changes. Varying the temperature from 37 °C to 25 °C changes the Kcat according 
to the Arrhenius Equation and also affects the Km. The Km is described as 
 m  
[ ] cat[ ] 
[ ]
 [ ]  
 
where [E] is the enzyme concentration, [S] is the concentration of long chain DEX 
and [P] is the concentration of isomaltotriose. The rate constant at 37 °C is given by 
the manufacturer as 1.0 µmol/min/U. The activation energy, Ea, of Arrhenius equation 
was determined from a previous study 
11
. Thus, the Kcat at 25 °C is 0.86 µmol/min/U.  
A dextranase concentration of 2.0 U/mL was used for the well-plate assay 
calculations and a concentration of 5.0 U/mL was used for the microfluidic assay 
calculations. Our experimental phase diagrams indicated that the phase transition 
weight percentage for DEX 500,000 varied only slightly with temperature and pH 





 mol/mL, respectively) were used for each condition. [S] is based on the 
initial starting DEX concentration and [P] is calculated from the number of DEX 
chains (6.4*10
-8
) multiplied by the number of isomaltotriose units (504.44 g/mol) 
released per chain as it is digested from 500,000 g/mol to 287,000 g/mol (422). In this 
model, [S] (mol/mL) is approximated to be constant over time. This is not 
unreasonable, as the molar concentration of long-chain DEX is assumed not to change 
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significantly within the time-frame of our experiments. Instead, the molecular weight 
of the DEX decreases with enzymatic digestion. As isomaltotriose is released from 
each DEX chain, the DEX chain length will decrease, as will the weight percentage of 
DEX. Thus, the Km values for the various long-chain DEX polymers are expected to 
be similar. Based on these parameters, we calculated the Michaelis constants (Km 
values) as shown in Table 7.1. 
 
7.3 Results and Discussion 
In this work, we maintained a constant PEG concentration, while degrading DEX 
by digesting it with dextranase. This resulted in a decrease in the weight/weight 
concentration of the largest molecular weight DEX species (Fig. 7.1A, right to left 
pointing horizontal arrow), while the molar concentration and total DEX-associated 
material mass of the system remained relatively constant. A two-phase to one-phase 
transition occurs when there is a decrease in weight/weight concentration of the 
original high molecular weight DEX (Fig 7.1A) or, if focusing on molar concentration 
of DEX of any molecular weight, when the molecular weights of the DEX decreases 
causing an upward shift of the binodal curve (Fig. 7.1B).  In contrast, diluting the 
solution would decrease the concentrations of both PEG and DEX, and increase the 
overall volume of the solutions (Fig. 7.1A, arrow towards the origin and Fig. 7.1B). 
We first tested enzymatic hydrolysis-mediated aqueous two-phase system 
transition using DEX solution droplets of 0.5 μL formed by pipetting into a well-plate 
filled with PEG solution.  Dextranase activity was modulated using three parameters: 
pH, temperature and dextranase concentration (Fig. 7.4). Determination of two-phase 
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to one-phase conversion was based on time-lapse experiments where aliquots of DEX 
phase solutions pre-incubated with dextranase were added to a PEG phase at 
designated time intervals and the phase boundary at the DEX-PEG interface was 
observed immediately (~20 seconds) after addition to the PEG phase. At a few time 
points, only a portion of the boundary was visible. In those cases, the droplet system 
was determined to be in an intermediate state. In all cases, the intermediate state 
underwent two-phase to one-phase conversion by the time the next time point was 
observed. Increasing the pH from 6.0 to 7.4 increased the dextranase-mediated time to 
DEX droplet degradation (i.e., the conversion from having the ability to maintain two-
phases when added to the PEG phase to immediately becoming a one-phase upon 
addition) by ~3 fold (Fig. 7.4a-b). Reducing the temperature from 37 °C to 25 °C also 
increased the time to DEX droplet degradation. Dextranase concentration was 
inversely proportional to time to DEX droplet degradation, displaying a nearly linear 
relationship; for example, when the dextranase concentration was increased by 10-
fold, the DEX droplet degradation time decreased by ~10-fold. These experiments 
where the DEX phase solutions were degraded first then added to the PEG phase 
solutions are important for confirming that the inability of the degraded DEX phase 
solution to form a two-phase system is not dependent on diffusion of the degraded 
molecules away from the DEX phase droplet. Rather, when a DEX droplet fails to 
form a two-phase system, it is mainly because the DEX polymers have been degraded 
sufficiently that phase separation cannot occur even though all of the original DEX 
polymer materials are still present (Fig. 7.1). After dispensing the dextranase-
degraded DEX droplets into the PEG phase, the droplets generally spread out due to 
their low interfacial tension with the PEG phase, which makes the droplets flatter (Fig. 
7.4c). We also carried out a similar well-plate assay, in which DEX/FITC-
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DEX/dextranase droplets were immediately place in a PEG-filled well and observed 
by time-lapse imaging at 2 sec intervals. The DEX droplet expanded over the course 
of imaging, before apparent voids began to appear in the droplet interior at ~35 min 
(Fig. 7.4d). By 50 min, the droplet was completely consumed. We considered the 35 
minute time point to be the point at which two-phase to one-phase transition occurred 
in this assay.    
This ATPS well-plate assay can be adapted for analysis of dextranase activity in 
other aqueous solutions such as industrial/manufacturing batch solutions, cell culture 
media and bacterial broth by simply observing DEX-PEG phase transition. For more 
sensitive detection that may be necessary to assess small-scale bacterial dextranase 
production, the assay detection limit can be lowered by decreasing the amount of 
dextran degradation required for two-phase to one-phase conversion. This can be 
achieved by using an ATPS composition that is closer to the binodial curve.  
We next used a microfluidic device 
12
 to produce single- to sub-nanoliter dextran 
droplets to increase the throughput of the assay and demonstrate the potential for 
automated, chip-based analysis (Fig. 7.5a-c). Without actuation from a computer-
controlled pin, a laminar stream of DEX was formed in the microfluidic channel, 
enclosed by two streams of PEG. Upon actuation, flow was interrupted, resulting in 
formation of DEX droplets carrying FITC-DEX as a tracer material (Fig. 7.5b). The 
FITC-DEX is not needed for purposes of measuring dextranase activity, but was 
included to help understand some of the dynamics of the degradation and droplet 
content release process, as will be explained below. We also monitored the droplets 
by brightfield microscopy. 
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In the absence of dextranase, the droplets maintained their size, fluorescence 
intensity and phase boundaries (Fig. 7.5c, first column). The addition of dextranase 
caused the degradation of the droplet emulsion into a single phase. At room 
temperature and a pH of 7.4, a high concentration of dextranase (5 U/mL) was 
required to degrade the DEX droplets in a timely manner as these conditions are 
enzymatically not optimal (Fig. 7.5c, second column). By adjusting the pH to 6.0 and 
increasing the temperature to 45°C (the optimal enzymatic conditions for dextranse), 
the DEX droplets could be degraded using much lower concentrations of dextranase 
(0.02 U/mL) (Fig. 7.5c third column). We confirmed the timescale of droplet 
disappearance under this condition using the pre-incubated well-plate assays (Fig. 
7.5c, fourth column). These observations suggest various possibilities for designing 
rapid or gradual DEX-hydrolysis-triggered release of reagents from the DEX droplets.   
To compare the different assay formats and enzyme degradation conditions, we 
calculated the Michaelis constants based on Michaelis-Menten kinetics and the 
binodial polymer concentration curves for the PEG-DEX ATPS (Table 7.1; binodial 
curves shown in Fig. 7.2). The similarities in time to transitioning to one-phase 
between the DEX droplets pre-incubated with dextranase before PEG addition and 
those that were incubated after addition to PEG, and the mechanistic explanation of 
Fig. 7.1B suggest that the process of DEX/PEG two-phase to one-phase transition due 
to dextranase degradation of DEX is not limited by diffusing away of degraded DEX. 
That is, DEX degradation products do not have to diffuse away for the phase 
transition to occur.  Thus, our assay should be minimally influenced 
thermodynamically by changes in droplet scale. We do note, however, that there is 
slightly more ambiguity as to exactly when one considers a droplet to have 
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transitioned to one phase (e.g. Fig. 4D 35 min) for larger droplets compared to smaller 
drops. As expected, the Michaelis constant decreased under conditions that were more 
favorable to enzymatic degradation of DEX (i.e., higher temperature and lower pH).   
 
7.4 Conclusions 
Our droplet dispersion technology has applications in the field of microfluidics 
13
, 
where in the future it may be applied for microfluidic chemical reactions 
14
 or creating 
dynamic chemical gradients for studying cell signaling applications by 
compartmentalizing and releasing reagents or cell signaling factors. Since eukaryotic 
cells typically do not produce dextran and have few important glycosidic bonds 
hydrolyzed by dextranase on their surface, the process may serve as a mild, cell 
culture-friendly, and localized controlled reagent-release mechanism. Dextranase is 
also of interest in clinical dentistry as it is secreted by oral bacteria that modify the 
formation of dental plaques and use the plaque constituents (including dextran) as a 
source of nutrients 
1
. With the ability to detect dextranase activities as low as 0.020 
U/mL in less than 90 minutes (robust oral dextranase-producing bacteria such as P. 
Oralis secrete extracellular dextranase up to 0.490 U/mL 
1
), it may be possible to 
analyze oral microbial flora using our system. Finally, highly sensitive dextranase 
activity testing can be helpful in the sugarcane industry for early detection of costly 
and potentially destructive contamination, as well as for standardization of dextranase 
enzymes used industrially to prevent dextran accumulation during sugar production 
15
.  
While we focus on just the analysis of dextranase activity, the concept of using 
aqueous two-phase system droplet transitions to directly visualize polymer 




Fig. 7.1 The binodial phase diagram for the PEG 35,000/DEX 500,000 system.  A) A 
two-phase system can be converted to a single phase either by dilution or by 
degradation of DEX by dextranase. This graph focuses on the weight % concentration 
of DEX 500,000. B) Another representation of how a two-phase system can be 
converted to a single phase either by dilution or by degration of DEX by dextranase.  
This graph focuses on the the molar concentration of long chain DEX of various 
molecular weights.  As dextranase digests DEX, the molar concentration remains the 
same for a significant time, but the average long chain DEX molecular weight 
decreases. As the molecular weight of DEX decreases, the molar concentration of 
DEX does not decrease, but the binodal curve shifts up because a higher concentration 
of PEG is required to form an ATPS with the same molar concentration of lower 
molecular weight DEX. The molar concentration point designated by the circle 





Fig. 7.2 DEX chain length vs. concentration of DEX required to form an ATPS with 
2.5% PEG 35,000. This plot was used to determine the amount of DEX chain 
shortening required for the degraded 3.2% DEX 500,000 to no longer form an ATPS 
with 2.5% PEG. As dextranase digests the 500,000 g/mol dextran chain, the dotted 







Fig. 7.3 Binodial Curves for the PEG 35,000/DEX 500,000 ATPS at the pH values 
and temperatures used for the dextranase assay.The binodal concentration of DEX at 




Fig. 7.4 Two-phase to one-phase conversion occurs following dextranase-mediated 
DEX degradation. (A-B) Dextranase activity can be assessed in a well-plate by 
recording the time at which DEX droplets pre-incubated with dextranase no longer 
form phase boundaries with PEG. DEX droplet degradation times vary by pH, 
temperature and dextranase concentration. A maxium incubation time of 210 min was 
used for these assays. (C) Phase separation (or lack thereof) of DEX droplets pre-
incubated with 2 U/mL dextranase for 2 min, 10 min and 30 min at pH 7.4, 37 °C as 
they are added into PEG. The black arrows indicate the phase boundary. (D) Phase 
separation of DEX droplets containing FITC-DEX and 5 U/mL dextranase (without 
pre-incubation) in PEG, as recorded by fluorescence time-lapse imaging. The white 
arrow indicates the initial location of the void that indicated droplet degradation and 
the conversion of the ATPS to a single phase. The 35 minute time point was 





Fig. 7.5 Operating principle of the droplet-generating device. (A) A central DEX inlet 
is flanked by two PEG inlets. The channel constriction is actuated by a computer 
controlled pin positioned at the black dashed circle. (B) Without actuation this 
constriction is open, resulting in the formation of a laminar stream of DEX in the 
center of the channel. Pin actuation at an appropriate frequency closes the constriction 
to produce droplets of DEX.  The DEX phase was visualized using a FITC-DEX 
tracer. (C) Droplets generated microfluidically allow sensitive detection of enzyme 
activity. Droplet degredation was not observed when dextranase was absent from the 
ATPS. (D) The pre-incubated well- plate assay produces comparable results for 0.02 




Enzyme Condition Time (min) Km (M) 
Well-Plate Assay (Pre-Incubation)  
 
pH 7.4, 25 °C 100  3.4 x 10
-4
 
pH 7.4, 37 °C 35 1.0 x 10
-4
 
pH 6.0, 25 °C 22 2.4 x 10
-5
 
pH 6.0, 37 °C 15 7.1 x 10
-6
 
Well-Plate Assay (Time-Lapse)  
 
pH 7.4, 25 °C 35 7.9 x 10
-5
 
Microfluidic (Time-Lapse)  
 




Table 7.1 Catalytic data for the various dextranase conditions and assay formats. *10 
minutes was added to the time point shown in Fig. 7.3b (20 min) to account for the 
additional time (including the time where temperature was kept low) that the DEX 






1. Igarashi, T.; Yamamoto, A.; Goto, N., Detection of dextranase-producing gram-
negative oral bacteria. Oral microbiology and immunology 1998, 13 (6), 382-6. 
2. Kaster, A. G.; Brown, L. R., Extracellular dextranase activity produced by human 
oral strains of the genus Bifidobacterium. Infection and immunity 1983, 42 (2), 716-
20. 
3. (a) Dobry, A.; Boyer-Kawenoki, F., Phase separation in polymer solution. Journal 
of Polymer Science 1947, 2 (1), 90-100; (b) Albertsson, P. A. k., Partition of cell 
particles and macromolecules : separation and purification of biomolecules, cell 
organelles, membranes, and cells in aqueous polymer two-phase systems and their 
use in biochemical analysis and biotechnology. 3rd ed.; Wiley: New York, 1986; p 
346 p. 
4. Albertsson, P. A., Partition of cell particles and macromolecules in polymer two-
phase systems. Advances in protein chemistry 1970, 24, 309-41. 
5. (a) Tsukamoto, M.; Taira, S.; Yamamura, S.; Morita, Y.; Nagatani, N.; Takamura, 
Y.; Tamiya, E., Cell separation by an aqueous two-phase system in a microfluidic 
device. The Analyst 2009, 134 (10), 1994-8; (b) Yamada, M.; Kasim, V.; Nakashima, 
M.; Edahiro, J.; Seki, M., Continuous cell partitioning using an aqueous two-phase 
flow system in microfluidic devices. Biotechnology and bioengineering 2004, 88 (4), 
489-94; (c) Soohoo, J. R.; Walker, G. M., Microfluidic aqueous two phase system for 
leukocyte concentration from whole blood. Biomedical microdevices 2009, 11 (2), 
323-9; (d) Tavana, H.; Jovic, A.; Mosadegh, B.; Lee, Q. Y.; Liu, X.; Luker, K. E.; 
Luker, G. D.; Weiss, S. J.; Takayama, S., Nanolitre liquid patterning in aqueous 
environments for spatially defined reagent delivery to mammalian cells. Nature 
materials 2009, 8 (9), 736-41; (e) Tavana, H.; Mosadegh, B.; Takayama, S., 
Polymeric aqueous biphasic systems for non-contact cell printing on cells: 
engineering heterocellular embryonic stem cell niches. Adv Mater 2010, 22 (24), 
2628-31. 
6. (a) Futai, N.; Gu, W.; Takayama, S., Rapid Prototyping of Microstructures with 
Bell-Shaped Cross-Sections and Its Application to Deformation-Based Microfluidic 
Valves. Advanced Materials 2004, 16 (15), 1320-1323; (b) Lai, D.; Frampton, J. P.; 
Sriram, H.; Takayama, S., Rounded multi-level microchannels with orifices made in 
one exposure enable aqueous two-phase system droplet microfluidics. Lab on a chip 
2011, 11 (20), 3551-3554. 
7. Gu, W.; Zhu, X.; Futai, N.; Cho, B. S.; Takayama, S., Computerized microfluidic 
cell culture using elastomeric channels and Braille displays. Proceedings of the 
National Academy of Sciences of the United States of America 2004, 101 (45), 15861-
6. 
8. Boreyko, J. B.; Mruetusatorn, P.; Retterer, S. T.; Collier, C. P., Aqueous two-phase 




9. Long, M. S., Dynamic and asymmetric protein microcompartmentation in aqueous 
two-phase vehicles. Penn State University Doctoral Dissertation 2005, Accessed on 
2/15/2014 at https://etda.libraries.psu.edu/paper/6801/. 
10. Fukumoto, J.; Tsuji, H.; Tsuru, D. Studies on mold dextranases. Journal of 
Biochemistry 1971, 69, 1113-1121. 
11. El-Tanash, A. B.; El-Baz, E.; Sherief, A. A., Properties of Aspergillus 
subolivaceus free and immobilized dextranase. European Food Research and 
Technology 2011, 233, 735-742. 
12. Lai, D.; Frampton, J. P.; Hari, S. A.; Takayama, S., Rounded multi-level 
microchannels with orifices made in one exposure enable aqueous two-phase system 
droplet microfluidics. Lab on a chip 2011, 11 (20), 3551-3554. 
13. (a) Sugiura, S.; Nakajima, M.; Iwamoto, S.; Seki, M., Interfacial Tension Driven 
Monodispersed Droplet Formation from Microfabricated Channel Array. Langmuir : 
the ACS journal of surfaces and colloids 2001, 17 (18), 5562-5566; (b) Sugiura, S.; 
Nakajima, M.; Seki, M., Effect of Channel Structure on Microchannel Emulsification. 
Langmuir : the ACS journal of surfaces and colloids 2002, 18 (15), 5708-5712; (c) 
Basu, A. S., Droplet morphometry and velocimetry (DMV): a video processing 
software for time-resolved, label-free tracking of droplet parameters. Lab on a chip 
2013, 13 (10), 1892-901; (d) Zeng, S.; Pan, X.; Zhang, Q.; Lin, B.; Qin, J., Electrical 
control of individual droplet breaking and droplet contents extraction. Analytical 
chemistry 2011, 83 (6), 2083-9. 
14. (a) Trivedi, V.; Doshi, A.; Kurup, G. K.; Ereifej, E.; Vandevord, P. J.; Basu, A. S., 
A modular approach for the generation, storage, mixing, and detection of droplet 
libraries for high throughput screening. Lab on a chip 2010, 10 (18), 2433-2442; (b) 
Schudel, B. R.; Choi, C. J.; Cunningham, B. T.; Kenis, P. J. A., Microfluidic chip for 
combinatorial mixing and screening of assays. Lab on a chip 2009, 9 (12), 1676-1680. 
15. Eggleston, G.; Monge, A., Optimization of sugarcane factory application of 


















Lab-on-a-chip biophotonics: its application to assisted reproductive technologies 
 
With the benefits of automation, sensitivity and precision, microfluidics has enabled 
complex and otherwise tedious experiments. Lately, lab-on-a-chip (LOC) has proven 
to be a useful tool for enhancing non-invasive assisted reproductive technology 
(ART). Non-invasive gamete and embryo assessment has largely been through 
periodic morpohological assessment using optical microscopy and early LOC ART 
was the same. As we realize that morphological assessment is a poor indication of 
gamete or embryo health, more advanced biophotonics has emerged in LOC ART to 
assay for metabolites or gamete separation via optoelectrical tweezers. Off-chip, even 
more advanced biophotonics with broad spectrum analysis of metabolites and 
secretomes has been developed that show even higher accuracy to predicting 
reproductive potential. The integration of broad spectrum metabolite analysis into 
LOC ART is an exciting future that merges automation and sensitivity with the 
already highly accurate and strong predictive power of biophotonics. 
 
A.1 Introduction 
Microfluidics is a relatively new field studying the physical principles of fluid 
behaviour that have already been extensively applied in chemistry
1
 and molecular 
biology
2
. More recently, microfluidics has also become increasingly applied to 
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cellular behaviour and interaction studies
3-5
. The scalability of microfluidics allows 
for unprecedented cost efficiency due to the minute amount of reagents necessary 
allowing for the execution of otherwise expensive experiments and automation 
provided by embedded microfluidic features can allow for high sensitivity without 
user variability.  For cell culture applications, the small volumes can enhance 
autocrine effects although nutrient depletion and waste accumulation also becomes 
faster.  At the microscale, the flow of even familiar fluids like water and aqueous 
solutions also becomes dramatically different due to a low Reynolds number, the ratio 
between inertial forces and viscous forces. When viscous forces dominate, a 
phenomenon called laminar flow results that where the fluid quickly and reliably 
moves in response to external forces. When two or more streams converge in laminar 
flow conditions, they do not mix save for the effects of diffusion due to a lack of 
turbulence.  
 These small volume and low Reynolds number flow conditions can be utilized to 
more closely resemble in vivo conditions of insemination and embryo culture than 
classical in vitro methods using culture dish, test tube or drops of media. In 1979, it 
was first reported that the microenvironment holds a dramatic importance in embryo 
handling and culture
6
. More recently, it has been shown that dynamic stimulation of 
oocytes increase fertilization rates
7
 as well as increase in oocyte health
8
.  
 Microfluidic devices are typically composed of a transparent elastomer and plastics 
such as PDMS and polystyrene. This allows many lab-on-a-chip (LOC) applications 
to use biophotonics for data acquisition.  For assisted reproductive technologies 
(ART), microfluidics provides a tool for non-invasive cell quality assessment 
especially for precious cell samples such as oocytes and embryos. The speed at which 
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samples can be sorted using microfluidic operations also allow for high-throughput 
screening in ART particularly for sperm samples.  
 
A.2 Basic Use of Biophotonics in LOC ART  
Less than half of in vitro fertilization (IVF) cycles result in a live birth even for 
women below the age of 35 that causes severe physical, emotional and financial 
stress
9
. The success decreases even more with frozen embryos and age. Thus embryo, 
oocyte and sperm quality assessment is an important procedure to identify the 
healthiest oocytes and sperm for IVF and the embryos with the highest reproductive 
potential for implantation. However even now, embryo morphology and cleavage 
rates are the most common form of embryo quality assessment. Early LOC ART 
technology also involved direct quality assessment with periodic morphology 
assessment mostly based on optical and at times fluorescence imaging.  
LOC morphology assessment of oocytes and embryos  
It was first shown in 2000 that microfluidic channels supported normal embryo 
development
10
 and later in 2001 to show that many microfabrication materials showed 
good biocompatibility with murine embryos
11
. Both studies used periodic optical 
microscopy to assess embryo morphology. Degree of biocompatibility was reported 
as the percentage of two-cell embryos developing into blastocysts by 96 hours 
compared to petri dish control.  
 Microfluidic devices later showed functionality of high-throughput single oocyte 
trapping, fertilization and embryo culture. Allowing multiple embryos to be 
individually monitored and tracked during their development showing comparable 
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fertility rates and embryo development to petri dish control
12
. The device improved 
upon classic embryo culture methods with ease of use through automation that 
simplified an otherwise labour intensive media changing process in IVF. Due to the 
scale at which the microfluidic device operates, it only required a small amount of 
sperm sample for successful fertilization as opposed to its macro-scale counterparts
13
.  
 Meanwhile with specialized channel architecture to produce dynamic fluid 
mechanical stimulation while maintaining autocrine factor distribution that mimic in 
vivo microenvironments (Fig. A.1), embryos cultured in microenvironments more 
resembling in vivo conditions had more reproductive potential than petri dish 
controls
14
. This too used periodic optical microscopy and morphology assessment for 
measure showing an increase in blastocyst development as well as blastocyst cell 
number as determined by terminal invasive evaluation on fixed and stained embryos. 
Rare among LOC ART, this study used viability assessment such as implantation 
percentage and ongoing pregnancy as a primary outcome and showed over 20% 
improvement by using dynamic microfluidic culture. The device was driven using 
peristaltic actuation of Braille pins allowing for portability and convenience without 
the need for extensive syringe pumps and lines connected to the device common to 
many microfluidic devices. The microfunnel architecture also provided accessibility 
of the oocytes in both insertion into and extraction from the device via simple 
pipetting. As opposed to culture in small droplets in a petri dish, LOC ART devices 
are capable of extracting media during culture through the outlet channel to prevent 
accumulation of toxic metabolic waste such as ammonia
15
 which may harm embryos
16
. 
LOC sperm morphology assessment  
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Currently, the most successful treatment for male infertility is using intracytoplasmic 
sperm injection (ICSI) where oocytes are fertilized via direct injection of sperm. 
Requiring only a small amount of viable sperm, ICSI drastically increases chances of 
contraception even for severe cases of sperm-based infertility. While theoretically 
only one viable sperm is required per harvested oocyte, identifying and isolating the 
most viable sperm is challenging
17
. Typically samples are purified using 
centrifugation methods but for difficult samples, laboratories may even hand-sort 
semen samples consisting of mostly dead sperm and debris to isolate the most motile 
sperm with healthy morphology.  In some cases of extremely low sperm counts, the 
procedure could take hours making automated sperm sorting a welcome technology in 
ARTs. 
 Using microfluidic channel that produce mild, biomimetic sorting mechanism 
based on sperm motility which avoids centrifugation reported to cause sublethal 
damage to sperm
17, 18
. Fluid flow using laminar flow regime consists of multiple 
streamlines. These streamlines are parallel to one another according to channel 
geometry with the absence of turbulent mixing. Dead sperm, nonmotile sperm and 
debris are unable to move on their own and thus are simply carried by the streamline 
they reside in towards the waste reservoir. However, motile sperm are able to swim 
under their own power and are capable of moving across streamlines into a secondary 
reservoir designated to contain only motile sperm for extraction
19
. With surface 
tension and gravity as the driving force, the channel geometry or loading conditions 
can be controlled to adjust initial surface tension to vary the motility threshold of 
sperm collected and purity.   
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 A device using fluorescence was design using a built-in micro-cuvette for male 
subfertility screening. A long microfluidic channel connected the sample chamber to 
the micro-cuvette produced a barrier that allowed only highly motile sperm to reach 
the micro-cuvette. Calcein-AM dyed sperm can be quantified using a 
microfluorometer to assess the level of sperm motility
20
 where higher fluorescent 
signal indicates higher motile sperm count. With signal recorded every 30s for 50 
minutes, a profile of sperm motility can be deduced.   
Pitfalls of morphology assessments  
 It cannot be ignored that morphology is a poor indicator of viability such as viable 
fetus and live birth. A major pitfall for basic use of biophotonics in LOC ART 
applications that limits their capability for translational human ART research, it opens 
a large demand for much more sophisticated biophotonics to provide more accurate 
primary outcome assessments. An issue spanning all fields of ART, not just LOC, it 
has allowed for an opportunity in ART for advanced predictive algorithms for long 
term viability assessment using data from simple photonics equipment that can 
eventually be integrated into LOC to improve primary outcome assessments. 
 
A.3 Advanced Use of Biophotonics in LOC ART  
With the increasing popularity of biophotonics, the integration of this technology into 
LOC ART has been exciting. In recent years, the use of continuous imaging, optical 
tweezers, traps and broad spectrum spectroscopy has widened the amount of non-
invasive analysis for ART purposes that provide quantitative information other than 
qualitative morphology assessments. 
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Sperm quality assessment and sorting  
In cases of extreme male infertility with the absence of motile sperm, ICSI is still 
capable of producing live births with non-motile but live sperm. This leaves a great 
need for the identification of live sperm, even if they are non-motile; a task that is 
labour intensive and currently requires single sperm isolation and exposure to hypo-
osmotic solutions and visualization of membrane swelling
21
. Devices were coated 
with a polyethylene glycol (PEG) antifouling layer and layered with a photosensitive 
layer to be used for optoelectronic tweezer (OET) applications. Projected light 
reduces the impedance on the photosensitive layer to create regions of high electric 
field.  The field generated produces dielectrophoretic force to manipulate micro- and 
nanoparticles. It was shown that OET is capable of non-invasive sorting of viable 
non-motile sperm from non-viable sperm without introducing DNA damage
22
. Due to 
a live cell’s ability and a dead cell’s inability to keep intact a charge gradient between 
its cytoplasm and extracellular microenvironment, they respond differently to an 
electric field. Since live cells have a higher dipole moment by maintaining an ionic 
gradient across its cell membrane, live cells experience attractive forces toward 
regions of high electric field while dead or dying cells have no or repulsive forces to 
the electric field (Fig. A.4)
23
. This OET selection process improves upon existing 
technologies to retrieve viable sperm independent of its motility overcoming 
significant challenges in the ICSI sperm selection process particularly for those with 
extreme infertility complications.  
 In situations with an abundance of motile sperm, the selection process for the ideal 
sperm for ICSI is often arbitrary. A group in 2008 developed an automatic microscope 





that previously required laborious joystick control. In addition to recording sperm 
swim speed using automated cell tracking technology, the system is capable of 
relocating sperm and releasing them at normal or tangential enter angles against an 
annular laser trap to which the swim behaviour in response to annular trap is assessed 
and categorized into three major groups: speeding up in response to and penetrating 
the annular trap, sperm changing its swimming trajectory and slides briefly along the 
annular trap, and sperm changing its swimming trajectory and slides along the annular 
trap for an extended period of time (20s) showing signs of fatigue.  
 Although not used routinely for human ART, biophotonics combined with 
microfluidic flow cytometry is now routinely applied for sex preselection of sperm in 
the agricultural industry. Sperm is extracted from the bull and its DNA stained with 
Hoescht 33342.  Using an argon laser for excitation, the resulting fluorescence signal 
allow accurate and high-throughput identification resulting fetal sex according to 
difference in DNA content, and therefore difference in fluorescence intensity between 
X- and Y- chromosome carrying sperm (approximately a 3.8% increase in signal due 
to larger X chromosome). After identification of sex, the droplet containing the sperm 
is charged according to the sex and deflected using a charged plate into collection 
tubes (Fig. A.5). Flow cytometry combined with fluorescence detection and 
downstream cell sorting were capable of preselecting the sex of calves with 90% 
accuracy and produced live calves without anatomical or neurological abnormalities. 
This system is capable of high-throughput sperm sorting up to 25,000 spermatozoa 
per second
25
. Although both cytometer and detector are capable of much higher 
speeds, 25,000 spermatozoa per second was empirically determined as optimal due to 
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limitations stemming from the need to individually encase each spermatozoa in its 
own droplet for accurate DNA assessment. 
Direct oocyte or embryo quality assessment  
Like morphology assessment of spermatozoa, selection of mature oocytes is also often 
subjective. A quantifiable measure is needed to eliminate subjectivity for optimal 
selection of the healthiest oocytes for IVF. However the need for non-invasive tests 
limits the number of biophotonic spectroscopies appropriate for direct analysis of 
precious cell samples. 
 Oocytes are positioned in the middle of two optical fibres within a microfluidic 
device by holding micropipettes commonly used in IVF micromanipulators for ICSI. 
With a white light illumination fibre and a collection fibre, the absorption spectra can 
be measured. The absorption spectra provided a quantifiable measure of oocyte 
maturity by comparing different spectra maxima and width. A fully immature oocyte 
was found to have maxima of ~630nm wavelength and a width of ~270nm while a 
fully mature oocyte was found to have maxima of ~580nm and a width of ~210nm 
(Fig. A.6)
26
. Using the absorption spectra, the subjectivity of determining maturity has 
been eliminated with quantifiable measures. 
 Optoelectric tweezers were also used to separate normal oocytes from abnormal 
oocytes. Via the same mechanism as for sperm, normal oocytes are able to move 
against gravity under OET induced electric field while abnormal oocytes stay 
stationary at their initial starting point
27, 28
. With selective discrimination of healthy 
oocytes, OET induced electric fields provide another non-subjective mechanism for 
selecting oocytes with the best developmental potential.  
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 The advancement of LOC ART optical microscopy from periodic to continuous 
imaging has enabled the control of osmotic shock associated with oocyte 
cryopreservation. Vitrification is the transformation of a substance into glass and the 
vitrification of oocytes has recently been shown to be more successful than classical 
slow-freezing cryopreservation in establishing pregnancy
29
. However to prepare 
oocytes into vitrification solution, a highly hyperosmotic solution, oocytes are 
transferred stepwise into ever increasing concentrated CPA solutions while suffering 
from an osmotic shock on each step. Studies have been conducted to show that using 
extra transfer steps with less change in concentration on each step decreases osmotic 
shock and increases cryopreservation quality
30
 but at the cost of practicality as the 
transfer of oocytes is delicate, prone to accidents and requires extensive training
31
. 
With the precision and sensitivity afforded by microfluidics, LOC is capable of 
exposing oocytes to a continuous profile of gradually increasing CPA concentrations. 
With a continuous profile, essentially an infinite amount of steps, and microfluidic 
automation and continuous optical microscopy, the oocytes were shown to be 
successfully exposed to vitrification solutions with dramatically less osmotic shock 
and labour than manual controls
32
. 
Indirect oocyte or embryo quality assessment  
As understanding of reproduction and associated technologies become more advanced, 
simple measures of oocyte quality such as morphology and maturity become 
insufficient
33
. Indirect oocyte or embryo quality assessment opens the full field of 
biophotonic spectroscopies to quantify cell quality. Indirect assessments typically 
perform spent media analysis to calculate oocyte or embryo metabolism. Embryo 
metabolism provides a much clearer indication of embryo health. For example, mouse 
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blastocysts with low glycolytic activity (closer to in-vivo levels) have been shown to 
indicate high viability
34
 and human blastocysts with the highest glucose uptake were 
correlated with the highest reproductive potential
35
. 
 An automated, computer-controlled microfluidic device was designed for 
continuous embryo culture with integrated spent media analysis on-chip. Using a 
versatile Braille display for pumping and valving, the chip is capable of automated 
glucose measurement assays with fluidic sampling, pumping, mixing and washing 
steps (Fig. A.7)
36
. The glucose assay uses coupled glucose oxidase-peroxidase 
reaction to produce fluorescent resorufin from colourless amplex red reagent at a 1:1 
stoichiometry. The long emission wavelengths of resorufin (587nm) allow for 
sensitive fluorescent quantification of glucose. The chip is capable of real time and 
continuous culture with measurements every 5 seconds for over 6 hours. Use of a 
glucose assay that utilizes long excitation wavelengths (488 nm) that are safer for 
embryos than typical ultraviolet light used in NADPH-linked glucose assays 
previously used for off-chip embryo metabolism measures was important to prevent 
exposure of embryos to damaging UV light.  
 The need of shielding embryos from harmful UV light was the basis of other 
groups using two devices to perform LOC embryo metabolism measurements to 
separate embryo cultures from the metabolite assay device later to be subject to UV 
light. This method was capable of measuring more metabolites using shorter 
excitation wavelengths but required periodic manual transfer of spent media from 
embryo culture to microfluidic device. Spent media was extracted via pipetting from 
microdrops containing embryos on a petri dish and transferred into a microfluidic 
device. Upon manual loading of spent media sample and reagents necessary for 
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performing glucose, pyruvate, and lactate enzymatic assays in full automation 
involving enzyme cocktail aliquotting, mixing of reagents, data acquisition, and data 
analysis
37
. The device is also capable of serial measurements of metabolites within 5 
minutes and full automated analysis of 10 samples with intermittent calibration in a 3 
hour period.   
 
A.4 Future of Biophotonics in LOC ART 
Due to low pregnancy rates per embryo transferred in IVF, IVF treatments typically 
transfer multiple embryos simultaneously to increase pregnancy potential. However 
with each addition of an embryo, the chance of multiple births dramatically increases. 
Single embryo transfer (SET) is an effective technique to minimize risks of multiple 
pregnancies but its acceptance is limited due to the inaccuracy of embryo reproductive 
potential assessments
38
. For SET to gain popularity, a more selective process for the 
embryo with highest reproductive potential is needed. Biophotonics has made 
significant advances particularly in metabolic profiling for ART. However current 
LOC metabolic profiling requires assaying for a specific metabolite of interest.  When 
multiple metabolites of interest are involved, the LOC quickly becomes convoluted in 
design. The integration of LOCs with external optics also becomes more difficult due 
to the need to place supporting optics syringe pumps within close proximity to the 
device. However groups within the biophotonics community, although not on LOC 
devices, have shown the use of spectroscopy capable of capturing a broad spectrum of 
metabolites without the need to assay for a specific metabolite.  
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 Although not photonics, nuclear magnetic resonance (NMR) spectroscopy is a 
powerful technique for non-invasive examination of biological fluids. Based an 
atomic nuclei’s magnetic properties, NMR provides data rich in simultaneous 
structural and quantitative information capable of screening urine samples for 
hundreds of pathophysiological conditions in a single spectral measurement
39
. 
However the technique is expensive in both time and financial costs, although some 
measurements can take less than a minute, some may take a few hours. NMR also 
requires highly specialized personnel not always available in a clinical setting to 
operate equipment and analyse results. 
  Mass spectroscopy (MS) has also emerged as a popular tool for metabolic profiling 
providing advantages over other spectroscopies such as the ability to detect many 
metabolites at physiological conditions from µM concentrations with a high mass 
accuracy in parts per million
40
. MS was shown to not only be able to detect 
metabolites consumed by embryos, but also the secretomes of mouse and human 
embryo. Noting a dramatic difference in secretomes of degenerating embryos and a 
developing blastocyst
41
, MS is providing a new field of opportunities to understand 
embryonic physiology.  
 Although not as specific and detailed in information provided compared to NMR, a 
group used spent embryo media with near-infrared (NIR) spectroscopy to distinguish 
viable embryos from non-viable embryos independent of morphology. Spectral 
regions (ROH, -SH, C=C, -OH and –NH groups) of metabolic profiles were 
quantified using inverse least-squares regression and leave-one-out cross validation to 
produce a relative embryo viability score to assess embryo reproductive potential
42
. 
NIR broad spectrum metabolic profiling was shown to be superior to morphology 
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assessment for selective embryos for SET to produce an on-going pregnancy
43
. At day 
2 after SET, metabolic profiling was shown to be 40% more accurate in assessing 
viable embryos than morphology (69% and 27.6%). At day 3 after SET, it was 15% 
more accurate with 53.6% accuracy with NIR metabolic profiling as opposed to 
38.5% for morphology. The study showed a large inter-patient or inter-embryo 
variability with regards to the calculated viability score and more studies are needed 
to identify the causes of this variability. Nevertheless, a low viability score was highly 
predictive of poor pregnancy. In another study, NIR was shown to have 75% 
sensitivity at predicting embryo implantation and resultant delivery between binary 
groups of patients (0 or 100% implantation rates)
42
. With each study, NIR metabolic 
profiling proves to be a powerful analysis to be used in embryo selection for SET. 
  Raman spectroscopy uses a laser of monochromatic light that provides similar but 
complimentary results to NIR spectroscopy. Raman spectroscopy is superior to NIR 
for aqueous samples due to water producing very weak Raman signals. Raman 
spectroscopy based metabolic profiling by itself was capable of 80.5% accuracy for 
predicting (100%) implantation and associated delivery or (0%) failed implantation
44
. 
In agreement with previously described studies of metabolic profiling, there is a clear 
correlation between metabolism and reproductive potential for human embryos 
leaving no question that metabolic profiling is a powerful tool for clinical screening 
for the best embryos for procedures such as SET in the future.  
 Currently, embryo cultures were done in microdrops consisting of 50 µL media. 
Raman and NIR spectroscopy can be performed with 15 µL of spent media in 
approximately one minute
42
. Its integration into LOC technology will provide 
quantitative information on how recreating physiological conditions during culture 
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increase embryo reproductive potential. Using only a fraction of media necessary with 
conventional microdrop embryo culture, spent media from LOC devices will have a 
higher ratio between embryos and surrounding media allowing for higher 
concentrations of secretomes for heightened detector sensitivity to embryo secretion 
rates. Automation provided by LOC ART promises a less laborious process as well as 
elimination of operator variability. 
 The advancement from periodic to continuous imaging alone delivered incredible 
insight on human embryo development. Continuous monitoring with dark field 
microscopy is capable of predicting human embryo development into the blastocyst 
stage with 93% sensitivity by measuring only three parameters by day 2 after 
fertilization (Fig. A.8)
45
. This study used an automatic computer algorithm for real-
time embryo development monitoring and prediction showing that with continuous 
imaging, promise of advanced diagnosis of embryo potential. The integration of this 
highly accurate predictive technology to LOC ART applications will greatly increase 
its viability assessment power and address one major pitfall to LOC ART applications 
translational human research. 
 Integration of spectroscopy with microfluidics that allows for broad spectrum 
analysis of metabolites or secretomes poses significant challenges. LOC automation 
typically necessitates microfluidic operations embedded into the device. With each 
operation (mixing, diluting, valving), the device often becomes much more 
complicated requiring supporting equipment off-chip such as additional syringe 
pumps (Fig. A.9). For this reason, LOC is often a lab-on-a-chip-in-a-lab of specialized 
equipment, a major challenge to many biology and chemistry labs adopting the 
technology. Flexibility of operations such as valve timings is limited due to the built-
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in automation nature of LOC. So often when rather small features need adjustment, 
entirely new masters need to be prepared using photolithography, a specialized 
technique involving equipment also not available to most chemistry and biology labs. 
To address these issues to increase the usability of LOC technologies to a broader 
scientific community, many groups make progress in developing ease fabrication 
techniques without the use of photolithography
46
 and using intelligent design built-in 








Fig. A.1 Integration of LOC with simple biophotonics [35]. Currently most advanced 
LOC requires a large amount of supporting equipment, limiting its integration into 
complex photonics. Progress in implementation of microfluidic operations without the 
addition of supporting equipment will make LOC integration with highly complex 




Fig. A.2 (A,C) Dynamic microfunnel architecture provides both autocrine factor 
retention and mechanical stimulation . (B) The accessibility of the funnel allows for 
easy embryo introduction into and extraction from the device via simple pipetting. 
Outlet channel also provided an effective method to prevent the accumulation of 





Fig. A.3 A passively driven sperm sorter was built using surface tension and gravity 
as a driving force and laminar flow regime. Flow is from left to right. Sperm sample is 
loaded in the reservoir at the top left. Dead sperm, non-motile sperm and debris are 
carried straight across the top stream while motile sperm are able to swim under their 





Fig. A.4 (A-B) A microfluidic line connects the sample reservoir to a 50nL micro-
cuvette. (C-D) The microfluidic line which serves as a selective filter to separate 
motile sperm from dead sperm, non-motile sperm and debris is 52 µm
2
 in cross 
section and 6 mm in length. (E-H) Sperm is labelled with Calcein-AM and upon 
reaching the micro-cuvette are excited by excitation light and the fluorescent light 
emission is detected to assess the number of motile sperm reaching the micro-cuvette 




Fig. A.5 Live cells due to the ability to maintain an ionic gradient to the extracellular 
space are highly polarized in an electric field. While dead cells have no gradient are 
not polarized. (A) sample is loaded into a microfluidic chamber for OET sorting. (B) 
Live cells experience attractive forces towards regions of high electric field while 





Fig. A.6 (A) Overview of sperm sorter set up. Computer not included. (B) Integration 
of optics and hydrodynamics. (C) Instabilities in the stream are applied via 
mechanical vibrations. (D) Droplets are given either a negative or positive charge 
depending on their sex. Under an electric field, the droplets experience a horizontal 





Fig. A.7 The degree of oocyte maturity can be analysed using the absorption spectra 





Fig. A.8 Braille-driven device is highly programmable capable of complex operations 
such as (A) priming, (B-C) mixing and reactions, and (D) washing and injection with 
minimal support from external sources unlike typical syringe-driven devices that 





Fig. A.9 (A-B) Continuous imaging combined with automatic monitoring algorithm. 





 mitoses, the algorithm is capable of predicting whether embryos will 





Fig. A.10 With each additional operation in syringe-driven LOC devices, more 
supportive equipment is necessary (each tube is typically connected to a syringe pump 
not pictured). With complicated LOCs, it becomes increasingly difficult to integrate 
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Thinking big by thinking small: application of microfluidic technology to 
improve ART 
 
In Vitro Fertilization (IVF) laboratories often carry a penchant to resist change while 
in the pursuit of maintaining consistency in laboratory conditions. However, 
implementation of new technology is often critical to expand scientific discoveries 
and to improve upon prior successes to advance the field. Microfluidic platforms 
represent a technology that has the potential to revolutionize the fundamental 
processes of IVF. While the focus of microfluidic application in IVF has centered on 
embryo culture, the innovative platforms carry tremendous potential to improve other 
procedural steps and represents a possible paradigm shift in how we handle gametes 
and embryos. The following review will highlight application of various microfluidic 
platforms in IVF for use in maturation, manipulation, culture, cryopreservation and 
non-invasive quality assessment; pointing out new insights gained into functions of 
sperm, oocytes and embryos. Platform design and function will also be discussed, 
focusing on limitations, advancements and future refinements that can further aid in 





Within the field of assisted reproductive technologies (ART), like many other fields, 
there is an ongoing endeavor to improve outcomes and optimize efficiency. Achieving 
this goal is facilitated by various scientific discoveries regarding the development and 
function of gametes and preimplantation embryos, of which more are revealed each 
day. Importantly, technological innovations, several of which are developed with 
entirely different disciplines in mind, permit many of these new discoveries. 
Furthermore, in addition to novel information gained from their application, these 
new technologies may be adapted to change the fundamental approaches used for 
everyday laboratory procedures, like cell culture. Microfluidics represents such a 
technological advancement. 
While the focus of microfluidic application in ART has recently been centered on 
embryo culture,
1,2
 the innovative platforms carry tremendous potential to 
revolutionize all aspects of ART and represents a possible paradigm shift in how we 
handle gametes and embryos (Fig. B.1). The following review will highlight 
applications of various microfluidic platforms in ART, pointing out new insights 
gained into functions of sperm, oocytes and embryos, while also highlighting the 
platforms themselves; specifically focusing on limitations, advancements and future 
refinements that can further aid in their widespread clinical implementation . 
 
B.2 Andrology 
One of the earliest applications of microfluidic platforms in ART entailed assessment 
of spermatozoa. The constrictive nature of microfluidic platforms and ability to create 
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complex networks of channels and reservoirs proved a useful combination in 
assessing characteristics of motile sperm. 
As early as 1993, simple microchannel devices made of silicone were used to 
evaluate rudimentary aspects of sperm function via interactions with cervical mucus, 
hyaluronan, spermicide and anti-sperm antibody beads as motile sperm traversed 
various network layouts.
3
 Follow-up studies demonstrated the ability to perform 
quantitative sperm counts and motility assessments on etched glass microchannel 
devices.
4
 While these early devices did not integrate active fluid flow or utilize the 
unique physical aspect of fluids during flow through microfluidic channels, they did 
provide insight into the potential applications of the platforms. As design and 
fabrication processes have advanced, application of microfluidics in andrology has 
grown. 
Sperm counts 
A microfluidic chip was recently developed consisting of channels etched on a glass 
wafer fabricated to perform sperm counts. Directing sperm movement at varying 
velocity by adjusting height of fluid columns from two media reservoirs, cells were 
able to pass along a microfluidic channel flanked on either side with planar electrodes. 
The resulting electrical impedance measurements recorded as sperm passed the 
electrodes permitted estimation of sperm concentration.
5
 While the simple media flow 
generated by gravity and hydrostatic pressure is easy-to-use, careful regulation is 
required to ensure proper speed of sperm for accurate assessment. Importantly, the 
approach was able to distinguish sperm from polystyrene beads and HL-60 cells, 
which is important for clinical application due to other debris in seminal plasma. With 
refinements and considerations to production costs, a similar system could be 
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envisioned for use for routine semen analysis to streamline and standardize sperm 
counts. 
Sperm separation 
Perhaps the most widespread application of microfluidic technology in andrology 
entails use for sperm separation. Many of these approaches rely on devices that 
generate fluid flow from media reservoirs through some sort of microchannel. 
Devices designed using microfluidic channels for sperm separation are highly 
dependent upon variables affecting the laminar flow and velocity of the fluid streams 
in motion. Factors like channel width, height, depth, as well as fluid velocity and 
viscosity are all critical parameters that must be considered when trying to optimize 
separation of a specific sperm population. This task is further complicated by the 
varying viscosity of semen and presence of cellular debris in addition to sperm. 
Despite these sometimes difficult variables, several modern devices have addressed 
some of these issues. 
One of the earlier reports using microfluidic technology for separation of motile 
sperm from semen samples utilized a polydimethylsiloxane (PDMS) passive gravity-
driven device where the hydrostatic pressure of two separate inlet reservoirs drove 
media flow down a converging microfluidic channel
6
 (Fig. B.2) The principle of the 
device took advantage of the fact that only motile sperm can traverse the border that 
separates the parallel streams of diluted semen and fresh medium. Thus, the laminar 
flow properties exhibited by media in microchannels allowed motile sperm to swim 
away from non-motile sperm, debris, and seminal plasma and collect in a separate 
outlet reservoir. Follow-up experiments demonstrated this microfluidic device design 





The novel approach appeared to offer a feasible 
alternative to isolate sperm from oligozoospermic patients for use in intra-cytoplasmic 
sperm injection (ICSI). 
Another approach employing microfluidics for sperm sorting utilized mouse sperm 
placed into a PDMS/glass device, to isolate sperm based on motility, but 
also via chemotaxis towards cumulus cells.
8
 Sperm were placed into an inlet reservoir 
and allowed to swim down a straight channel, whose dimensions were optimized for 
motile sperm recovery. Sperm were then collected in a small central reservoir, where 
video imaging could occur, before swimming onward into 1 of 2 branching channels, 
each leading to separate collection reservoir. Other microfluidic devices to explore 
sperm chemotaxis also exist and offer further unique tools to explore sperm function.
9
 
In another use of microfluidic technology for andrology, a PDMS/glass device was 
constructed that directed sperm flow within microchannels to separate, align and 
orient sperm of mouse, bull and human,
10
providing potential applications for ICSI. 
Utilizing the fact that motile sperm orient themselves against media flow within these 
devices, and that motile sperm can swim against media flow of certain velocity, a 
series of three reservoirs and four microfluidic channels allow processing of 
sperm via hydrostatic media flow. Of note, this device requires very precise regulation 
of media volumes within the reservoirs to regulate hydrostatic pressure. 
Utilizing these advantages of a microfluidic device for sperm isolation, 
implementation of a microfluidic sperm sorter manufactured out of quartz has begun 
in clinical IVF. A preliminary report indicates human semen can be processed rapidly 
and isolated motile sperm can be used to successfully fertilize human oocytes 
following ICSI
11
 (Fig. B.2). Follow up studies by the same group have since produced 
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PDMS versions of the sperm separation device that have widened microfluidic 




Due to the limitations inherent in a microfluidic sperm sorting device, utilization of 
the technology must provide some added benefit over conventional processing 
methods. Conventional sperm preparation methods, such as serial centrifugation, 
density gradient separation or swim-up, are reported to induce sperm DNA damage, 
perhaps to exposure to reaction oxygen species (ROS).
13–15
 Preliminary data indicate 
that sperm isolated using a microfluidic sperm sorting device had significantly lower 
levels of DNA damage and higher motility compared to these more conventional 
approaches.
16
 Thus, microfluidic sperm sorting may allow for selection of higher 
quality sperm, potentially leading to improved embryo quality. With the above 
mentioned applications, one can envision a microfluidic device that assesses sperm 
concentration, motility, progression and then separates sperm based on various 
qualities or characteristics. This isolated sperm could then be manipulated in a fashion 
to make it suitable for ICSI within the same microfluidic platform to streamline the 
current practice of moving sperm from dish-to-dish. This approach could prove a 
powerful tool in reducing variability in andrology laboratory testing and processing 
and help improving ART outcomes. However, it should be noted that, despite the 
ability of microfluidic devices to perform high-speed and high-throughput sperm 
sorting, selection is based solely on motility. Thus, the approach is unable to identify 
non-motile but viable sperm for ICSI, which is relevant for patients suffering from 





Employing microfluidic technology for embryology requires considerations unique 
from microfluidic devices utilized with adherent cells, or even those used for sperm 
assessment. The main obstacle to consider is reliability of cell recovery. While it may 
be acceptable to recover only a portion of an initial cell population when dealing with 
hundreds of thousands or millions of cells, 100% recovery is essential for applications 
involving oocytes and embryos. Thus, platform design must make accessibility and 
recovery of paramount importance, and it must do so without limiting the inherent 
properties of microfluidics that make it advantageous to cell biology, namely the 
constrictive nature. In addition, the added effort and cost of applying microfluidics 
must be offset by a measurable benefit on gametes or embryos to justify 
implementation of the technology. Fortunately, many of these issues are actively 
being addressed, and, as a result, platforms have begun to receive initial testing in all 
aspects of embryology, including in vitro oocyte maturation (IVM),in 
vitro fertilization (IVF) and embryo culture. 
Oocyte maturation 
In vitro oocyte maturation is an especially appealing approach for human ART 
considering the tremendous advantages offered, including reduced cost and reduced 
health risk to disorders such as ovarian hyperstimulation syndrome 
(OHSS).
17
 However, IVM is still an inefficient practice. Fortunately, microfluidic 
approaches offer the potential to improve current IVM success rates. In the first report 
of oocyte maturation using microfluidics, a microfluidic channel flanked by two 
media reservoirs with no regulated media flow, did not result in porcine oocytes 
maturing efficiently in silicone devices (2% Metaphase II; MII). However, when these 
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oocytes were matured in PDMS devices, they matured at a significantly higher rate 
compared to control microdrops (2% vs. 71% to MII, respectively).
18
 Interestingly, 
cumulus cell expansion was noticeably diminished in oocytes matured in 
microchannels compared to larger microdrops. This observation may be indicative of 
quality oocyte cytoplasmic maturation, as oocytes regulate cumulus cell development 
and function.
19
 Thus, while the size and/or volume limitations of microchannels may 
improve nuclear maturation, they may also have some limiting effect on porcine 
oocyte cytoplasmic properties, or physically restrict cumulus expansion. In contrast, 
subsequent follow-up experiments by Walters and coworkers from the same research 
group suggest oocyte cytoplasmic maturation may actually be enhanced in static 
microchannels. Pig oocytes matured in 250 μm wide PDMS/borosilicate glass 
microchannels produced significantly higher numbers of 2-cell embryos following 
IVF and embryo culture in microdrops compared to oocytes matured in 500 μl drops 
(67 vs. 49%).
20
 Unfortunately, pronuclear formation, embryo development past the 
maternal-zygotic transition, or blastocyst cell numbers as measures of improved 
oocyte developmental competence were not reported. The differential results from 
these studies in similar designed devices of differing materials suggest that material 
selection is of paramount importance for the sensitive oocyte. 
Interestingly, preliminary studies indicate bovine oocytes matured in PDMS 
microfunnels with Braille pin regulated media flow actually yields improved 
blastocyst development following IVM compared to static matured oocytes 
(unpublished results). Despite these preliminary findings, the field awaits peer 
reviewed publications examining effects of fluid flow in microfluidic devices on more 
informative markers of oocyte developmental competence. Toward this end, a 
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microfluidic device does exist that utilizes magnetically actuated manipulators in 
conjunction with ultrasonic vibration for single cell manipulation.
21
 This device can 
move and orient porcine oocytes and may be modified for potential 
micromanipulation purposes. Interestingly, a vibrating culture platform was 
previously shown to enhance porcine oocyte developmental competence when applied 
to standard culture dishes with larger volumes.
22
 Thus, the vibrational aspect of the 
previously mentioned microfluidic device used to move oocytes may also offer some 
benefit to oocyte cytoplasmic maturation and could be potentially modified to 
improve IVM. 
In vitro fertilization 
Another demonstration of microfluidic application in ART can be seen in 
insemination performed “on chip”. Insemination is a particularly difficult procedural 
step in ART, as sperm motility characteristics and interactions with oocytes in 
microfluidic channels are highly dependent upon fluid flow rate. The speed of fluid 
movement influences sperm motion and a threshold exists where sperm are no longer 
capable of independent movement.
23
 Furthermore, sperm motion paths can be 
influenced by the contours of the device. These qualities have immense implications 
for success of fertilization within microfluidic platforms. 
The first attempt at the procedural step of insemination was performed using 
porcine oocytes placed into PDMS/borosilicate microchannels (Fig. B.3). Sperm were 
added in a manner where hydrostatic pressure differences created from differing 
volume of media added to reservoirs at either end of the microchannel resulted in 
gravity-driven fluid flow of sperm past oocytes, which were immobilized at a 
constriction point within the microchannel. Fertilization in this device resulted in 
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significantly lower rates of polyspermic penetration compared to fertilization in 
control microdrops.
24
 Reduced polyspermic penetration rates were attributed to the 
physical characteristics of the microfluidic device, mimicking the environment in vivo. 
It was hypothesized that microfluidic devices served to limit time of oocyte exposure 
to sperm, as sperm were not confined to the vicinity of the oocytes, but allowed to 
flow past the eggs. 
Subsequently, Suh and colleagues demonstrated successful fertilization of mouse 
oocytes on a more complex microfluidic device that consisted of a series of open slots 
within a microchannel
25
 (Fig. B.3). Although initial experiments utilizing high 
concentrations of sperm revealed that overall fertilization rates were decreased on the 
microfluidic device compared to control microdrops, subsequent experiments 
demonstrated that, by lowering sperm concentration, fertilization rates in microfluidic 
devices were actually higher than controls. These results appear to be the result of 
chip design, as authors observed increased concentration of sperm in the vicinity of 
the oocyte in microfluidic devices. 
More recently, fertilization has been performed on a microfluidic microwell 
device
26,27
 (Fig. B.3). Similar to previous devices, platforms were made of PDMS and 
constructed with an inlet and outlet reservoir, which generated media flow using 
gravity. Microchannels leading from each reservoir connect to a larger microchamber 
that housed individual square microwells containing individual oocytes. Microwell 
depth was optimized to permit retention of oocytes while allowing adequate debris 
removal and sperm interaction with oocytes. Media and sperm could then be flowed 
over the microwells housing the oocytes. Using this approach, similar rates of mouse 





alternate device from the same research group with differing design to incorporate 
multiple procedural steps also yielded promising fertilization results.
27
 Additional 
microfluidic devices incorporating insemination with other procedural steps have also 
been developed and are discussed later.
26
 
Other oocyte manipulations 
In addition to maturation and insemination, other oocyte manipulations are common 
during routine IVF procedures. Microfluidic devices have been developed that can 
perform some of these tasks. Cumulus cell removal can be performed in a series of 
microchannels.
28,29
 Utilizing fluid flow driven manually via attached syringes, 
exposing oocytes to chemical and physical manipulation, cumulus cells could be 
removed, leaving the oocyte intact. A similar approach has also been successful in 
removing the zona pellucida.
30
 More recently, a system combining microfluidic 
channels and an optical ablation laser was used to manipulate clam oocytes through a 
series of channels, which permitted media exchange and positioning of cells for laser 
ablation.
31
 Application of a similar device that could rotate cells
32
 could be envisioned 
as useful for clinical procedures like assisted hatching. 
Embryo culture 
Exhaustive studies have been conducted aimed at optimizing preimplantation embryo 
culture system in vitro, and, similar to IVM and IVF, a microfluidic platform may aid 
in this endeavor. The initial report on embryo culture using microfluidics by Raty and 
colleagues indicated that 2-cell mouse embryos could be cultured to the blastocyst 
stage within static microchannels
33,34
 (Fig. B.4A). Compared to 30 μl control 
microdrops, culture within these microchannels containing about 500 μl of media 
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resulted in significantly greater 16-cell/morula formation at 24 h, greater blastocyst 
formation at 48 h and 72 h, and a greater portion of hatched blastocysts at 72 and 96 h. 
However, impact on implantation or live birth was not evaluated. Subsequent 
experiments utilizing a similar device by Walters and coworkers from the same 
research group showed that in vivo derived 4-cell porcine embryos could be cultured 
to blastocyst and transferred, resulting in live birth.
35
 However, in these follow-up 
experiments, no observable beneficial effects on embryo development were seen 
when compared to culture in control organ-well dishes. Furthermore, cell recovery 
issues were apparent when culturing cells in microchannels.  
Building upon their initial microchannel static embryo culture studies, Hickman et 
al. examined mouse embryo development in microchannels with media flow, 
controlled via an external large syringe infusion pump.
36
 Flow rates examined (0.1 
and 0.5 μl h
−1
) did not enhance development compared to static culture. In fact, a 
flow-rate of 0.5 μl h
−1
 resulted in significantly lower development of 2-cell mouse 
embryos to morula and blastocyst stages, while producing higher numbers of 
abnormal embryos compared to controls. Thus, flow rate and manner of flow delivery 
appeared to be important variables for embryo culture in microfluidic devices. Indeed, 
embryos can sense sheer stress, which can induce apoptosis and be detrimental to 
embryo development.
37
 However, it is questionable if flow rates necessary for 
dynamic fluid flow in microfluidic channels would approach velocities high enough 
to cause concern. Additionally, it should be noted that these data on the impact of 
media flow and flow-rate on embryo development should be re-assessed, as culture 
conditions may have been suboptimal. In this particular study, control mouse embryos 
cultured in control static microchannels did not improve embryo development as 
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previously reported by Raty and colleagues from the same research group.
33
 One 
possible source of variation requiring future study was the increased number of 
embryos cultured in each device, a factor which undoubtedly would have an impact 
due to influence of group embryo culture,
38,39
 especially within the confines of a 
microfluidic platform. 
Yet another approach to culturing embryos within microfluidic device employed 
not only dynamic media flow, but also co-culture. Mizuno and coworkers developed a 
“womb-on-a-chip”, where endometrial cells can be grown in a lower chamber, while 
embryos are cultured in an upper chamber, separated from the lower by a thin 
membrane
40,41
 (Fig. B.5A). The design permits embryo exposure to secreted factors 
from the endometrial cells, while avoiding direct cell contact. In their preliminary 
report, authors demonstrated that mouse ova fertilized on and resulting embryos 
cultured in these devices showed similar cleavage to 2-cell and similar blastocyst 
formation rates compared to 50 ul control microdrops.
40
 Furthermore, cell number 
was significantly higher in blastocysts fertilized/cultured in microfluidic devices. 
Subsequently, blastocysts obtained from microfluidic devices were transferred to 
recipient female mice and resulted in live offspring at rates similar to embryo cultured 
in static microdrops. A similar co-culture approach was taken by the same group, 
culturing 2-cell mouse embryos to blastocyst stage on the refined OptiCell 
microfluidic device. OptiCell microfluidic co-culture culture yielded chromosomally 
normal embryos, capable of yielding live offspring.
42
Mizuno and colleagues later 
published an abstract reporting the first instance of human embryo culture within their 
co-culture microfluidic devices. Donated 2–4 stage frozen human embryos were 
cultured to the blastocyst stage, resulting in significantly higher rates of blastocyst 
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development from microfluidic devices compared to control 
microdrops.
41
 Additionally, visual scoring of microfluidic-derived blastocyst 
development revealed higher quality blastocysts with significantly higher cell 
numbers compared to static controls. A similar device was later constructed using a 
microporous membrane to separate mouse embryos from endometrial cells
43
 (Fig. 
B.5B). Unfortunately, co-culture confounds interpretation of results obtained, as it is 
impossible to discern if beneficial effects are attributed to co-culture or the physical 
properties of the microfluidic device/design. 
Notably, a braille pumping system using tiny electric piezo actuators has been used 
successfully to grow embryos by peristaltic media motion along microchannels 
formed in PDMS through a microfunnel housing the cells
44–47
 (Fig. B.4B) This 
approach is unique from other microfluidic devices used in ART, in that it permits 
precise computerized regulation of speed and flow patterns, rather than passive media 
flow due to gravity, or the more course media flow provided by external syringes. It 
was demonstrated that regardless of media flow pattern (back and forth vs. flow-
through) or speed (fast vs. slow), 1-cell mouse embryos cultured in these microfluidic 
devices showed greater hatching of blastocysts and significantly higher cell number 
than static controls, yielding numbers similar to those obtained from in vivo derived 
blastocysts.
45,47
 It was also shown that this approach produced greater number of 
mouse embryos reaching morula stage at 48 h, blastocyst at 72 h and hatched 
blastocyst at 96 h compared to control static chips, while significantly more bovine 
embryos reached the blastocyst stage at 144 h in microfluidic devices compared to 
control static devices.
44
 Follow up experiments indicated that beneficial effects of 
embryo culture in the dynamic culture device are additive and require a minimum 48 
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h of culture at the beginning or end of 96 h culture periods.
46,47
 Importantly, this 
device was the first report that a microfluidic dynamic culture platform could not only 
improve preimplantation embryo development, but that quality of embryos cultured in 
a microfluidic device with media flow are superior to those grown in static systems, 
as evidenced by increased implantation rates, lower rates of absorption and higher 
ongoing pregnancy rates in mouse.
47
 Also important to note, the studies were 
eloquently controlled using static controls within the microfunnel platform, which 
permitted the conclusion that the media flow as responsible for beneficial effects, 
rather than simply an effect of the material or microfunnel design. Subsequently, a 
modified microfunnel constructed for clinical trials was able to support human 
blastocyst formation, while producing higher quality embryos on day 3 with lower 
levels of fragmentation
48
 (Fig. B.4C) 
More recently, at least one study has used a tilting culture system in conjunction 
with microfluidic channels to gently agitate embryos during culture. Bovine embryos 
were tilted 10° over 1 min and cultured inside straight microchannels or 
microchannels with a 150–160 μm constriction. Though no difference in blastocyst 
formation was observed, and the influence of the tilting system alone was not 
examined, authors suggest that combining an embryo tilting system with a 169 um 
constricted microchannel may offer a means of improving bovine embryo cleavage, 
yielding higher rates of 8-cell development after 44 h or culture compared to straight 
channels (56.7 vs. 23.9%).
49
 It should be pointed out, however, that the tilting 
approach is simply agitation and doesn't necessary remove or replenish the existing 
media like perfusion systems. A similar microchannel system from the same group 





 Similar methods of combining a simplified 
microchannel or microfluidic devices with other dynamic methods of inducing fluid 
movement, generally used at the macro-level, such as vibration or agitation, may be 
helpful, as gentle agitation appears to beneficial for human embryos.
51,52
 Though the 
more recent dynamic culture platforms that agitate media and embryos by simply 
placing traditional culture dishes with microdrops or larger volumes of media on a 
moving or vibrating platform have been examined and appear promising,
51–54,22,49
 in 
the context of this review, these aren't considered microfluidic culture platforms and 
may not utilize the full potential of the constrictive microenvironments offered by 
microfluidic approaches. 
Regardless, microfluidic systems with perfusion, or some other means of agitation, 
may benefit embryo development for a variety of reasons. One intriguing possibility 
is the idea that gentle mechanical stimulation, either through fluid flow or gentle 
movement of the embryos, could be beneficial. This “Active Embryo Hypothesis”, 
theorizes that gentle physical stimulation of embryos can activate embryotrophic 
signaling pathways and promote embryo development.
55
 However, excessive forces 
can be detrimental. Indeed, it is well known that various sensory mechanotranduction 
systems are evident in a variety of cells types, usually manifested by regulation of ion 
channels.
56
 The same may hold true in embryos, or even oocytes, as it is known that 
embryos can sense sheer forces for rotating embryo culture or other pipetting, which 
activates various signaling cascades.
37,57
 Whether beneficial signaling pathways are 
activated in mammalian oocytes or embryos within these dynamic culture platforms, 




Finally, another aspect of novel microfluidic culture devices that may convey an 
unexpected benefit to developing embryos is the use of novel materials. While these 
materials may be initially selected due to ease of manufacturing intricate designs 
using techniques such as photolithography, the platforms surfaces themselves may 
improve embryo development. Indeed, it has been postulated that coating of platform 
surfaces with specific molecules may benefit embryo development, either through 
direct physical effects, or through modifications of the chemical environment.
2,55
 Thus, 
the actual material used in device construction may also impact the culture 
microenvironment. This was found to be the case when using PDMS for culture 
device construction, as the material is absorptive and caused detrimental osmolality 
shifts unless a specialized parylene coating was applied.
58
 It was later reported that 
PDMS embryo culture devices that were “softer” supported better embryo 
development.
59
 In comparing polystyrene of high stiffness, with a softer PDMS or 
collagen, it was found that softer surfaces improved embryo and placental 
development. However, due to the zona pellucida as a barrier preventing direct 
contact to the embryo, the stiffness of the polymer or substrate likely played no role. 
Rather, the absorptive nature of the varying surfaces likely differed and differently 
impacted media characteristics. Interestingly, it was recently reported that standard 
polystyrene petri dishes, as most commonly used to culture embryos, may weaken 
cells, as evidenced by reduced proliferative capacity along a vertical wall of adherent 
cell lines
60
 Specifically, it found a subtle softening and swelling of the polystyrene 
surface due to interactions with water that created nanoscopic layers of hydroxide ions 
that altered localized pH and induced a layer of ROS. This may have ramifications for 






Expanding upon the application of microfluidic devices for specific procedural steps 
within ART, the precise fluid control offered by these dynamic platforms may be 
especially well-suited to exposure to cryoprotectants. Conditions of cryoprotectant 
exposure can impact cell function and survival, with factors like concentration and 
time of exposure as crucial variables.
61
 This is especially true for vitrification 
approaches, which utilize very high concentrations of cryoprotectant agent (CPA) and 
require very low exposure times to prevent toxicity. Detrimental effects 
of CPA exposure on genotoxicity, even without cryopreservation, have been 
shown.
62
 Even sub-lethal genotoxicity such as DNA fragmentation
63
 can still cause 
catastrophic outcomes.
64
 Thus, given the fact that oocyte vitrification procedure 
successes to date have been achieved despite the lack of a quantitative understanding 
of the mechanical and chemical effects different CPAs and CPA exchange procedures 
can have on gametes and embryos, microfluidics may permit 
optimizing CPA exchange procedures and reduce sub-lethal damages. 
Importantly, practical issues exist with current manual cryoprotectant exposure 
regimes that limit preciseness and repeatability. There is inherent variability in timing 
of manual procedures between individuals. Also, discrete manual dilution steps are 
required to make cryoprotectant exposure feasible. While logistically important for 
the embryologist, these approaches may not be ideal for the cell. Thus, it is clear that 




Although the two or three step CPA exchange concept is now relatively broadly 
accepted for embryo or oocyte vitrification, the exact procedure differs from lab to lab 
contributing to the variability in cryopreservation success rates. More fundamentally, 
there is a problem that there are more potential combinations of CPAs 
and CPA exchange procedures that could be utilized than can be efficiently and 
reliably tested for by trial and error experiments alone. The approach of using 
specialized bioengineered devices to design vitrification CPA exchange protocols, 
where manual dilutions do not limit efficacy, might help alleviate both the osmotic 
shock (mechanical effects) and CPA toxicity (chemical effects). A more gradual, 
rather than sudden stepwise increases in CPA concentration, is known to increase 
viability.
65
 There is a practical and capability limit, however, in terms of how many 
exposure steps and in what time the CPA exchange can be performed using the 
current gold standard; manual pipetting. Furthermore, the transfer of cells from 




To address these current limitations with manual approaches, microfluidic devices 
have been designed where, rather than moving the oocyte from one CPA solution to 
another by pipetting, the oocyte will be stationary and the CPA solutions will be 
pumped over it by computer control. This permits continuous and gradual, rather than 
discrete step increases, in CPA concentrations that the oocyte is exposed to. 
Preliminary reports indicate potential of this approach. Controlled CPA exposure with 
a microfluidic platform reduced the size change of oocytes compared to traditional 
approaches, which may be important for cell viability
66
(Fig. B.6A). However, the 
platform design yields limited access to cells for loading and removal, which is 
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problematic in terms of clinical practicality. A similar approach for using 
computerized control of media exposure to permit gradual cryoprotectant exchange to 
limit large osmolality changes have been used with embryos
67
 (Fig. B.6B). Perhaps 
more importantly, use of a microfluidic platform for gradual CPA removal during 
oocyte/embryo warming may be beneficial in further optimizing cryosurvival. This 
application remains to be explored. 
Another obstacle that has hindered rapid and wide-spread acceptance of 
vitrification approaches has centered on ease-of-use issues of vitrification devices. 
There are numerous commercially available and in-house devices to contain oocytes 
or embryos for low temperature storage following vitrification.
68
 These utilize very 
small volumes of vitrification solution to permit the vitrification process and avoid 
damaging ice crystal formation. While both open and close containers can be used 
successfully, the combination of the low volume and rapid time needed to load 
devices to prevent toxicity from cryoprotectant exposure can be problematic, 
especially compared to 0.25 cc straws used with slow-rate approaches. A novel 
microfluidic platform regulating CPA solution exposure to oocytes, that integrates a 
novel vitrification device, could simply bypass the current step-wise procedure and 
eliminate errors with manual dilutions and movement of cells through various media 
and loading of complicated devices. 
 
B.5 Future Directions 
Though incremental advances in application of microfluidic technology to enhance 
current ART protocols should now be readily apparent, the full potential of the 
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approach has yet to be recognized. Much of this is due to the limitations in design and 
function, both perceived and actual. However, emerging studies are pushing the 
envelope to harness the capability of these novel devices. Three main areas in 
microfluidic refinement that hold tremendous promise for revolutionizing efficiency 
of IVF include ability to implement multiple IVF procedural steps on a single device, 
automation of procedural steps and implementation of diagnostic inline assays. If 
implemented in a clinically feasible platform, these advancements may lead to 
improved culture conditions, reduction of in vitro stressors, as well as improved 
embryo selection; ultimately culmination in improvement in ART outcomes. 
Multiple ART procedural steps on a single device 
Many of the above mentioned studies implement a single procedural step on a 
microfluidic device. However, implementation of multiple steps on the same device 
would be advantageous, as it would reduce cell handling and the associated 
environmental stressors. Keeping the delicate cells in place, while gradually changing 
media, or gently rolling the cell to a new location may produce a less stressful 
environment and help optimize the in vitro culture system. 
One of the first examples of integration of multiple procedural steps on a single 
microfluidic platform was presented by Clark and coworkers. Their preliminary data 
demonstrated that both IVM and IVF of porcine oocytes could be performed on the 
same microfluidic device without removal of the cells between procedures.
69
 Media 
within devices were changed by withdrawing from the 2 reservoirs and sperm 
added via manual pipetting without disturbing oocytes, which were housing in a 
connecting microchannel. Although there were no observable benefits achieving 
cleavage to 2-cell compared to control treatments (49% vs. 51%), this demonstrated 
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that multiple tasks of in vitro embryo production could be performed upon the same 
microfluidic platform. 
Another example of integrating multiple IVF steps on a single platforms entails 
separation of porcine sperm using laminar flow in a microfluidic device, and then 
fertilizing oocytes that were then placed in a chamber near the exit point of the 
separated, motile sperm.
70
 Rates of monospermic penetration varied depending on 
oocyte location in the exit chamber. Subsequent analysis revealed that the 
microfluidic device yielded higher rates of normal fertilization and subsequent 
blastocyst development compared to standard insemination protocols in petri dishes. 
More recently, mouse embryos have been cultured successfully in microwells 
housed on the same microfluidic device where fertilization occurred. Han et 
al.
26
 demonstrated that oocytes could be fertilized in microwells using media and 
sperm movement via gravity driven hydrostatic pressure . Fertilization media was 
then replaced with embryo culture media by flowing media though the channels on 
the same device and embryos cultured. Though there was no active media flow during 
the 96 h of embryo development, similar high rates of blastocyst formation were 
obtained following culture in microwells compared to controls (87.5vs. 87.8%). 
Similarly, using a revised device design employing the “octacolumn” to house 
oocytes/embryos rather than microwells, the same group again demonstrated mouse 
oocyte fertilization and subsequent embryo development on the same microfluidic 
platform, yielding high rates of blastocyst formation, similar to controls 
(86.9% vs. 85.3%).
27
 Another device also exists that performs IVF and embryo culture 





More ambitious and complex devices are emerging. One report details a device 
that incorporates a variety of procedural steps from oocyte manipulation, insemination 
and embryo culture.
27
 Similarly, another “chip” has been developed that attempts to 
integrate each step of the IVF process including oocyte positioning, sperm screening, 
fertilization and embryo culture with media replacement.
26
 
Most recently, a miniaturized embryo array has been developed that can trap 
multiple zebrafish embryos, holding them in individual locations while utilizing 
microfluidic perfusion to supply fresh media or pharmacologic compounds to 
examine effects over time.
71
 Integrated with a perfusion pump, stage heater and valves 
to help regulate flow and remove waste, this platform is also combined with real-time 
video analysis. A similar approach could be envisioned for use with mammalian 
embryo culture, where real-time embryo imaging devices placed in incubators has 
received widespread attention.
72,73
 Using a miniaturized approach, each microfluidic 
“chip” could in theory have its own thermal heat source below the embryos, contain a 
miniaturized camera and self-contained LED light source for observation, and even 
maintain their individual atmosphere in isolated chambers. This would be a large 
departure from multiple dishes/patients sharing a large common incubator, where 
dishes are removed on a regulator basis for microscopic observation and subject to 
changes in temperature and pH. 
Automation 
Automation of intricate step-wise procedures performed on microfluidic platforms 
within the ART laboratory is a potential method to reduce variability and perhaps 
improve ease-of-use. Others have already conjectured that some level of automation 
may be the future of the IVF laboratory.
74
 As an example of the promise of this 
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approach, automation of blastomere visualization/tracking during mitosis and use of a 
predictive algorithum for automatic embryo selection has been 
utilized.
72,73
 Additionally, more complex procedures that could utilize a microfluidic 
platform, such as automated microinjection have been explored.
75,76
Toward this end, 
an automated microfluidic device aimed at sorting, collecting, 
orienting xenopus oocytes for subsequent microinjection has been 
developed.
77
 Authors claimed a dramatically improved efficiency, reducing the time 
needed to process 400 oocytes from 1 day to 4 h. While this may have application 
for large scale animal production purposes, the relevance to human oocytes, which are 
limited in number for each case, may not be as significant. It does, however, introduce 
the ability to reduce variability and stress in the culture system. Automation of 
vitrification procedures has also been examined as a way to reduce variability in this 
highly sensitive approach,
67
 and may prove to be an instrumental tool in further 
improving success. 
Inline diagnostic assays 
Implementation of inline diagnostic assays to aid in selection of viable gametes for 
use or embryos for transfer would further help realize the immense potential of 
microfluidics in ART.
78
 Microfluidic devices have been developed to assess embryo 
metabolism
79
 (Fig. B.7A) and oxygen consumption,
80
 though these devices were not 
developed with extended culture or cell recovery for subsequent use in mind. More 
recently, a promising approach of measuring glucose consumption in the same 
microfluidic device where embryos are cultured has been developed
78,81
 (Fig. B.7B). 
This approach may permit real-time metabolic assessment of embryos, ultimately 
providing a profile of metabolism over time. Such a profile could be used in 
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conjunction with similar profiles collected over time, such as those collected using 
emerging morphokinetic time-lapse analyses. Combining multiple real-time analytic 
profiles would undoubtedly provide greater insight into embryo development and 
permit better selection for transfer.  
 
B.6 Conclusions 
It is clear that microfluidics offer many opportunities to revolutionize the ART 
laboratory as we currently know it. Importantly, these technologies would not negate 
the need for an embryologist. Rather, they would serve to streamline processes, act as 
an adjunct to reduce stress imposed upon gametes and embryos, reduce variability 
between personnel/lab, and serve to help optimize the culture environment. Though 
personnel would be required to change their current procedures and likely undergo 
extensive training to learn to operate and troubleshoot new microfluidic or automated 
systems, this should be viewed as enhanced job training; a necessity in any position 
that attempts to constantly improve upon past successes. That being said, it is 
acknowledged that microfluidic devices are generally designed with functionality first 
and foremost, with little or no regard to ease of clinical applications. In this respect, 
future designs should consider simplicity and usability to facilitate the adoption of 





Fig. B.1 Schematic of basic steps involved in the in vitro fertilization process that 






Fig. B.2 A) Schematic of a microfluidic device created for sperm sorting. Passively 
driven by a difference in surface tension, the separation of motile sperm relies on 
laminar flow of the merging fluid streams, and motile sperm can swim across the 
interface to collect in a reservoir.
7
 B) Sperm sorter device made of PDMS used in 
initial design and testing. C) Modification of the microfluidic sperm sorting device 





Fig. B.3 A) First device design used to successfully perform fertilization of pig 
oocytes using microfluidics.
24,69
 This device utilized a straight microchannel with a 
small constriction point to prevent oocytes from rolling the length of the channel, 
while permitting sperm to flow past the oocyte. This particular device utilized gravity 
driven media flow and was not engineered to sustain controlled fluid flow over time. 
A similar device was used for oocyte maturation.
69
 B) A modified microfluidic 
platform used to successfully perform fertilization of mouse oocytes.
25
 C) Alternate 
fertilization device using microwells.
26,27
This device may create a more suitable 
microenvironment, while also permitting individual identification of zygotes 
following fertilization. All of the aforementioned fertilization microdevices are 
designed with controlled width/depth/height of microwells or channels tailored 




Fig. B.4 A) First microfluidic channel used to culture mammalian embryos.
33,34 
 
Microchannels are problematic with regard to cell access and consistent recovery. B) 
First microfluidic platform using microfunnels formed in PDMS with actively 
controlled media flow via use of Braille pin actuators for culture of mouse embryos 
that was shown to improve implantation and live birth outcomes.
45,47
 C) Modified 
microfunnel platform made of polystyrene to permit automated media flow suitable 
for clinical use.
48
 The microfunnel design for embryo culture provided ease of access 
to the embryo for clinical purposes, while maintaining effective fluidic stimulation for 




Fig. B.5 A) Microfluidic platform used for endometrial co-culture of mouse and 
human embryos.
40,41
 B) Alternate microfluidic device using a microporous membrane 
to separate mouse embryos during co-culture with endometrial cells.
43
 Both devices 
have porous membranes as an essential part of design. However, within the field of 
IVF, there has been a movement away from co-culture towards use of more define 




 Fig. B.6 A) Microfluidic device used to optimize cryoprotectant exposure schemes 
for oocytes by measuring volume changes.
66
 Serpentine channels were used to 
effectively mix two solutions of temporally changing flow rates to produce a gradual 
cryoprotectant exposure scheme. A valving mechanism was also introduced to lock 
the oocyte inside the analysis chamber during flow. B) Alternate device used to 




Fig. B.7 A) Microfluidic device used to analyze embryo metabolism.
82
 External 
tubing used for pneumatics or syringe driven inlets can be cumbersome and 
problematic for clinical application B) Microfluidic device used to culture embryos, 
while simultaneously permitting assessment of glucose utilization as a means of non-
invasive embryo assessment on the same device.
81
 Clinical usability is preserved by 
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Microfluidic Automation Using Elastomeric Valves and Droplets: Reducing 
Reliance on External Controllers 
 
This paper gives an overview of elastomeric valve- and droplet-based microfluidic 
systems designed to minimize the need of external pressure to control fluid flow. This 
Concept article introduces the working principle of representative components in 
these devices along with relevant biochemical applications. This is followed by 
providing a perspective on the roles of different microfluidic valves and systems 
through comparison of their similarities and differences with transistors (valves) and 
systems in microelectronics. Despite some physical limitation of drawing analogies 
from electronic circuits, automated microfluidic circuit design can gain insights from 
electronic circuits to minimize external control units, while implementing high-
complexity and high-throughput analysis. 
 
C.1 Introduction 
Two key features of microfluidics are small volumes and fluid flows. These two traits 
give rise to many compelling advantages for microfluidic bioassays such as: reduced 
reagent use, rapid mixing for reactions and assays, rapid serial analysis such as in 
droplet microfluidics, spatio-temporal micropatterning of biochemical for cellular 
analysis, and recreating physiological fluid mechanical microenvironments.
1–4
 These 
benefits and well-established microfabrication technology make microfluidic devices 
promising for high-throughput and complex analysis. Accordingly, microfluidic 
209 
 
devices are becoming increasingly sophisticated, integrating increasingly larger 
numbers of passive components such as channels and chambers as well as 
components that need active control such as valves and regulators. While the cost 
associated with increasing the number of microfluidic component features in these 
complex devices is small, the cost associated with increasing the number of the 
external control units to operate the microfluidic components is still large because 
even single external pressure control units such as a pump is relatively expensive. 
With increased recognition of this control-challenge that hampers broader use of 
microfluidic devices for high-throughput and high-complexity analysis, microfluidic 
engineers are searching for new ways to enable sophisticated on-chip control without 
increasing the number of large external controllers. 
In this Concept paper, we focus on schemes to minimize the use of off-
chip mechanical pressure controllers in elastomeric valve and droplet microfluidic 
devices for high-throughput analysis. Other microfluidic control schemes also have 
the potential to minimize mechanical pressure controllers: Interested readers can find 




 and microfluidic 
control using viscoelastic polymer solutions.
7
 On the other hand, digital microfluidics 
by electrowetting
8
 and electrokinetic flows
9
 are excluded because their flows are 
directly controlled by electricity. Also, we exclude fluidic automation schemes using 
pipetting robots
10
 because they extensively rely on external controllers. In Section 2, 
we explain the history of fluidic automation. Section 3 introduces the working 
principles of elastomeric valve circuits along with their biochemical applications. 
Section 4 presents droplet circuits focusing on key functions for autonomous rapid 
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serial processing. To conclude, in Section 5, we discuss the outlook for design of 
more sophisticated automated microfluidic circuits in the near future. 
 
C.2 History of Macroscale Fluidic Control 
The history of automatic fluidic control can be traced to the legendary water clock, 
which was made by Ctesibius (around 250 BC), a Greek physicist and inventor.
11
 His 
clock was operated by a self-regulating water supply similar to the mechanism for 
flushing toilets nowadays. More recently, in the 1800s to early 1900s, pneumatic 
systems, or vacuum- and compressed-air-based fluidic systems, became a major 
mechanism for the operation and control of machinery (Fig C.1). We see remnants of 
these control systems even today in the pneumatic tube system used to transport light 




Interestingly in the 1950s and 60s, during the transient time from pneumatic to solid-
state electronic control circuitry, there was very active development of fluidic logic 
circuits and they can be classified into three categories: (i) high Reynolds number 
flow-driven fluid logic (HRFL), (ii) pneumatic logic, and (iii) hydraulic control. 
HRFL refers to technology that takes advantage of a jet of fluid (air or water) having 
high Reynolds number to create logic elements that have no moving parts.
13
 A jet of 
fluid is to be deflected by a side-striking control jet, resulting in non-linear 
amplification and other logic operations. On the other hand, pneumatic logic 
particularly refers to high pressure, low mass flow, on/off control systems that utilize 
millimeter to centimeter scale pneumatically actuated valves. Pneumatic logic is 
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different from HRFL in that it has pressure-actuated moving solid parts. The 
pneumatic logic systems are highly reliable and are still used today in specialized 
control settings where compressed air is the only energy source available, the danger 
of spark generation exists, or high concentration of dust/moisture is 
present.
13
 Hydraulic control circuits also exist. Despite their long time delays and 
requirement for high operating pressures, they offer higher accuracy in delivering 
force and are still used today in systems such as the braking system of cars.
14
 
As electronic components became more readily available, many of the fluidic controls 
were replaced by electronics. This transition accelerated with the development of 
solid-state “electronic valves”—more commonly known today as transistors—and the 
commercial rollout of integrated microelectronic circuits in the 1960s. Fluid logic 
devices normally cannot compete with their electronic counterpart because the size 
and the speed of electronic logic circuits are far more advantageous. With the 
increased use of microfluidics for biomolecular studies, however, the need for fluidic 
controls with minimal external units has also increased, leading to a renewed interest 
in fluidic components analogous to electronic circuits. Recently, use of a viscoelastic 
polymer solution, flux stabilizer, a bistable flip-flop memory, and flow rectifier have 
been implemented.
7
 It is important to realize that these and other microfluidic circuits 
developed recently are very different in size and operating mechanism from the 
millimeter to macroscale fluidic logic systems investigated decades ago. Much of the 
difference arises due to use of smaller channel sizes and in some cases also to 
introduction of mechanically compliant materials for device construction. Key 
considerations for operation of these newer generations of microfluidic devices 
include: (i) elasticity of the material, (ii) viscosity, and (iii) interfacial phenomena of 
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fluids. In the next sections, we present elastomeric-valve-utilizing and droplet-based 
microfluidic devices that take advantage of these features. Elastomeric microfluidic 
devices extensively use the first two properties and droplet devices exploit the last 
two. 
 
C.3 Advent of Elastomeric Microfluidic Devices 
Because of the great success of microelectronics, size similarity in terms of being 
miniaturized, and electrohydraulic analogies, electronic circuits have inspired much of 
what is developed in microfluidics. With only a power source, an electronic circuit 





 Such functions are enabled by the smart arrangement of electronic 
transistors, resistors, and capacitors, which are the key components of electronic 
circuits. Notably, an interesting analogy exits between electric and microfluidic 
parameters: voltage corresponds to pressure and current to flow rate. Owing to the 
similarity in equations between electric/electronic and microfluidic components, 
electric resistors correspond to microfluidic channels having fluids, capacitors to 
chambers having elastomeric membranes, and electronic transistors to elastomeric 
valves. 
Such elastic property of microfluidic components comes from polydimethylsiloxane 
(PDMS, Young's modulus of ∼1 MPa),17 a widely used material for soft lithography 
that is to make microstructures by molding. Owing to its moderately stiff elastic 
property, microfluidic valves and capacitors containing PDMS membranes have 
appropriate operational pressure-ranges for microfluidic devices. Elastomeric valves 
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are suitable for parallel processing of biochemicals, thereby implementing high-
throughput analysis. Some of the applications like digital polymerase chain reaction 
(PCR)
18
 need only one control source because all valves are on/off simultaneously. In 
many cases, however, valves should be controlled individually for sequential 
processes; thus typically requiring many control lines and sources. In this section, for 
the minimal external control, we introduce microfluidic analogues of electronic 
components, present their working principle, and show related biochemical 
applications. 
Key Components 
Multiplexer and Demultiplexer 
A multiplexer is a component that selects one out of many possible inputs and 
connects that input to a single output. Control lines regulate the selection process and 
the number of external controllers can be significantly reduced through a smart 
arrangement of control lines. Fig. C.2A depicts the process of how one out of 4 input 
channels is selected by the manipulation of 4 control channels in a binary 
multiplexer.
19
 The vertical lines are flow input channels (Ii) transferring input liquids 
and the horizontal lines are control channels (Ci) containing hydraulic rectangular 
membrane valves. As shown in the cross-section of the multiplexer valve (Fig. C.2A), 
Ii is formed under membrane valves of Ci.
20
 Note that a particular valve (shown in 
squares of the right panel) is considered “on” when it is open with regards to flow 
through Ii. Two Ci constitute one bit. Note that, in each bit, on-off states of valves in 
the two Ci are opposite; for example, in bit 0, when valves in C1are on, valves in 
C2 are off. Thus, each bit has only two states (state 0 and 1); for instance, in bit 0, 
state 0 is valves-off in C1 and valves-on in C2 and state 1 is C2 off and C1 on. Fig. 
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C.2A shows bit 0 and 1 are both in state 1 so I3 is selected to be output (i.e., 1 × 2
0
 + 1 
× 2
1
 = 3). Because of this binary characteristic and a smart arrangement of 
valves, n control lines (or n/2 bits) can regulate up to 2n/2 flow channels. A greater 
saving of the control lines can be achieved by using a ternary, a quaternary, and a 
combinatory multiplexer that can regulate up to 3n/2, 4n/2, and n!/((n/2)!)
2
 flow 
channels, respectively, with n control lines (or n/2 bits).
21, 22 
The efficiency of the 
multiplexers is summarized in Fig. C.2B. 
Compared to the multiplexer, a demultiplexer functions conversely. That is, it 
connects a single input channel to a selected output channel out of multiple possible 
outlets; thus working as an output selector. As a result, input and output channels in a 
demultiplexer are simply reversed from that of a multiplexer.
23
 Even with the use of 
multiplexers and demultiplexers, multiple control sources are still necessary to 
address many flow channels individually. Additionally, only 1 input or output can be 
selected at a time making this type of control unsuitable for some applications. In the 
next section, we show that logic gates in combination with multiplexers and 
demultiplexers have potential to save more control line resources. 
Logic Gates for Boolean Operations 
Logic gates are components that implements Boolean functions such as AND, OR, 
NOT, and XNOR operations.
24
 They are the elementary building blocks of digital 
circuits. The power of digital circuits is that more complex components like shift 
registers can be implemented by cascading logic gates, theoretically enabling the 
control of unlimited number of outputs with a set small number of control signal 
inputs. Both pneumatic and hydraulic logic systems have been implemented 
microfluidically. Both logic systems have the capability to control a biochemical 
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analysis unit when the logic systems and the analysis unit are monolithically 
integrated in a device. 
A key element of the microfluidic pneumatic logic (i.e., channels are filled with air or 
vacuum) is a normally closed (NC) valve. The NC valve is analogous to a p-channel 
enhanced mode MOSFET in that the valve has three terminals (gate, source, and drain) 
and the closed valve is on only when the source minus gate pressure is greater than 
some value (threshold pressure).
25
 As shown in Fig. C.3A, source and drain terminals 
are in the same plane (see left panel or black areas of right panel), but there is a valve 
seat between them (left panel); the gate terminal is the only access port to the bottom 
chamber (gray area of right panel) that is under the membrane, the gray line is 
connected to the gate, and the black lines are linked to source and drain. NC valves 
can directly be pneumatic NOT gates
26, 27
 depending on their pressure connections. As 
shown in the right panel of Fig. C.3A, gate is used as an input (I1), and drain is 
connected to control (C1) at a constant vacuum and to output (O1) channel. We define 
positive and vacuum pressures as state 0 and 1, respectively. When the pressure of 
I1 is positive (state 0, i.e., pushing membrane upward), NC valves is off (closed), 
making O1 at vacuum (state 1). On the other hand, when I1 channel is at high vacuum 
(state 1), NC valve is on (open) because source pressure is higher than gate pressure 
(i.e., pushing membrane downward). At that moment, because fluidic resistance in 
C1 is designed to be greater than that in O1 channel, air dominantly flows to 
O1 channel thus making the pressure of O1 positive (state 0). As a result, pressure 
states of I1 and O1 (= 11) are always opposite; thus making the unit an analogue of the 
electronic NOT gate. 
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The more logic units are cascaded, the more sophisticated a system can be 
implemented. For example, two NOT gates can make a gated D latch (Fig. C.3B) and 
its behavior is illustrated in Fig. C.3C. In contrast to a single NOT gate, I1 is 
connected to the source terminal of a valve. As long as clock pulse (E) is in state 1 
(i.e., the valve is on for I1), O1 follows I1 because O1 is directly connected to I1through 
the valve controlled by E. Note that even after E is in state 0, O1 maintains (i.e., 
latches) the original I1 state when E is in state 1. This is because, as shown in Fig. 
C.3B, O1 and O1 bar can retain their original states when the valve controlled by E is 
off. As such, cascading structures with 23 NOT gates can be made to constitute a 4-bit 
shift register, which can decode the sequential inputs from a single port into 4 parallel 
output ports.
26
 When a shift register's outputs are connected to the control lines of a 
multiplexer, the outputs can regulate the control lines. Theoretically, by increasing the 
number of bits a shift register can handle, an arbitrarily large number of control lines 
can thus be regulated using the same number of external control units. 
The basic building block of the hydraulic logic gates (i.e., channels are filled with 
liquids) is a normally open (NO) valve; it is analogous to an electronic p-channel 
junction gate field-effect transistor and makes a pressure gain.
28
 Note that definition 
of state in hydraulic logic is the opposite of that in the pneumatic logic just described. 
That is, high pressure (∼100 kPa) and atmospheric pressure are state 1 and 0, 
respectively. Fig. C.3D shows an AND gate; dark gray, light gray, and black lines in 
the right bottom panel are bottom, middle, and top channels, respectively; and when 
gate pressure is high (state 1), the membrane containing a stiff disk (marked in white 
of left bottom panel) deflects upward and flow from the top to middle channel is 
prevented (valve-off). Control line C1 is always at high pressure and C2is at 
217 
 
atmospheric pressure. Only when the two inputs (I1 and I2) are both at high pressures 
(state 1), thus closing the two NO valves (off), does the output also take on state 1. 
The OR gate can be defined in a similar way (Fig. C.3E). A static latch consists of 
two OR and one AND gate (Fig. C.3F). Here the state of each input or output (I1, E, 
or O1) is similar to that of the pneumatic latch (Fig. C.3C). The difference is that the 
hydraulic static latch needs two clock inputs (E and E bar) but have one output (O1). 
The advantage of the hydraulic logic over the pneumatic logic is that it prevents 
potential bubble formation due to the lack of a vacuum line and latching times can be 
permanent. However, as the hydraulic logic system serially cascades more logic gates, 
it suffers significant pressure drops compared to pneumatic logic because viscosity of 
water is two orders of magnitude greater than that of air. 
Constant-Input-Driven Oscillators 
A constant-input-driven oscillator is a device that converts constant input (flow or 
pressure) to an oscillatory output flow. Because the device does not need dynamic 
external control units such as solenoid valves, it can simplify the need of off-chip 
control units. The generated output can be used as an on-chip timing source for 
microfluidic logic gates. Also, when a biochemical solution is used as an input, the 
output itself can be used to directly manipulate biomolecules. To date, constant flow- 
and pressure-driven oscillators have been presented. 
A constant-flow-driven oscillator uses NC valves, which are analogous to p-type 
metal-oxide-semiconductor field-effect transistors (pMOSFETs), as a key 
element.
29, 30
 Fig. C.4A shows how the drain and gate terminals of two NC valves (the 
NC valve structure is shown in Fig. C.3A) are connected to each other to make the 
two valves alternate on-off states with an opposite phase to each other. This happens 
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because when the difference between the source and gate pressure surpasses a 
threshold pressure causing a valve to open and release its pressure, the flow output 
increases the gate pressure in the other valve causing it to close. Then, owing to the 
constant inflow, the pressure in the newly closed valve accumulates until the pressure 
surpasses a threshold value at which point the valve opens increasing the gate 
pressure in the other valve and closing it. In this way, the two valves open and close 
alternately. To control the duty cycle of the outflow, the opening width (wo) of the 
two valves can be made asymmetric. This geometrical difference in the valve design 
changes the threshold pressure of opening for each valve. This in turn causes the 
pressure accumulation time of the two valves to become different, thereby changing 
the duty cycle or the relative duration that each valve is on.
30
 
A constant-pressure-driven oscillator uses a free-standing flexible disk (Fig. C.4B).
31
 
Because the disk edge is not bonded to the device, flow passes through the disc edge 
when the disc deflects. Significant inertial force of flow initiates at a high-pressure 
input (70 kPa) and, by the interaction of the elastic force of the disk, vibration of the 
disk occurs, thereby oscillating the outflow (∼100 Hz at the order of 1 mL/min flow 
rates). Another constant-pressure-driven oscillator is a pneumatic ring resonator, 
which uses cascaded odd numbers of NOT gates using NC valves.
32
 The drains of the 
valves are connected to a common atmospheric pressure and the other gate terminal. 
Because of the pressure condition and the internal capacitance of each valve, the 
membranes (or drain pressures) of the valves oscillate alternately and the frequency 
range is reported at 1–100 Hz. The ring oscillator is used as an on-chip timing source 
for a finite-state machine capable of sequential metering, mixing, and flushing.
33
 The 
operating oscillation frequency of two constant-pressure-driven oscillators are fast 
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(∼100 Hz) compared to that of the constant-flow-driven oscillators (< ∼ 1 Hz). It is 
because these pressure-driven oscillators either have very high operational pressure 
ranges owing to utilization of inertial effects
31
 or use air
32
 that gives rise to much 
lower fluidic resistance than that of water. 
Other Useful Components 
A device that controls the flow-rate ratio of two outflows using a single periodic 
pressure source has been described.
34
 In this device, two flow channels merge at the 
outlet and each flow channel has two membrane fluidic capacitors serially connected 
through fluidic resistors and a NC valve. In each flow channel, a combination of two 
capacitors work as a bi-directional pump at a specific range of pressure excitation 
frequency because the second capacitor functions like a bandpass filter. The 
frequency range can be tuned by the product of capacitance and resistance in the 
channel. The NC valve changes the bi-directional flow into a uni-directional flow 
because the gate is at atmospheric reference pressure and source pressure of the valve 
alternates between positive and negative values. As a result, when two channels have 
different ranges of working excitation pressure frequency, the flow-rate ratio of the 
two outflows is controlled by the excitation frequency. 
Another interesting component is a peristaltic micropump, which uses a single 
periodic pressure source.
35
 The device has different size, quasi NC valves connected 
in series through source and drain terminals, and the gate terminals are linked to each 
other. The smaller valves have faster response times owing to the small, internal 
membrane capacitance. Because the size of the connected valve increases (or 
decreases) along the flow direction, the valves close sequentially by the arrival of a 




To date, compelling biochemical applications using microfluidic logic gates, 
oscillators, frequency-specific flow controllers are not reported. This may be because 
such components are at a primitive stage and they have limited operational ranges and 
flexibility compared to those extensively depending on external controllers. On the 
other hand, with the combination of external controllers, microfluidic multiplexers 
using elastomeric valves have been widely used for the parallel processing of 
biochemicals. An initial compelling application of the multiplexers was protein 
crystallization.
36, 37
 For crystallization, metering and mixing of reagents while keeping 
a constant nL-scale reaction-volume are essential.
36
 Owing to the microscale of the 
devices' chamber, the assay can highly concentrate precise amounts of target 
molecules and can mix reagents rapidly; more recently, these advantages have also 
been utilized in the study of protein binding kinetics.
38, 39
 Compared to the crystal 
growth of conventional microbatch and hanging-drop formats, the device 
implemented faster growth and higher hit rate of crystals. The device also measured 
phase behavior of xylanase crystallization systematically (Fig. C.5A-D).
37
 Two 4-bit 
binary multiplexer arrays (Fig. C.5A) select one of 16 reagents and 16 buffers 
separately, thereby enabling 144 parallel chemical reactions. The selected solutions 
are metered and injected as consecutive slugs (∼80 pL each) through a positive 
displacement cross-injection junction (Fig. C.5B) into the ring structure (Fig. C.5C) 
and then mixed in less than 3 s (Fig. C.5D). Because such a process is done 




Multiplexers can also be used for cell culture systems: Gomez-Sjoberg et al. 
developed an automated cell culture and screening system that provide arbitrary 
culture media in 96 chambers having 60 nL individual volume.
40
 Composition of the 
media provided through 16 inputs could be changed with high temporal resolution. 
Human primary mesenchymal stem cells (hMSCs) were cultured for weeks to 
examine effects of osteogenic stimulation on differentiation, proliferation, and cell 
motility. Multiplexers can also be applied to other cell applications such as a single-
cell analysis
41–43
 and arrayed cell analysis.
44, 45
 In single-cell analysis, each cell is 
seeded in parallel multiple chambers individually and its response is individually 
analyzed; thus enabling cyclopedic data collections. For detection of target 
intracellular materials such as DNA or mRNA, they are extracted and their 




C.4 Droplet Circuits 
Droplet circuits are appropriate for rapid serial processing of biochemicals because 
the droplet generation frequency can be over a kHz and subsequent droplet processing 
and analysis can also be rapidly performed. Many factors affect generation of 
droplets.
46
 Important factors are size and shape of channel junctions, viscosity of 
immiscible phases, interfacial tension between phases and channel walls. For example, 
between two phases, a less viscous phase tends to be droplets such as air droplets in 
water and water droplets in oil. Typically, high interfacial tension between two phases 
is necessary for spontaneous droplet formation; to make droplets in two phases that 
have low interfacial tension like aqueous two-phase system, additional mechanical 
perturbations are necessary.
47, 48
 Also, like water (or oil) droplets in a hydrophobic (or 
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hydrophilic) channel, a relatively less wettable channel with respect to the phase that 
forms the droplets is necessary. After the generation of droplets, other serially 
connected components perform key functions. In this section, we introduce key 
functions of droplet circuits. Although some of the functions are not directly 
analogous to that of electronic circuits, the overall system is inspired by electronic 
circuits in that the modularity of each component is essential for the serial processing. 
We briefly discuss their working principle and show how they are used in the overall 
system for rapid biochemical processing. 
Key Components 
Droplet Sorter, Mixer, and Splitter 
Passive sorting mechanisms are based on droplet size and weight. Sorting of different 
size droplets can use channel geometry that vary the ratio of shear forces.
49
 When a 
droplet meets bifurcating channels, it flows into a branch with a relatively high shear 
force because the force drives the droplet into the branch instantaneously. Small 
droplets select low-resistance channel because higher flow rate of the channel results 
in high shear force (left panels of Fig. C.6A). On the other hand, with increasing 
droplet size, the droplet gets higher shear force toward the high-resistance channel 
because droplet's effective area to that direction increases. Accordingly, large droplet 
flows into the high-resistance channel (right panels of Fig. C.6A). A device using 
gravity also works for sorting of the droplets having different size and 
weight.
50
 Despite its simplicity and high efficiency, the device requires relatively 
small sample velocities to allow gravity to take effect over designed flow distances 
(sedimentation of ∼200 μm over 2.5 cm in channel length at 1 mL/h sample velocity). 
Droplet sorting is also achieved via electric fields that generate a force to steer 
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droplets into branching downstream channels depending on its fluorescence 
output,
51
 and complex traffic operations were achieved with droplet sorting into five 
individual channels.
52
 In addition, passive droplet rearrangement can be achieved with 
a channel loop design.
53
 For example, a droplet traveling in series ABCDE can be 
rearranged to be ACDBE through the change of flow resistance in channels. 
At high interfacial tension, droplet fusion will occur spontaneously with channel 
geometry
54, 55
 between the two droplets containing different reactants (Fig. C.6B). 
Further rapid mixing (∼2 ms) is achieved through chaotic advection through a long 
serpentine channel (Fig. C.6C).
56
 Using bifurcating channels or T channels, a passive 
splitter makes a monodisperse mother droplet into evenly split two sister 
droplets.
57
 The ratio of droplet volume splitting is roughly equal to daughter channel 
length ratio or inversely proportional to the daughter channel flow rate. This process 
can be repeated numerously in series achieve the desired droplet number or droplet 
size for both single and double emulsions (Fig. C.6D).
58
 Droplets can also be actively 
split or mixed repeatedly via electrofusion,
59
 one that is advantageous for mixing 
droplets at low interfacial tensions. Although active forms of droplet operations are 
capable of complex droplet manipulations,
60
 external control technologies have yet to 
produce droplet operations at the rate of flow-focusing droplet generation. 
Another recent passive operation is the passive droplet dilutor. This technique is 
capable of high-throughput dilution and screening of nanoliter droplets via a passively 
activated side valve geometric design
61
 (pillar structures of Fig. C.6E). A large droplet 
is trapped in a dilution chamber and forms the mother droplet containing contents to 
be diluted. Subsequent input droplets contain the diluent that fuses with the mother 
droplet, thus diluting the mother droplet. The increased volume of the mother droplet 
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closes the side valve, and shear force to the downward channel increases thereby 
generating output droplet from the mother droplet until the side valve is re-opened. As 
this process repeats, concentrations of mother and output droplets are significantly 
diluted with high precision. 
Traffic Control via Boolean Operations, Flip-Flop Switching, and 
Synchronization 
Other droplet microfluidic analogues of electronic circuits such as logic gates, 
switches, and synchronizers make elegant use of channel geometry (Fig. C.6F).
62
 The 
existence of a droplet affect the flow of the other droplet, thereby enabling Boolean 
functions. The working principle is similar to the passive sorter in that designed flow 
resistance and shear force govern the traffic of the droplets, thus implementing 
embedded functions. Further characterization of the synchronizer geometry was 
studied by Ahn et al.
63
 and is useful for synchronizing droplets for downstream 
droplet fusion. In the synchronizer, the leading droplet experiences higher resistance 
than the lagging droplet, allowing for the lagging droplet to have higher velocity and 
catch up. When the droplets are synchronized, the pressures differences stabilize and 
the droplets exit the ladder network synchronized and traveling at the same velocity. 
Biochemical Applications 
Droplet microfluidics is well suited for the applications that require rapid analysis 
such as high-throughput single-cell analysis, protein analysis, and PCR requiring 
ultrafast reaction times. Rapid single-cell analysis can be performed through the 
sequence of single-cell encapsulation, exposure to stimulant of choice via droplet 





 The advantages of such applications are the ability to keep precise 
amounts of reactants separate until the desired conditions are met for them to be 
mixed and after mixing as started, the small diffusion lengths allow for rapid reaction 
times for high-throughput functionality. Through the use of a few simple electrodes, 
complex operations can be performed on protein for a multi-step assay with 
fluorescent readout.
64, 65
 This device greatly simplifies an otherwise laborious 
laboratory protocol at a greatly reduced cost on both operator cost and material costs 
through automation and miniaturization. Similarly through automation and 
miniaturization, droplet microfluidics is capable of performing a commonly used 
technique: PCR with 1.5 million amplifications in parallel at over 99% 
accuracy.
66
 Purified genomic DNA and reactants necessary for PCR are encapsulated 
into droplets at the specified concentrations. Using mostly passive operations and a 
simple electrode for electrofusion, the device enables complex droplet operations and 
droplet fusion to achieve appropriate delivery and mixture of droplet components at 
the correct sequence and conditions for PCR to occur. 
Owing to its relatively simple device geometry, droplet microfluidic devices are 
relatively easy to design, serially cascade, and fabricate. However, the device may be 
inappropriate for applications that need to keep target biomolecules in the droplet 
while removing and changing solutions, and for assays requiring immobilization of 
biomolecules on channel surfaces. Although elastomeric microfluidic devices are 
conceptually more complex and need more expertise to design, they would be more 
suitable for these latter types of applications. 
 
C.5 Outlook and Perspectives 
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Although microfluidic control circuits that are analogues of electronic circuits are in 
their infancy, they have the potential to minimize external control units and to 
perform autonomous, embedded functions. Nevertheless, to make development of 
such electronics-inspired microfluidic circuits more useful, we should understand the 
(i) operational, and (ii) physical limitations behind the analogy. There are many types 
of electronic circuits but some electronic circuit designs may be more appropriate for 
conversion into fluidic circuits than others. Given the nice analogy between electronic 
and microfluidic circuits in terms of designing and analyzing microfluidic circuits, 
what might the analogy provide in terms of fruitful directions for future development? 
In terms of operation, both elastomeric and droplet microfluidic circuits have an 
inherent limitation because, once such devices are fabricated, their functions and 
operational ranges are more restricted than those that extensively use external 
controllers. For example, in the microfluidic oscillator circuit, the input flow rate or 
pressure determines the oscillation period for a given device. In other words, flow rate 
and oscillation period cannot be independently regulated; thus limiting flexibility. 
Also, the range of oscillation periods is narrower compared to those relying on 
external controllers. This also applies to droplet circuits where flow rate in 
conjunction with the bifurcating channel's shape and size determine droplet size and 
its generation frequency. Nevertheless, when specific operational ranges are 
determined and the devices are designed accordingly, they will be useful like 
application-specific integrated circuit (ASIC) chips in electronics. 
Physical limitation exists in elastomeric microfluidic circuits. To perform even 
relatively simple digital functions using Boolean operations, elastomeric valve circuits 
need relatively large number of valves. In the 4-bit shift resistor, ∼60 valves were 
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necessary to convert sequential signals of a single source to 4-bit parallel signals. As 
the number of Boolean operations increase, as required for more sophisticated 
functions, the number of serially connected valves drastically increases due to the 
nature of the modular approach (functional partition by elementary components). In 
electronic circuits, however, this serial/modular approach is plausible. For example, 
the Intel Itanium 2 processor, which is a microprocessor introduced in 2004, has ∼6 × 
10
8
 transistors with each having sizes on the order of ∼100 nm.67Because electrical 
resistance of integrated wires and transistors can be easily regulated, the processor 
performs sophisticated digital computing (Boolean operation) with an acceptable 
internal voltage drop. In contrast, if microfluidic valves were to be fabricated with 
such high density and small size, control of pressure would become a significant issue. 
Threshold pressures of microfluidic valves would be high due to their small, stiff 
membranes. More importantly, the pressure drop would be enormous due to the 
reduced channel size and the serial connection of channels. For instance, a 10-fold 
reduction of channel radius (e.g., 100 to 10 μm) results in a 10
4
-fold increase of flow 
resistance. Also, total resistance linearly increases with the increasing number of 
serially connected channels and valves. Such analysis suggests limits in effectively 
transferring digital circuit design concepts that use Boolean operations to 
microfluidics. 
In this regard, microfluidic circuits may gain more fruitful insights from analog 
electronics, where electric components and transistors give continuous output voltages 





 and frequency-specific flow controller.
34
 Notably, they have 
simpler structures; thus implying easier fabrication and less pressure drop. Also, their 
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own feedback control and continuous output enable their input flows directly to be 
output flows. In contrast, digital microfluidic circuits using Boolean operations are 
designed to indirectly control biochemical solutions.
26–28
 Parallel biochemical 
processing with such analog microfluidic circuits, however, has not been 
demonstrated yet except for a very simple immunoassay.
29
 A clever arrangement of 
microfluidic valves, capacitors, and resistors in conjunction with selection of control 
input would be needed to enable more sophisticated parallel biochemical processing. 
Such devices can be inspired by analog electronics because they perform parallel 
processing with electric resistors, capacitors, and transistors. 
In droplet circuits, on the other hand, a serial/modular approach is plausible and, 
through the approach, droplet circuits have already demonstrated several rapid/serial 
biochemical processing. Because each component of droplet circuits is simple and 
does not suffer high pressure drop, components like droplet generators, splitters, and 
sorters are serially connected without high pressure drops. Nevertheless, despite 
seemingly facile serial modularity, integrating each component can result in 
unexpected issues due to the relatively small actuation forces generated and 
susceptibility to fluctuations and disturbances. By overcoming such obstacles and 
finding good biochemical applications, droplet circuits have become excellent tools 




Fig. C.1 Timeline showing development of macroscopic and microscopic fluidic 





Fig. C.2 Microfluidic multiplexers. A) Binary multiplexer. Horizontal and vertical 
lines are control (Ci) and input (Ii) flow channels, respectively. Cross-sections (AA' 
and BB') of the valves show that control and input liquids are in top and bottom 
channels, respectively, and depict on- and off-states. In each bit, on-off states of 
valves in the upper and lower Ci are opposite; state 1 (or 2) is upper valves off (or on) 
and lower valves on (or off). The diagram shows that bit 0 and 1 are both in state 1 
and thus I3 is selected to be an output. B) Maximum number of controllable flow 




Fig. C.3 Microfluidic logic gates. A) Pneumatic NOT gate. Cross-section of a valve 
shows the valve-on state; source and drain terminals are in the top channel; and a gate 
terminal locates at the bottom channel under the membrane. In the top view of the 
valve, black area is in top channel and gray area is in bottom channel. B) Pneumatic 
gated D latch consisting of NOT gates. C) State of each line in gated D latch. Vacuum 
and atmospheric pressure are defined as state 1 and 0, respectively. D) Hydraulic 
AND gate. Cross-section shows a normally open valve, which has a pressure gain 
with a rigid disk (white bar above gate in left panel); valve is off when gate pressure 
is sufficiently high to deflect the membrane containing the disk upward and to close a 
hole. In the top view of the valves, black, light gray, and dark gray areas are in the top, 
middle, and bottom channels, respectively. E) Hydraulic OR gate. F) Hydraulic static 
latch consisting of AND and OR gates. State of each line coincides that in (C). Note 
that high and low pressures are defined as state 1 and 0, respectively, and it is the 





Fig. C.4 Constant-input-driven microfluidic oscillator. A) Constant-flow-driven 
oscillator. In the two normally closed valves, one valve's drain is connected to the 
other valve's gate, thereby making alternating pressure accumulation and release of 
each valve. Reproduced with permission.
30
 Copyright 2012, American Chemical 
Society. B) Constant-pressure-driven oscillators. Vibration of free-standing, flexible 
disk results in outflow oscillation. Reproduced with permission.
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Fig. C.5 Applications of microfluidic multiplexers. A–D) Optical micrographs of 
“Formulation chip”. E) Large, single, 3D crystals grown directly from optimal screen. 
A–E, reproduced with permission.
37







Fig. C.6 Droplet microfluidic operations. A) Sorting by size. Reproduced with 
permission.
49
 Copyright 2008, Springer. B) Spontaneous fusion. Reproduced with 
permission.
55
 Copyright 2006, Royal Society of Chemistry. C) Mixing by chaotic 
advection. Reproduced.
56
 D) Droplet fission. Reproduced with 
permission.
58
 Copyright 2011, Royal Society of Chemistry. E) Dilution. Reproduced 
with permission.
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 Copyright 2011, Nature Publishing Group. F) Microfluidic 
analogues of electric logic gates. Reproduced with permission.
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Fig. C.7 Droplet microfluidic application flowchart. A) Cell stimulants are 
encapsulated into droplets and stored off chip. B) Stimulants are mixed together or 
with single-cell encapsulated droplets via fusion operations. C) After fusion, the 
droplets can then be recollected and incubated off chip if necessary. D) Droplets are 
once again loaded into a droplet device with fusion operations with separate reagents 
for protein assay. Fluorescence signals can then be acquired downstream after chaotic 
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